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Su m m a r y
Epidemiological evidence has shown that increased levels of respirable particulate air 
pollution leads to adverse cardiorespiratory health effects although the exact 
mechanism of damage is unknown. In the UK the largest single source of respirable 
air particulates is road transport. Currently the background levels of respirable air 
particulates are measured by stationary monitoring stations. However, traffic volumes 
often vary considerably within a city and hotspots of densely trafficked areas may 
give rise to microenvironments with increased respirable particulate levels.
The primary objective of this thesis was to investigate whether a high density of local 
motor traffic would give rise to microenvironments with increased levels of respirable 
air particulates. A selection of streets in Cardiff city were allocated into exposed and 
control group according to traffic volumes. Levels of respirable air particulates were 
measured for each residential location both indoor and outdoor, and individual 
residents provided blood, urine, and hair samples for the analysis of trace elements, 
which may serve as biomarkers of exposure to air particulates from motor vehicles. 
Results showed that for both indoor and outdoor respirable air particulate 
concentrations, the levels were found to be higher in exposed areas than controls, and 
there was a moderately high correlation between indoor and outdoor concentrations. 
However, the study failed to demonstrate any differential uptake of trace elements as 
reflected by the lack of differences in the levels of biomarkers in the biological 
samples of subjects residing in different exposure areas.
A separate study was carried out to investigate whether short-term changes in 
respirable air particulate levels would lead to acute exacerbation of disease symptoms 
in individuals with asthma, chronic respiratory diseases excluding asthma, and 
chronic cardiac diseases. Subjects were recruited through specialist hospital outpatient 
clinics located in South Wales and disease specific questionnaires were sent out 
during different episodes of respirable particulate air pollution. Results showed that 
symptoms of most subjects were not affected by short-term changes in air particulate 
levels, although individuals with more severe asthma and cardiac disease appeared to 
have benefited relatively more from lower levels of respirable air particulates than 
those with less severe disease symptoms as well as those suffering from chronic 
respiratory disease.
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Abstract
A b st r a c t
In the UK levels of respirable air particulates in a city are measured by one or more 
stationary monitoring stations. While this method provided information regarding the 
background levels of respirable air particulates in the sampled area, it did not take into 
account that hotspots of densely trafficked areas may give rise to microenvironments 
with increased respirable particle concentrations. Also, evidence from 
epidemiological studies have shown that short-term increase in the levels of respirable 
particles increased hospital admissions and mortality in compromised individuals 
suffering from chronic cardiorespiratory disease. However, relatively few studies have 
examined the effects of respirable air particulates on disease symptoms in subjects 
from the community.
This thesis was divided into two separate sections. Section 1 investigated the possible 
existence of microenvironments in terms of increased levels of respirable air particles 
caused by local traffic, and its relationship with the levels found in indoors. In 
addition, biomakers of exposure were also analysed to find out whether individuals 
residing in densely trafficked areas would result in higher levels of personal exposure 
and subsequently uptake of respirable air particulates. Section 2 examined the acute 
effects of short-term changes in the levels of respirable particulate air pollution on 
disease symptoms in individuals with chronic cardiorespiratory disease, using air 
quality data from stationary monitoring stations.
Methods: Section 1
Streets from heavily trafficked areas and from sub-urban areas with minimal traffic 
were chosen from the city of Cardiff and assigned to the exposed group and the 
control group respectively. Recruitment of subjects was carried out by sending letters 
to all houses in the target streets, and a permanent male resident aged 50-70yrs was 
selected from each participating household. A total of 123 individuals took part in the 
study, of which 73 were from the exposed group and 50 were from the control group. 
Indoor and outdoor levels of air particles were measured on the same occasion and 
biological samples including blood, hair, and urine were collected and analysed to 
study the uptake of biomarkers that may be related to exposure to respirable particles 
from motor vehicles.
Abstract
Methods: Section 2
Individuals with asthma, chronic respiratory disease excluding asthma, and chronic 
cardiac disease were recruited via specialist hospital outpatient clinics in South Wales. 
Daily levels of particulate pollution were monitored throughout the 12-month study 
period through databases accessible via the Internet. Disease specific questionnaires 
were sent out on four separate occasions subsequent to episodes of high and normal 
particulate air pollution. Each questionnaire contained items extracted form validated 
instruments that focused on changes in symptoms, medication use, and emotional 
well-being. Each answer given by the subjects corresponded to a “symptoms score” 
and from this the magnitudes of changes in symptoms between high and normal 
pollution episodes were calculated.
Results: Section 1
Mean levels of outdoor air particulates between exposed and control groups were 
compared and tested by Independent-Samples T-Test, and the difference in median 
indoor levels was tested by Mann-Whiney test. In addition the relationship between 
indoor and outdoor particulate levels were also examined by calculating the 
correlation coefficient. Levels of exposure markers to motor traffic measured in 
biological samples provided by individual subjects were compared and the differences 
in medians were tested by Mann-Whitney test. The presence of a dose-response 
relationship was also investigated by sub-dividing the exposed group into high and 
medium exposure groups. Results showed that the mean outdoor level of respirable air 
particulates was approximately 50% higher in the exposed group than the controls 
(17.5pg/m3 v 11.8pg/m3), and the median indoor level was approximately 40% higher
' X  ' Xin the exposed group than the controls (13.2pg/m v 9.4pg/m ). There was a 
significant correlation between the levels of indoor and outdoor respirable particles (r 
= 0.64; p<0.01). However, no differential uptake of biomarkers that may be associated 
with motor traffic were found in any of the biological samples collected.
Results: Section 2
Answers of all items in the questionnaires given by each subject were converted into 
symptoms score. Means of symptoms score were calculated for all asthma 
questionnaires and the differences observed were expressed as the percentage of net
Abstract
change. Because neither means nor medians could be calculated for both the cardiac 
and respiratory questionnaires, changes in symptoms score were evaluated by 
calculating the percentage of net changes, and changes in symptoms score at 
individual levels were also examined graphically. A sub-group of patients classified 
as more severe cases were chosen to find out if short-term changes in particulate 
levels will differentially affect individuals with more severe symptoms. Results 
showed that while most subjects had reported no changes in symptoms score between 
episodes of high and normal pollution levels, individuals suffering from more severe 
asthma and cardiac symptoms in overall obtained higher symptoms scores on 
occasions when particle concentrations were normal. In contrast, subjects with 
chronic respiratory disease had obtained low symptoms score throughout the study 
that were not greatly influenced by the levels of air pollution.
Conclusions: Section 1
Evidence obtained in the study showed that microenvironments exist within a city, 
based on the observation that higher levels of respirable particles were found in areas 
where traffic volume was high. The moderately high correlation between indoor and 
outdoor particle concentrations suggested that particles generated from motor vehicles 
outside entered the indoor environment, meaning exposure to respirable particles was 
higher in subjects residing within proximity to motor traffic. However, the study did 
not find any evidence of human uptake of exposure biomarkers, as reflected by the 
null findings that none of the levels of biomarkers measured in biological samples 
varied between different exposure groups.
Conclusions: Section 2
Results showed that the majority of patients in the study reported no changes in 
disease symptoms between episodes of high and normal respirable particulate air 
pollution. However, a subgroup of asthma and cardiac patients who suffered from 
more severe disease symptoms appeared to be more vulnerable to short-term increase 
in respirable particle concentrations, as reflected by the exacerbation of their disease 
symptoms during episodes of high pollution level. In contrast, symptoms reported by 
individuals suffering from chronic respiratory disease were generally worse than those 
with asthma and cardiac disease, and short-term changes in particle levels seem to 
have little effects on their respiratory symptoms.
Aikts & Objectives
A im s  a n d  O b je c t iv e s
This thesis aimed primarily to investigate whether the levels of respirable air 
particulates vary within a city due to differences in local traffic volumes, and whether 
for individuals residing in proximity to dense traffic there was evidence of personal 
uptake of markers of air particulates associated with motor vehicles. Three objectives 
relating to this aim were:
1. To measure the levels of respirable air particulates in outdoor environments in 
areas with different traffic flow to investigate the possible existence of 
microenvironments in terms of increased levels of respirable air particulates 
emitted from local traffic.
2. To investigate whether indoor levels of particles were associated with the 
outdoor particle concentrations.
3. To examine whether individuals residing in densely trafficked 
microenvironments show evidence of increased biomarkers of such exposure.
A separate study examined whether short-term changes in the levels of respirable 
particulate air pollution, as measured by stationary air quality monitoring stations, 
would lead to acute exacerbations of disease symptoms in chronically ill individuals. 
The objectives of this study were to detect any changes in an individual’s disease 
symptoms, medication use, and emotional well-being between episodes of high and 
normal pollution, using questionnaires that were specific to asthma, chronic 
respiratory disease excluding asthma, and chronic cardiac disease.
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Chapter 1 Introduction
C h a p t e r  1 - In t r o d u c t io n  
E n v ir o n m e n t a l  A ir  P o l l u t io n
1.1 History of air pollution and pollution control in the UK
The industrial revolution in the late 18th century and early 19th century brought major 
technological, socio-economic and cultural changes to Europe. Production was 
increased significantly through the use of fossil fuels as energy sources, but at the 
same time also brought in a new problem - air pollution. Large numbers of factories 
built within cities attracted workers and cities became densely populated. Soot and 
toxic gases from factory chimneys and residential burning of solid fuel for cooking 
and heating severely polluted the atmosphere.
In the last half of the twentieth century, several acute episodes of smog alerted us the 
danger of air pollution and consequently led to the birth of epidemiological research 
on air pollution and the introduction of legislated control strategies. One of the first 
documented episode of air pollution happened in the Mueuse Valley in Belgium 
between 1 December and 5 December 1930. During that period, high levels of sulphur 
dioxide (SO2), sulphuric acid mists, and fluoride gases released from steel mills, coke 
ovens, foundries, and smelters in the region were trapped in the atmosphere by stable 
atmospheric conditions. This led to the death of more than 60 people, which was more 
than 10 times the normal mortality rate of that area [Nemery et al 2001]. Later in the 
United Sates between 27 October and 30 October 1948, an intense meteorological 
inversion settled on the valley of Donora in southwestern Pennsylvania. Fuelled by air 
pollutants released from local industries and coal burning, 20  people died within the 
week and one-third of the population of 14,000 required medical attention [Schrenk et 
al 1949]. The fog of December 1952 in London, or “The Great Smog”, was one of the 
most infamous episodes of air pollution which ever took place and led to the 
premature deaths of thousands of people [Met Office 2005]. The term “smog”, being a 
portmanteau word meaning “fog intensified by smoke” was coined almost half a 
century earlier by HA Des Voeux, who first used it in 1905 to describe the conditions 
of sooty fog that occurred all too often over British urban areas. During the early 
hours on 5 December 1952 nothing was unusual except the cold weather that had 
existed for some weeks. However when nightfall came, a thick layer of fog appeared 
and visibility dropped to a few meters. In central London, the visibility remained
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below 500 meters continuously for 114 hours and below 50 meters continuously for 
48 hours. This fog was triggered by a natural phenomenon called temperature 
inversion, which happens when the night time temperature drops and cold air close to 
the ground is trapped by a layer of warm air above. Normally this can be dispersed by 
the morning sun but in December 1952 the accumulation of smoke close to the ground 
was so great that the sun never broke through. As a result pollutants emitted from 
local industries and residential coal burning were trapped in the atmosphere with the 
stagnant layer of air. This “pea soup-like” yellowish-black colour smog filled with 
black soot, particles, and SO2 stayed for 5 days until 10 December, when eventually 
winds from the west blew it down the Thames Estuary and out into the North Sea. The 
recorded levels of smoke and SO2 in the air were approximately 10 and 12 times 
higher respectively than the normal levels recorded at that period. It was estimated 
that on each day during the foggy period 1,000  tonnes of smoke particles, 2 ,000  
tonnes of carbon dioxide, 140 tonnes of hydrochloric acid and 14 tonnes of fluorine 
compounds were released into the atmosphere. In addition, and perhaps most 
dangerously, 370 tonnes of SO2 were converted into 800 tonnes of sulphuric acid. The 
destruction caused by this episode of smog was devastating -  road, rail, and air 
transport were brought to a stand still and theatre performances had to be cancelled. 
But most importantly the smog had led to a total death toll of 12,000 people and 
caused illness to many others. The majority of the deaths occurred in people suffering 
from chronic respiratory and cardiovascular conditions. In response to this tragedy the 
British government legislated the Clean Air Act in 1956 and produced legislation 
again in 1968. Both were later revised and combined to form the Clean Air Act 1993, 
which covered a number of air pollution control strategies including the control of 
chimney heights, prohibition of dark smoke emission from chimneys and industrial 
premises, as well as the declaration of smoke control areas by local authorities. 
However, air pollution control strategies did not stop here and more legislation and 
regulations were introduced in the coming years as shown in table 1.1. Thanks to the 
introduction of the Clean Air Acts and other legislations on air pollution control, 
emission of pollutants has been largely reduced since the 1952 London Smog. 
Nowadays, episodes of serious air pollution similar to the Great Smog are unlikely to 
occur again in the UK. However in 1991 another episode of London smog took place 
between 12 and 15 December. Although not as severe as the 1952 London smog it 
was still responsible for an estimated 160 excess deaths due to cardiorespiratory
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complications. Because there were no official figures recorded for the non-fatal cases, 
the total effects it caused on human health was unknown. The 1991 London smog was 
a warning sign of the potential damage air pollution can cause despite the 
implementations of active and tightened pollution control strategies.
Motor Vehicles 
Regulation 1973
Regulation of motor vehicles 
constructions and  u sag e
Control o f Air 
Pollution Act 1974
Regulation of m otor fuel com position and 
limited the  sulphur content in fuel oil
Air Quality Standards 
Regulation 1989 EU regulations for air pollutants
Environmental 
Protection Act 1990
Integrated control for significant industrial 
so u rces  of pollution. Inclusion of small 
em ission sou rces  under control by local 
authorities
The Road Vehicle 
Regulation 1991
Inclusion of carbon m onoxide and 
hydrocarbons em issions te s ts  in the MOT 
te st for petrol ca rs  and light goods vehicles
The Environmental Act 1995
To improve local air quality m anagem ents. 
Publication of National S trategy for setting 
air quality s tan d ard s  and  ta rg e ts  for the 
m ost concerned  pollutants
The National Air 
Quality Strategy 1997
Com m itm ents to achieve new  air quality 
objectives in the  UK, reviewed periodically
The National Air Quality 
Strategy for England, 
Scotland, Wales, and 
Northern Ireland
2000
S econd  National Air Quality S trategy 
published with new  air quality objectives 
for local authorities
Table 1.1: List of air pollution control strategies introduced in the UK after the Clean
Air Act 1968.
Since the introduction of the Clean Air Acts and other legislations, the type of 
emissions that caused air pollution has changed considerably. While black smoke and 
SO2 from coal combustion for industrial and domestic usage have been significantly
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reduced, a six-fold increase in road vehicle number between 1955 and 2001 means 
that emissions from the transport sector have huge impact on urban air quality. The 
main pollutants of concern are nitrogen oxides, respirable air particles, carbon 
monoxide, and volatile organic compounds. In addition, despite the use of cleaner fuel 
such as natural gas for power generation, the ever increasing demand in electricity 
usage and the dependence on fossil fuel means that the industrial sector still 
contributes a significant proportion of these air pollutants nowadays.
Each year the National Atmospheric Emission Inventory (NAEI), which is co-funded 
by the Department for Environment, Food and Rural Affairs (DEFRA), The National 
Assembly for Wales, The Scottish Executive, and the Department of Environment, 
Northern Ireland, compiles estimates of annual atmospheric emissions in the UK from 
a wide range of sources including those from the industrial, residential, and road 
transport sectors. These pollutants are divided into various groups including 
greenhouse gases, regional pollutants leading to acid deposition and photochemical 
pollution, persistent organic pollutants and other toxic pollutants such as heavy 
metals. Amongst them, the National Air Quality Strategy (NAQS) has set national 
objective standards under the Environment Act 1995 for several key pollutants 
including benzene, 1,3-butadiene, carbon monoxide, lead, nitrogen dioxide, air 
particulates, sulphur dioxide, and ozone to be met by Dec 2005. For “hotspots” of air 
pollution areas in which air quality standards objectives are unlikely to be achieved by 
the end of 2005, the corresponding local authorities are required to designate Air 
Quality Management Areas (AQMA) and set up an Air Quality Action Plan (AQAP) 
to assess, monitor, and control the air pollution levels in those target areas. The city of 
Cardiff currently has 4 declared AQMA zones dedicated to reduce the levels of 
nitrogen dioxide in accordance to the NAQS objectives.
Levels of air pollutants in the UK are monitored by a network of over 1,300 national 
air quality monitoring stations set up across the country. One hundred and twenty of 
these sites are fully automatic and provide hourly data on several key pollutants of 
interest, while the non-automatic sites measure mean concentrations over a specified 
timeframe which is typically a week or a month. Together they provide invaluable 
information to build a larger picture of the levels and the impacts of air pollution in 
the UK. The type of pollutants being monitored varies from site to site but may
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include one or more of the following: respirable particles, nitrogen dioxide, ozone, 
sulphur dioxide, carbon monoxide, metals, volatile organic compounds and other 
toxic air pollutants.
In the automatic monitoring stations respirable particles are measured by TEOM 
(tapered element oscillating microbalance). Briefly, the TEOM draws air from its 
surrounding environment through a size-specific inlet head onto an oscillating quartz 
tube with a known frequency. Particles present in the air will change the frequency of 
oscillation of the quartz tube, which is proportional to the changes in the mass of the 
particles collected. Air drawn into the TEOM is heated to 50°C in order to remove 
water vapour which may confound the result. Inevitably, this causes the loss of some 
volatile compounds which are often attached on particle surfaces. Gaseous pollutants 
are measured by optical methods such as ultraviolet (UV) and infrared (IR).
1.2 Common air pollutants
This section summaries some of the most commonly seen air pollutants in the UK, 
together with their physical/chemical properties, effects on the environment/human 
health, and emission sources and trends.
1.2.1 Gaseous pollutants 
Carbon Monoxide
Carbon monoxide (CO) is a colourless and odourless gas formed from incomplete 
fuel-combustion and is of concern mainly because of its effect on human health and 
its role in tropospheric ozone formation. CO is a very dangerous gas because once 
breathed in it reacts strongly with the oxygen-carrying protein haemoglobin, thereby 
preventing oxygen from binding to the red cells and causing oxygen starvation 
throughout the body. Excess inhalation will lead to hypoxic injury, neurological 
damage, and possibly death. Even at low levels CO will result in the decreased 
exercise capacity in individuals with ischaemic heart disease and lead to a lower 
threshold for ischaemia. In the environment, CO indirectly contributes towards the 
formation of tropospheric ozone by reacting with hydroxyl radicals (OH) in the 
atmosphere which would otherwise remove other pollutants in the air. Through
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natural processes in the atmosphere CO is eventually oxidised into carbon dioxide 
(CO2) which is one of the main constituents of greenhouse effects.
Road transport and in particular petrol driven vehicles is the most important source of 
CO in the UK. Despite a slight reduction in CO emission from road transport which 
was seen between 1970 and 1990, and more significantly from the early 1990s, it was 
still the single largest source of CO emission accounting for 59% (1916 kilotonnes) of 
the total UK emission in 2002. Other emission sources of CO are small compared 
with transport, they include industrial (12%) and domestic (7%) fuel combustions, and 
power generation (2%). Overall, CO emission in the UK is decreasing and there was a 
56% reduction observed in 2002 compare with the emission level in 1990, mainly due 
to reduction in emissions from the road transport sector after the introduction of 
catalytic converters.
Nitrogen oxide
The term nitrogen oxide (NOx) is imprecise and can be used to refer to any of the 
oxides of nitrogen. Many of the nitrogen oxides are colourless and odourless. 
However, one common pollutant, nitrogen dioxide (NO2) along with particles in the 
air can often be seen as a reddish-brown layer of smog over many urban areas and 
impair visibility. NOx is also a precursor of acid rain that will contaminate the 
environment and damage plants and buildings. One member of the NOx, Nitrous 
oxide (N2O) is a greenhouse gas that contributes towards global warming. The 
formation of smog by NOx and its association with air particulates can lead to a 
number of adverse health effects including reduction in lung functions, lung tissue 
damage, and worsen symptoms of individuals who suffer from chronic 
cardiorespiratory diseases.
Road transport is the most significant source of NOx, with approximately one-third of 
the emissions deriving from major sections of roads. In 2002, 45% of the total UK 
emission equivalent to 711 megatonnes of NOx was contributed by motor traffic 
alone. Because NOx emission is the greatest when travelling at high speeds, high 
levels of NOx are measured along motorways and major roads. In urban areas, high 
volumes of motor traffic together with residential and commercial combustions 
released a significant amount of NOx into the atmosphere. Power generation is the 
second largest source of NOx in the UK (24% in 2002). Industrial combustion
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contributed approximately 10% to total UK emissions in 2002. Overall, UK emissions 
of NOx have fallen significantly from 2.5 megatonnes to 1.6 megatonnes in 20 0 2 , 
representing a 43% reduction in the 1990 emissions estimate. This was primarily due 
to emission control in the road transport sector and increased use of other fuels for 
power generation.
Sulphur dioxide
Sulphur dioxide (SO2) is a colourless gas with a smell of burning sulphur. High 
concentrations of SO2 can result in temporary breathing impairment for asthmatics 
who are active outdoors. Short-term exposures of asthmatic individuals to elevated 
SO2 levels during moderate activity may result in breathing difficulties that can be 
accompanied by symptoms such as wheezing, chest tightness, or shortness of breath. 
In conjunction with high levels of air particulate it may lead to the exacerbation of 
respiratory and cardiovascular symptoms of susceptible groups.
In the UK the largest contribution to SO2 emissions is from power generation and 
accounted for 68% (680 kilotonnes) of the total emission in 2002. Historically coal 
combustion has been the most important source and estimation of SO2 emissions was 
directly proportional to the sulphur content of coal. The increase in the use of nuclear 
energy and gas for power generation has led to a gradual decline in SO2 emission in 
the UK. Industrial combustion of coal and oil, as well as some refinery processes and 
the production of sulphur-related chemicals contributed 149 kilotonnes (15%) of SO2 
released in 2 0 0 2 . In contrast, SO2 emission from road transport is relatively 
insignificant and accounted for less than 1% of the total emission in 2002. Overall, 
UK emissions of SO2 have fallen from 3.72 megatonnes in 1990 to 1 megatonne in 
2002, representing a decrease of 73%. This was a result of decreasing use of coal in 
favour of cleaner fuel in power generation as well as in the industrial and residential 
sectors.
Tropospheric ozone
Ozone (03) is a gas composed of three oxygen atoms and is a key constituent of the 
troposphere, which is the lowermost portion of the atmosphere where greenhouse 
effect occurs. O3 is not directly emitted by motor vehicles or industrial processes and 
has therefore no significant anthropogenic sources. Instead, it is created by chemical
7
Chapter 1 Introduction
reactions between NOx, CO, and volatile organic compounds in the presence of 
sunlight. Ozone occurs naturally in the stratosphere approximately 10 to 30 miles 
above the earth's surface and forms a layer to absorb biologically harmful ultraviolet 
(UV) radiation from the Sun. However, at ground level ozone contributes towards the 
formation of smog. The health effects of ozone include lung airways irritation, asthma 
exacerbation, reduced lung functions, and increase susceptibility to respiratory 
illnesses such as pneumonia and bronchitis. Repeated exposure to ozone pollution can 
also lead to permanent lung damage.
1.2.2 Volatile organic compounds
Volatile organic compounds (VOC) are organic chemical compounds that have a high 
tendency to evaporate under normal conditions. Examples include aldehydes, ketones, 
and hydrocarbons. Some of the VOC are involved in the formation of ozone and while 
some others are capable of causing adverse health effects in humans such as benzene 
and 1,3-butadiene.
When estimating the national emissions of VOC, NAEI measures methane separately 
from the other members of VOC and as a result they are referred as non-methane 
volatile organic compounds (NMVOC). Unlike SO2 and NOx in which the 
contribution from combustion is much higher, only 22% (284 kilotonnes) of the 
NMVOC emissions arose from combustion sources in 2002. The largest sources of 
NMVOC in the UK were solvent production and solvent use in industrial and 
domestic applications. NMVOC are mainly released from the chemical industry, 
petroleum refining, and food and drink manufacture as well as minor sources such as 
iron and steel production and road construction. Road transport is currently 
responsible for 16% of the national NMVOC emissions, equivalent to 171 kilotonnes 
in 2002. NMVOC emission rate is increased when vehicles are idle or travelling at 
low speed, which is reflected by the higher concentrations of the pollutant in urban 
major roads than on high-speed motorways. Overall, UK emissions of NMVOC have 
decreased from 2.6 megatonnes in 1990 to 1.4 megatonnes in 2002, representing a 
46% reduction. The observed decrease arose primarily from the road transport and 
industrial sectors.
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Benzene
Benzene (CeHe) is classified as VOC and is a colourless flammable liquid with a 
sweet, pleasant smell. It is carcinogenic and has been shown to increase the risk of 
leukaemia development in occupationally exposed individuals [Glass et al 2003] and 
caused DNA damage in animal model [Lee et al 2005, Vestergaard et al 2002].
Benzene is released from petroleum products via combustion and also evaporation 
because it is a component of petrol. The road transport sector is the largest source of 
benzene emission in the UK and accounted for approximately 33% of the 2002 
emission estimate total. At lower speeds motor vehicles release relatively higher 
levels of benzene thus higher emission densities can be found in densely populated 
areas. Benzene escaped during its manufacture and use in the chemical industry is 
also one of the major sources of emission (16% in 2002). Overall, benzene emissions 
have decreased by 75% between 1990 and 2002, giving an emission of 13.5 
kilotonnes in 2002. This was mainly due to the reduced emissions from road transport 
after the introduction of catalytic converters and the decreased content of benzene in 
petrol.
1.3-butadiene
1.3-butadiene (C4H6) is classified as VOC and is a colourless gas with a mildly 
aromatic odour. Its ability to damage DNA means that it is a potent carcinogen, i.e. 
capable of causing cancers, as demonstrated in the increased risks of cancer in both 
occupational exposure studies and animal experiments [EPA 2002]. Having said that, 
the risk of adverse impact caused by the atmospheric concentrations of 1,3-butadiene 
seen in the UK is considered to be acceptably small [NAEI 2004].
Similar to benzene, 1,3-butadiene is released from the combustion of petroleum 
products and its manufacture and use in the chemical industry. However, because 1,3- 
butadiene is not present in petrol but rather a by-product of combustion, it is therefore 
not present in road transport evaporative emissions. In the UK the single largest 
source of 1,3-butadiene is road transport which contributed 75% of the total emission 
in 2002. As with benzene, the introduction of catalytic converters has a significant 
impact on the emissions from the road transport sector. Emission of 1,3-butadiene 
from its manufacture and usage is relatively small (8% in 2 002 ) in contrast to motor
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traffic emissions. Overall, emission of 1,3-butadiene has reduced by 73% between 
1990 and 2002.
Poly cyclic aromatic hydrocarbons
Polycyclic aromatic hydrocarbons (PAH) are organic chemical compounds that 
consist of fused rings formed entirely from carbon and hydrogen. They are classified 
as VOC and are produced from incomplete combustion of carbon-based fuels. There 
are over 100 species of PAH identified and some are known to be carcinogenic in 
nature. A dedicated section on PAH can be found in chapter 1.4.
1.2.3 Heavy metals
Heavy metals are defined as elements between copper and bismuth on the periodic 
table of elements, or more strictly as those metals heavier than the rare earth metals. 
Living organisms require trace amounts of some heavy metals such as copper and zinc 
but excessive levels can cause damage to health. Some heavy metals including 
mercury, lead, and cadmium are not required by living organisms and their 
accumulation in the bodies of mammals can cause serious health issues. The health 
effects of each heavy metal are different. Some are able to cause minor and short-term 
effects such as irritations of the respiratory tract caused by cadmium, copper, and 
selenium. However some can cause severe and long-term health effects such as 
damage to the central nervous system by mercury and lead. In some cases prolonged 
exposure to heavy metals such as arsenic and nickel can also increase the risks of 
cancer. The NAEI currently reports emissions of nine heavy metals in the UK 
including arsenic, cadmium, copper, lead, mercury, nickel, selenium, tin, and zinc. In 
addition to the heavy metals, four other metals including beryllium, chromium, 
manganese, and vanadium are also monitored.
Metal emissions arise from a number of different sources, but in general fuel 
combustion and certain industrial processes that produce dust are the main 
contributors. In the case of combustion, metals are emitted either as vapour or 
particles or both. Volatile metals such as mercury and selenium are mostly emitted as 
vapour. Whereas metals such as cadmium and lead are emitted as both with some of 
the vapour condensing onto ash particles. Other metals such as chromium do not 
vaporise and may be emitted in ash particles. Metal emissions can be reduced by
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cleaning equipment which removes particulates from waste gases. This abatement 
equipment can be fitted to large coal-fired industrial boilers and power station boilers 
and also industrial processes which produce large amounts of dust. Table 1.2 below 
shows the annual national emission estimates of various metals in 2 0 0 2 , and the 
percentage of which were emitted from road transport.
Total UK 
emission 2002 
(tonnes)
Emission from 
road transport
Arsenic 24 0 %
Cadmium 4 .5 4%
<5
Q>
Copper 50 < 1%
Lead 162 1%
S
£<00)ac
Mercury 8 0 %
Nickel 98 1%
Selenium 32 < 1%
Tin* 65 1%
Zinc 583 2 %
£ Beryllium* 15 36%% m 2 45 Chromium 44 .8 < 1%A •
o £ M anganese 232 no d a ta
Vanadium 161 < 1%
* Accuracies on these data are uncertain.
Table 1.2: Estimated metal emissions in the UK, 2002 [NAEI2004].
1.2.4 Particulate matter
Particulate matter (PM) is a complex mixture of extremely small particles or liquid 
droplets. Particulate pollution is made up of a number of components such as acids, 
organic chemicals, metals, and soil or dust particles. Emission sources of air 
particulates are wide and they can be generated naturally such as abrasion, sea salt, 
forest fires, and anthropogenically such as road traffic, power generation, and 
industrial processes. Health effects of air particulates are well documented and there is 
a large amount of evidence relating exposure to elevated levels of air particulates and 
acute exacerbation of cardiorespiratory symptoms, increased medication use as well 
as increased number of deaths. Studies carried out in the United States also
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demonstrated the chronic health effects of long-term exposure to airborne particles 
including cancer.
1.3 Particulate air pollutants
1.3.1 Physical properties and lung deposition of air particulates
Air particulates have diverse physical and chemical properties. These particles are 
typically very small and can be a few nanometers (nm) in diameter to 100 or more 
micrometers (pm). Particles have irregular shapes and their aerodynamic properties 
determine how they are transported in the air and how far they can penetrate into the 
respiratory system. The aerodynamic behaviour is expressed in terms of the diameter 
of an idealised sphere, and the sampling and description of particles are based on their 
aerodynamic diameter. Because the potential for particles to cause health effects is 
related to size, therefore it is important to define the size of the particles that are to be 
measured with a universal standard. One of the standardised methods is the 
International Standard IS 7708 which comprises four main fractions and are 
summarised in table 1.3 below.
IS 7708 
standard Definition
Median
aerodynamic
diameter
Inhalable fraction
The m ass  fraction of total airborne 
particles which is inhaled through 
the  nose  and/or mouth
>10pm
Thoracic fraction
The m ass  fraction of inhaled 
particles penetrating the 
respiratory system  
beyond the  larynx
10pm
Respirable fraction
The m ass  fraction of inhaled 
particles which penetra tes  
to the unciliated airw ays of the 
lungs, i.e. alveolar region
4pm
High risk respirable 
fraction
The respirable fraction for the 
sick and infirm, or children 2.5pm
Table 1.3: IS 7708 definitions of different airborne particle sizes
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In addition to the IS 7708 standards, there is also the US Environmental Protection 
Agency (USEPA) definition of the thoracic aerosol fraction known as PMio. It is 
defined as the particulate fractions with a median aerodynamic diameter of less than 
10pm, and with a 50% efficiency when sampled by a PMio sampling device. Strictly 
speaking PMio is slightly different from the ISO thoracic fraction due to the 
differences in the upper cut-off size, although in practice such difference is not 
significant. Moreover, USEPA also has a definition of particle size equivalent to the 
high risk respirable fraction and is known as PM 2.5 (particulate matters with a median 
aerodynamic diameter of less than 2.5pm). This would separate the larger particles 
that are generated mostly from natural sources from the finer particles of 
anthropogenic origin.
Generally, air particulates are often being referred to as coarse, fine, and ultrafine -  
coarse particles include those that are within PMio with a size ranging from 2.5- 10pm. 
On the other hand, PM 2.5 is known as the fine particles and contains smaller particles 
with a size up to 2.5pm. The particles in the fine fraction which are smaller than 
0.1pm are called ultrafine particles. Table 1.4 summarises various particle sizes under 
different definitions, and figure 1.1 shows a graphical comparison of particles with 
different sizes in contrast to a human hair.
Median
aerodynamic
diameter
IS 7708 USEPA
Coarse 2.5 - 10pm Thoracic fraction PM 10
Fine 0.1 - 2.5pm
High risk respirable fraction
PM2.5
Ultrafine <0.1 pm PM01
Table 1.4: Sizes of air particulates under different definitions.
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Diameter of human hair 
(for sc a le ): 60 |jm
PMlO
(S10pm )
Coarse 2 5 -1 0pm 
Fine: s2  5pm 
Ultrafine SO 1pm
L_______________________________________________
Figure 1.1: Comparisons between different particle sizes 
and a strand of human hair (Source: www.greenfacts.org).
Deposition of particles within the respiratory system is mainly determined by particle 
size, although other factors such as breathing pattern, airway diameter, and the 
anatomy of the nasal, oral, and pharyngeal areas also play important roles. Generally, 
the smaller the particle size the further it can penetrate into the lungs, as seen in figure
1.2 which shows the deposition of particles of different sizes in various regions within 
the respiratory system. Once inhaled, particles are removed from the lungs by several 
mechanisms. For larger particles deposited in the upper nasopharyngeal areas, 
clearance is often by entrapment in the mucous lining and removed either by reflex 
responses, such as sneezing and coughing, or through the continuous movement of 
mucus up the mucociliary escalator, where the particles are then swallowed or spit 
out. For smaller particles that penetrated as far as the terminal bronchioles and alveoli, 
clearance is carried out primarily by phagocytosis by pulmonary macrophages. Some 
particles may actually be solubilised by body fluids and absorbed into the 
bloodstream. Deposition and clearance of particles in the body can be affected by 
smoking or the presence of an underlying respiratory condition such as chronic 
obstructive pulmonary disease (COPD), which increases particle deposition in the 
lungs and reduces the rate and efficiency of the mucociliary escalator [Lourenso et al 
1971, Anderson et al 1990, Svartengren et al 1996, Brown et al 2002].
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Particle size (pm) / Deposition location
7.0 -  11 .0pm / Nose
4.7 -  7.0pm / Pharynx, larynx
3.3 -  4.7pm / Trachea & primary bronchi -
2.1 -  3.3pm / Secondary bronchi 
1.1— 2.5pm / Terminal bronchi
0.43 -  1.1 urn / Alveoli
Figure 1.2: Particle deposition by size distribution in various regions of the respiratory
system (Source: Rosenstock et al. Textbook o f clinical occupational and environmental 
medicine, 2nd edition. Philadelphia, USA: Elsevier Saunders, 2005).
For many years the levels of ambient air particulates have been measured by the 
levels of black smoke. Briefly, black smoke estimates the levels of air particulates by 
a simple non-gravimetric method in which air is sampled through a filter and the 
resulting blackening measured. The method was calibrated for domestic coal smoke 
when most of the emissions came from coal combustion in the past. However, smoke 
from different sources has a different blackening effect and so there is no simple 
relationship between black smoke and the mass of particulate emissions. Although in 
some places black smoke is still being used an indicator of particulate levels 
nowadays, its use is limited and has been generally replaced by PMio and PM 2 .5 . 
Sometimes ambient air particles are also measured as TSP, or total suspended 
particulates, which measures the total mass of airborne particles irrespective of their 
sizes. The lack of size-specificity means that TSP is less favourable to be used for air 
pollution studies.
1.3.2 Sources, formation, and fate of air particulates
Air particulates found in the atmosphere arise from a variety of sources and can be 
classified into two general groups. The first is the direct emission of particulates into
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the atmosphere which can be generated naturally such as surface erosion and wind 
blown dusts, or anthropogenically such as fuel combustion or through mechanical 
break up in quarries and construction sites. These are known as “primary” 
particulates. The second source is by the formation of particulates in the atmosphere 
through chemical reactions of other pollutants such as SO2, NOx, and NH4 to form 
solid sulphates and nitrates, as well as organic aerosols formed from the oxidation of 
VOC. These are called “secondary” particulates.
There is no doubt that the transport sector contributes significantly to air pollution and 
in particular, this is evident for the local air quality since light and heavy-duty 
vehicles often operate in populated areas. For example, in London road transport can 
account for up to 80% of the total primary particulate emissions [Buckingham et al 
1997]. Particulates along with other pollutants such as CO and NOx are emitted from 
motor vehicles through fuel combustion. In relative terms diesel vehicles emit a 
greater concentration of particles per vehicle kilometre than those running on petrol 
[NAEI 2004]. Concerns have been raised that modem diesel engines, which emit a 
low mass of particles, have high emission of particles in the nanometer range that are 
capable of reaching the deepest regions of the lungs and have relatively large surface 
areas [AQEG 2005]. Despite this the market penetration for light duty diesel cars has 
been increasing in most European market and has reached over 30% in 2001 [Ahlvik 
2002]. A number of factors determine the emission levels of motor vehicles, including 
the age of the vehicle, condition of the engine, load, driving speed, operating 
temperature, and fuel quality. In Europe the introduction of catalytic converters in all 
new cars with spark ignition engines in January 1993 has contributed towards the 
decreased levels of CO, NOx and PAH. At optimal operating conditions the main 
emissions from an engine is water and CO2, although CO2 itself is also of great 
concerns as a greenhouse gas. However, in urban areas the predominance of short 
journeys and cold starts as well as slow or idle engine operating speed rendered the 
catalyst less efficient. In 2000 the Committee on the Medical Effects of Air Pollutants 
(COMEAP) discussed the relative merits of diesel and petrol light vehicles in terms of 
health-damaging pollutants [COMEAP 2000]. The committee concluded that the 
comparison between the two fuel types was difficult and they were unable to provide 
a definite answer as to the preferability of diesel or petrol fuel on health grounds, but 
they suggested that concerns about the effects of particles on health in urban areas
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seem to be more in favour towards petrol. Particles are also released through brake 
and tyre wear. It has been estimated that the wear rate of brake linings for passenger 
cars to be around l-9mg/km and for heavy duty vehicles around 20-40mg/km 
[USEPA 1995, TNO 1997]. For tyre wear the typical wear rates have been reported 
to be 10-90mg/km per tyre [AQEG 2005]. In addition, although not strictly caused by 
traffic, turbulences of moving motor vehicles also cause settled dust on road surfaces 
to re-entrain. These dust particles are often generated from erosion of road surfaces, 
exhaust emissions, and brake and tyre wear which contributed a significant proportion 
of air particulates in the atmosphere.
In the industrial sector, air particulates are formed in the production processes of 
metals, cement, lime, coke, and chemicals, and released during bulk handling of dusty 
materials, construction, mining and quarrying. Emissions from these sources are 
difficult to quantify due to the contribution of the so-called “fugitive emissions”, 
meaning those diffused emissions which are released directly into the atmosphere 
from a process rather than being collected in a controlled manner and then vented to 
the atmosphere. Usually a major fraction of the particles from these sources is larger 
than 10pm but the large quantities emitted ensure that the fraction less than 10pm is 
still substantial. In contrast particles emitted from combustion are much smaller in 
size. Burning of fossil fuels including coal, wood, gas, and oil in both industries and 
domestic sectors all contributed significantly toward the total PMio emission in UK. 
Note that although the use of coal for domestic combustion has been restricted by the 
Clean Air Acts, domestic coal is still being used in Northern Ireland and certain 
smaller towns and villages.
The mechanism of how air particulates are formed is crucial in determining particle 
size. The finest particles within 1-1 Onm in size are often result from the condensation 
of small numbers of involatile molecules formed in combustion processes or in 
evaporation from hot surfaces. This mechanism is known as nucleation. For slightly 
larger particles within the range of 0.05-2pm, they are often formed by the 
accumulation mode in which the finest particles adhere to form larger droplets or long 
chains of particles. Finally the coarsest particles with the size of ~10pm- 100pm are 
often produced through mechanical break-up of solids and liquids. In a mixture of air
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particulates, the greatest numbers of particles are those formed by nucleation, 
although they only represent a small fraction of the total mass due to their small sizes.
Particles in the atmosphere are removed in two ways known as dry deposition and wet 
deposition. In dry deposition particles are retained by surface forces and remain on the 
ground, whereas in wet depositions they are removed from the atmosphere through 
precipitation. In the UK, about 7% of the 1pm size particles are removed by wet 
deposition per day, and 15-30% for those 3-5pm or larger [Harrison et al 1996]. 
Particles in the nucleation mode are often very short-lived (~10mins) because they 
rapidly adhere to other particles and grow into the accumulation size range. Coarse 
particles are short-lived ( 10-20hrs) and are likely to travel distances from a few metres 
to a few hundred kilometres depending on their size and wind speed. Finally, particles 
formed in the accumulation mode are long-lived (~10days) because both dry and wet 
depositions are least efficient in this size region. They are also capable of travelling 
long distances in the range of several thousand km.
1.3.3 Chemical constituents of air particulates
Apart from their size range, the complexity of air particulates is also demonstrated by 
their diverse chemical compositions. As discussed previously, specific sources give 
rise to particles of a certain size range, therefore the chemical constituents of particles 
in certain extent are also related to its size. For example, suphate produced from the 
oxidation of SO2 is typically present in fine particles, whereas silicon from the 
resuspension of soil and surface dust is normally found in coarse particles. However, 
particles of different sources can sometimes be internally mixed via the process of 
condensation and coagulation, and give rise to a mixture of particles containing 
components that have arisen from different sources. Table 1.5 below shows the 
typical components that are often found in particulates. The list is divided into major 
and minor components, with the former comprising at least a few percent of the mass 
of particles.
18
Chapter 1 Introduction
Component Source
Sulphate A tm ospheric oxidation of S 0 2
Nitrate A tm ospheric oxidation of NOx
+4c Ammonium A tm ospheric oxidation of NH3
<D
Coa Sodium and chloride S ea  salt
E
Ooh.o Elemental carbon
High tem peratu re com bustion of fossil 
and biom ass fuels
'5P2 Organic carbon Automotive, industrial, or oxidation of volatile organic com pounds
Mineral components Earth 's crust or anthropogenic activities such  a s  quarrying and construction
Water Taken up by the  w ater solublecom ponents of particles
M
in
or
co
m
po
ne
nt Trace metals 
Trace organic compounds
Com bustion of fuel and metallurgical 
p ro cesse s
Com bustion and oxidation of organic 
com pounds
Table 1.5: Typical components found in air particulates and their sources.
1.3.4 Emission trends of air particulates in the UK
Each year NAEI measures the emission sources of PMio in the UK. Figure 1.3 shows 
the annual emission of PMio in the UK since 1970 [NAEI 2004]. Overall emissions of 
PMio in the UK have declined since 1970, and between 1990 and 2 002  the total 
national PMio emission has declined by 48%, measured as 160 kilotonnes in 2002. A 
trend away from coal use has also been seen, in which in 1970 over 65% of the total 
PMio emission was from the use of solid fuel and approximately 16% from the use of 
petroleum. Over the years this trend has changed and in 2002 the burning of coal only 
contributed approximately 23% of the total emission, whereas emissions from 
petroleum was increased to 27%. The trend reflects the reduction in coal use 
especially in the domestic setting, and replacement by other fuel type such as gas.
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Domestic burning of coal contributed more than 40% of the total PMio emission in 
UK in 1970 and released 222 kilotonnes of PMio into the atmosphere. In 1980 this 
was reduced by more than 50% to 103 kilotonnes, and further reduced to 52 
kilotonnes in 1990. Since then the level of PMio emission by domestic burning of coal 
has remained at around 30 kilotonnes per year. Similarly in the industrial sector, the 
reduced use of coal and the installation of particles abatement equipment has led to 
the reduction in PMio emission caused by industrial combustion processes. Emissions 
from electricity generation have also recently been declining since 1991 despite a 
significant growth in the electricity generated between 1970 and 2002. This is due to 
the move away from coal to natural gas and nuclear power for electricity generation 
and to improvements in the performance of particulate abatement plant at coal-fired 
power stations. Also the installation of flue gas desulphurisation plants at two power 
stations in Drax and Ratcliffe in 1994 have reduced particulate emissions further. 
Emissions from road transport have not seen any significant changes in the past 30 
years or so in terms of total mass, but the contribution to the total emission has 
increased with time due to other sectors decreasing. The contribution to the total UK 
emission has risen from 8% in 1970 to 24% in 2002. The main source of road 
transport emissions is exhaust from diesel engine vehicles. Emissions from diesel 
vehicles have been growing due to the increased number of heavy duty vehicles and 
the move towards more diesel cars. Since around 1992, however, emissions from 
diesel vehicles have been decreasing due to the penetration of new vehicles meeting 
tighter PMio emission regulations, such as the Euro Standards for diesel vehicles 
introduced in 1992. Although the resuspension of road dust is not monitored 
routinely, an estimation based on the deposition of primary particles from all UK 
sources, including vehicle tailpipes and from brake and tyre wear that are returned to 
the air from the turbulence of passing vehicles has been provided by NAEI (table 1.6). 
In 1970 approximately 8.2 kilotonnes of resuspended dust was caused by the 
turbulences of passing motor vehicles. Since then the trend has been increasing and 
accounted for 20.3  kilotonnes in 20 0 2 , which reflects the increased number of road 
vehicles in the UK in the past 30 years. Among the non-combustion and non-transport 
sources, the major emissions are from industrial processes, the most important of 
which is quarrying whose emission rates have remained fairly constant. Other 
industrial processes, including the manufacture of steel, cement, lime, coke, and
20
Chapter I
x
 Introduction
primary and secondary non-ferrous metals, are collectively important sources of air 
particulates although emissions from individual sectors are relatively insignificant.
600
1970 1972 1974 1976 1978 1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002
■ Public Power ■  Comm. Res.&lnstit. Comb. □  Industrial Combustion
■ Production Processes ■  Road Transport □  Other
Figure 1.3: Time-series of UK annual PM)0 emissions by category, 1970, 1980, 1990 & 
1996-2002 (Source: NAEI).
Year PM10 resuspension  (kilotonnes)
1970 8.2
1980 11.2
1990 16.9
1996 18.2
1997 18.6
1998 19.0
1999 19.3
2000 19.3
2001 19.6
2002 20.3
Table 1.6: UK PM10 emission estimates from resuspension, 
1970, 1980,1990 & 1996-2002.
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1.3.5 Health impact of air particulates
The epidemiological evidence of the effects of air particulates shows good correlation 
between short-term and long-term exposure to PMio and increased cardiorespiratory 
mortality or morbidity [AQEG 1995, 2005]. Such effects are likely to occur in 
susceptible group of the population such as those with underlying heart and lung 
conditions, the elderly and the children. Evidence suggested it is the combustion- 
derived PMio responsible for the effects seen, because they predominantly comprise of 
particles in the high risk respirable range and with trace elements or organic 
compounds attached to the surfaces. Therefore PMio has become the generally 
accepted measure of particulate material in the atmosphere in the UK and in Europe. 
Particles outside of this size range are relatively very large in size and have little 
impact on health, but their capability to induce damage cannot be completely ruled 
out. Although the exact mechanism of damage is unknown, studies have suggested 
that particles are capable of inducing inflammation by oxidative stress, probably via 
the generation of free radicals. The long-term effects of particles appeared to be more 
significant for mortality due to cardiovascular disease than respiratory disease. It is 
estimated that there will be a gain of 0 .2 -0 .5 million life years in 2000  for every 
1 pg/m3 decrease in PM2.5 over the lifetime of the current population of England and 
Wales [COMEAP 2001]. However, such gain is not spread evenly over the whole 
population and thus it is not possible to calculate the distribution of life gain in each 
individual. In the UK each adult is estimated to have approximately 250pg of PM]0 
particles deposited in their body daily. Having said that, there is no convincing 
evidence to show that the levels of ambient particulates found in the UK have 
significant health impact on healthy individuals [AQEG 2005]. It is important to note 
that, such estimations were calculated based on studies carried out in the United States 
which has a different particle composition and population lifestyle.
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1.4 Polycyclic aromatic hydrocarbons
The significance of polycyclic aromatic hydrocarbons (PAH) as a major air pollutant 
is due to their ability to cause cancer as well as their close association with air 
particulates. For PAH that are absorbed onto the surfaces of air particulates, 
approximately 90% of them are associated with particles less than 3.3pm in diameter, 
with a peak distribution between 0.4 and 1.1pm [Venkataraman 1994]. Particles of 
this size range are often deposited deep in the lungs. Moreover, research has shown 
that carcinogenic PAH are mostly associated with air particulates [Lyall et al 1988, 
Hart et al 1994].
1.4.1 Physical and chemical properties of PAH
Polycyclic aromatic hydrocarbons are a large group of organic chemical compounds 
that consist of two or more fused aromatic rings which can be in linear, angular, or 
cluster arrangements. Although PAH consist of aromatic rings made entirely from 
carbon and hydrogen, the physical and chemical properties of individual PAH vary 
and the semi-volatile properties of some PAH make them highly mobile throughout 
the environment. There are over 100 different PAH identified but 16 of them were 
designated by the USEPA as compounds of interest (table 1.7). From these 16 PAH 
the International Agency for Research on Cancer (IARC) identified a subset of 6 
compounds which included benzo[a]anthracene, benzo[b]fluoranthene, 
benzo[k]fluoranthene, benzo[a]pyrene, indeno[123cd]pyrene, benzo[ghi]perylene, 
and dibenz[ah]anthracene as “probable” or “possible” human carcinogens [IARC 
1983, 1987].
PAH can either be present in ambient air in the form of gases or associated with air 
particulates. Generally, PAH that contain up to 4 fused benzene rings are know as 
light PAH and those containing more than four benzene rings are known as heavy 
PAH. The lighter PAH such as phenanthrene are found almost exclusively in the air in 
gaseous form, while heavy PAH such as benzo[a]pyrene (B[a]P) are absorbed onto 
particle surfaces [DERFA 1999]. PAH that are associated with particles can remain in 
the air for a longer period than gaseous PAH because firstly they have a slower dry 
deposition and take longer to settle to the ground, and secondly they have less 
efficient wet depositions and are thus less likely to be lost by precipitation [Baek et al 
1991]. These PAH-bound air particles deposit slowly from the atmosphere, and
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depending on atmospheric conditions they may be airborne for a long period of time 
and travel long distances. This is supported by evidence that PAH have been detected 
in a remote area situated in the Mediterranean Sea distance from any major sources 
[Masclet et al 1988]. Degradations of PAH are more efficient under summer 
conditions because of higher sunlight intensities, temperatures, and ozone 
concentrations [Menichini et al 1999]. PAH are lipophiclic in nature, i.e. they are 
relative insoluble in water but dissolves in fats and oils.
PAH Molecularweight
Chemical
formula
Chemical
structure
N a p th a le n e 128 C i0H8
A c e n a p th y le n e 152 C 12H8
A c e n a p th e n e 154 C 12H 10
(9 E3 I
F lu o re n e 167 C 13H9 g o ®
A n th ra c e n e 178 C 14H 10
P h e n a n th re n e 178 C 14H 10
( O j Q J
F lu o ra n th e n e 2 0 2 C 16H 10
P y re n e 2 0 2 C 16H 10
( Q l O J
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B e n z [a ]a n th ra c e n e * 2 2 8 C 18H 12
C h ry s e n e 2 2 8 C 18H 12
B e n z o [b ]flu o ran th en e# 2 5 2 C 20H 12
B en zo [k ]flu o ran th en e# 2 5 2 C20H12 (810/%
B en zo [a ]p y ren e* 2 5 2 C 20H 12
ln d e n o [1 2 3 c d ]p y re n e # 2 7 6 C 22H 12
^JdsdiigCpQl
B en zo [g h i]p e ry len e 2 7 6 C 22H 12
r861
D ib en z [a h ]a n th race n e* 2 7 8 C 22H 14
*IARC Group 2A “probably carcinogenic to humans”
# IARC Group 2B “possibly carcinogenic to humans ”
Table 1.7: Molecular weight, formulae, and structure of the sixteen PAH classified by 
the USEPA as compounds of interest.
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1.4.2 Emission sources and trends in the UK
PAH found in the environment are formed both naturally and through human 
activities. Natural sources of PAH include thermal geological reactions, natural fires, 
biosynthesis of algae, bacteria, and plants, and synthesis from degraded biological 
matters such as fossil fuels [Harrison et al 1996]. Human activities are the more 
significant sources of PAH and they are formed in all processes that involve the 
incomplete combustion of carbon-based fuels such as coal, oil, wood, and gas. In 
addition PAH are also produced through a process known as pyrolysis, which is when 
organic materials are heated in the absence of oxygen or any other reagents. The 
major anthropogenic sources of PAH can be divided into industrial, automobile, 
domestic, and agricultural. The most important industrial sources include cokeries and 
aluminium production in particular to plants using the Vertical Stud Soderberg (VSS) 
process [NAEI 2004].
Figure 1.4 shows the annual PAH emission by source in the UK since 1990. Note that 
only the 16 PAH classified by the USEPA were included. Back in 1990 the annual 
national emission was 8326 tonnes. Approximately 42% were contributed by the 
production processes of non-ferrous metals which were mainly aluminium production 
and anode baking. The second largest source was road transport which contributed 
28% of the estimated emission total. Except emissions of PAH from domestic 
combustion have slightly increased between 1997 and 1999, emission levels from 
other sources have been declining in a steady rate throughout the years between 1995 
and 2002. In contrast, emissions from non-ferrous metals production processes have 
undergone dramatic changes. Aluminium production and anode baking was the largest 
source of PAH emissions in the UK until 1996, which contributed nearly half of the 
total emission. However, since then they have declined and in 2002 these sources 
accounted for only 6% of the total UK emissions. According to NAEI, this was a 
consequence of the closure of the production plant at Kinlochleven and investment in 
abatement equipment following the regulations of the Environmental Protection Act 
1990. Since then one of the anode baking plants has dramatically reduced its 
emissions and as in 2002 the other was timetabled to follow shortly. On the other 
hand, although the total PAH emissions in tonnage by motor transport have been 
reduced by more than 50% since 1990, it has become the largest single source of PAH 
in the UK due to decreased emissions in the other sectors. In 2002, PAH emission
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from motor transport was approximately 52% of the total annual emission. While 
industrial sources most strongly influence the PAH levels in the vicinity of the plant, 
road traffic emissions are a dominant source in towns and cities. In a study conducted 
in Birmingham UK using B[a]P as indicator, traffic emissions were estimated to 
associate with 80-82% and 61-67% of the PAH concentrations in the city centre and 
outskirt respectively [Lim et al 1999]. Moreover, the authors estimated that of the 
total PAH emissions contributed from motor traffic at the city centre site, 
approximately 60-84% were originated from diesel vehicles.
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Figure 1.4: Time-series of 16 PAH Emissions (tonnes) in the UK, 1990-2002 (Source: 
NAEI).
During combustions and industrial processes mixtures of PAH are formed which are 
varied by the combustion source. For example, PAH in diesel and petrol exhaust are 
predominantly consist of phenathrene, fluoranthene, pyrene, and benzo[ghi]perylene 
[Rogge et al 1993, Westerhold et al 1994], and in primary aluminium production 
involving the VSS process, the main PAH are anthracene, phenanthrene, and pyrene 
[Wenbom et al 1999]. Nonetheless, naphthalene is the most predominant compound 
of all PAH in both industrial and motor vehicle emissions [Wenbom et al 1999].
Indoor levels of PAH are likely to be contributed from both indoor and outdoor 
sources. According to the USEPA report on indoor concentrations of environmental
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carcinogens, smoking has the greatest effect on PAH concentrations indoors [Gold et 
al 1990]. In a smoke-polluted environment, the concentrations of some PAH 
including the carcinogenic benzo[a]pyrene, benzo[ghi]perylene, 
dibenz[ah]anthracene, and fluoranthene were found to be within the range of 0.1 to 
99ng/m3 [WHO 1983]. The effect of smoking on indoor PAH levels was evaluated in 
a study involving 8 US homes, and it was estimated that the effect of smoking 10 
cigarettes in an 8-hr period produced an increase in the level of B[a]P by 110% of the 
overall average level observed in the study [Chuang and Mack 1991]. Sometimes 
track-in soil and dust accumulated indoors may also be a significant source of indoor 
PAH. In a non-industrial non-agricultural region in North Carolina USA, dust samples 
were collected from 25 middle class homes located in the suburban areas. The 
collected dust was split into different size fractions and for particles less than 4pm in 
diameter the concentration of several PAH compounds including the carcinogenic 
benzo[b]fluoranthene and indenol[123cd]pyrene were found to be between 1.3 and 
2.0pg/g [Lewis 1999 et al].
Most of the PAH in soil are believed to result from atmospheric deposition after local 
and long-range transport. They can volatilise, be biodegraded or taken up and 
accumulate in plants. PAH in soil can also enter groundwater. Sources of PAH in soil 
include sludge disposal from sewage works, emissions from motor traffics, and the 
use of soil compost and fertilisers [ATSDR 1995]. In addition, soil in landfill sites, 
industrial sites, and former gas manufacturing plants can also be contaminated with 
PAH [Bewley et al 1989, Turney and Goerlitz 1990, ATSDR 1995]. For example, 
soils collected from a former charcoal production facility were found to contain 
concentrations of up to 80mg/kg of PAH [Snow-Ashbrook and Erstfeld 1998]. Levels 
of PAH found in sewage sludge may be higher in industrialised regions than in non­
industrial regions [Bodzek 1999].
Small amount of PAH can often be found in food and water through contaminations 
of soil and water and be taken up by plants, and food is considered to be one of the 
major non-occupational sources of exposure to the compounds [WHOROE 2000]. A 
report by the World Health Organisation (WHO) showed that the typical levels of 
PAH in meat, fish, dairy products, vegetables and fruits, cereals and their products, 
sweets, beverages, and animal and vegetable fats and oils are within the range of 0 .0 1 -
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lOpg/kg [IPCS 1998]. According to a Dutch study, the largest contribution to the 
daily PAH intake came from sugar and sweets, cereals, oils, fats, and nuts, and the 
estimated mean daily intake was between 5 and 17pg/day [De Vos et al 1990]. Food 
processed by certain cooking methods such as smoking and barbecuing contain a 
more substantial amount of PAH since they are formed in the process of flaming 
combustion.
1.4.3 Exposure to PAH and health risks
It is now well known that some PAH compounds are capable of causing cancer, which 
were demonstrated in men exposed to high occupational levels of these compounds 
with increased incidence and mortality of cancers of the lung [Armstrong et al 1994, 
Constantino et al 1995], bladder [Bonassi et al 1989, Claver et al 1994], and other 
sites [Berger and Manz 1992, Chau et al 1993]. The carcinogenic ability of PAH 
varies between different compounds but through animal studies three potent 
carcinogenic PAH compounds namely benzo[a]pyrene, benz[a]anthracene, and 
dibenz[ah]anthracene have been classified as “probably” carcinogenic in humans 
[IARC 1987]. The qualification of “probably” reflects the lack of any data on the risks 
associated with human exposure to these compounds in isolation [EPAQS 1999]. 
Carcinogenic PAH compounds in their natural state are incapable of inducing 
tumours. Instead, they are dependent on their conversion in the body into compounds 
that are able to react with and subsequently damaging the genetic material DNA in the 
nuclei of cells. Such activation process is mediated by various enzyme systems in 
susceptible target tissues. In fact, it is known that once inhaled PAH compounds are 
rapidly absorbed and can be activated in the lungs [IARC 1983].
Epidemiological studies of the health effects of PAH is often difficult because 
individual PAH compounds have different toxicities, and exposure is always to a 
complex mixture of PAH and not individual compounds. Moreover, the most 
significant endpoint of PAH toxicity is cancer which takes a significantly long period 
of time to develop and is likely to be due to long-term exposures to the compounds. 
The average level of PAH an individual is exposed to is unknown due to the 
variations between background PAH levels and each individual’s activities. Exposure 
to PAH can be through active or passive inhalation of tobacco smoke, wood smoke,
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and contaminated air, ingestion of the compounds in food and drinking water, and 
through skin contact with soot and tars. The US Agency for Toxic Substances and 
Disease Registry (ATSDR) estimated that the average total daily intake of PAH by a 
member of the general population in the United States to be 0.207pg from air, 
0.027pg from water, and 0.16-1.6pg from food. In addition, the total potential 
exposure to carcinogenic PAH for adult males in the United States was estimated to 
be 3pg/day [ATSDR 1995]. The annual mean concentrations of B[a]P in major 
European urban areas are in the range of 1 to 10ng/m3, and in rural areas <lng/m3 
[WHOROE 2000].
Risks of lung cancer due to exposure to PAH compounds have been calculated using 
three different methods as shown in the WHO report on Air Quality Guidelines for 
Europe 2000 [WHOROE 2000]. The first approach was based on epidemiological 
data from studies in coke oven workers. Using the typical levels of coke oven PAH 
emissions, the most plausible upper-bound individual lifetime risk of developing 
respiratory cancer associated with a continuous exposure to lpg/m of benzene- 
soluble compounds of coke-oven emissions in ambient air was approximately 
6.2x1 O'4 per ng/m3. The second approach was to use B[a]P as the indicator of general 
PAH mixtures from emissions of coke ovens, and using the reported value of 0.71% 
as the concentrations of B[a]P in the benzene-soluble fraction of coke oven emissions, 
the lifetime risk of respiratory cancer was estimated to be 8.7x10‘5 per ng/m3. The 
third approach was based on the lung tumour development rate obtained in a rat 
inhalation study with coal tar/pitch condensation aerosols, and the lifetime cancer risk 
of 2x10'5 per ng/m3 for B[a]P as a constituent of a complex mixture was calculated 
[Heinrich et al 1994]. Overall, the estimated corresponding concentrations of B[a]P 
producing excess lifetime cancer risks of 1/10,000, 1/100,000 and 1/1,000,000 were 
1.2, 0.12 and 0.012 ng/m3, respectively.
Currently there are no specific guideline values recommended by WHO regarding the 
levels of PAH in air. This is due to the fact that PAH are often present in the form of 
complex mixtures and is further complicated by their interactions with a number of 
other compounds and air particulates, which on their own may also play a role in 
cancer development. Food containing PAH is considered as one of the major sources 
of human exposure to the compounds. However, the presence of PAH in food is in
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part due to contamination from air pollution, therefore WHO recommended that the 
levels of PAH in air should be kept as low as possible [WHOROE 2000]. In the UK, 
the Expert Panel on Air Quality Standards (EPAQS) recommended an air quality 
standard of 0.25ng/m3 of B[a]P as an annual average [EPAQS 1999]. This 
recommendation was intended to reduce any risk to the UK population from exposure 
to PAH to one, which the panel believed would be so small as to be undetectable.
1.4.4 Exposure biomarkers of PAH in humans
There are a number of ways to monitor uptake of PAH by different biomarkers, such 
as the detection of metabolites in urine, urinary thioethers, urinary mutagencity, PAH- 
protein adducts, and PAH-DNA adducts [Jongeneelen 2001]. However, both urinary 
thioethers and urinary mutagenicity are non-specific indicators of exposure to 
mutagenic agents, and PAH-protein adducts and PAH-DNA adducts lack sensitivity 
in the case of occupational exposure to PAH and that results are often strongly 
confounded by smoking [Clonfero et al 1989, Reuterwall et al 1991, Ferreira et al
1994]. Thus these methods are not suitable for routine applications. In the search of a 
reliable human exposure biomarker to PAH, a specific metabolite of pyrene, 1- 
hydroxypyrene (1-HP), has been suggested [Jongeneelen et al 1985]. The non- 
carcinogenic pyrene is an abundant PAH compound that is often present in mixtures 
of PAH [Jongeneelen et al 1985, Buchet et al 1992]. It is metabolised by various 
enzyme systems in the body into 1-hydroxypyrene-glucuronide, which is then 
excreted [Jongeneelen et al 1987]. Pyrene is rapidly distributed, metabolised, and 
eliminated from the body, this makes 1-HP a reliable indicator of systemic exposure 
to this PAH compound. Furthermore, because pyrene is always present in PAH 
mixtures it is therefore not just an indicator of uptake of pyrene, but also an indirect 
indicator of all PAH. The half-life for the urinary excretion of 1-HP in occupational 
exposed workers is 18hrs [Buchet et al 1992] and the individual half-life ranges from 
6 to 35hrs [Jongeneelen et al 1990]. The presence of 1-HP in urine is determined by 
high-pressure liquid chromatography (HPLC). At present, urinary 1-HP is a widely 
used biological indicator of exposure to PAH and studies using this biomarker is well 
documented [Jongeneelen 2001]. Despite the widely use of 1-HP as an exposure 
marker of PAH, its use is not without drawbacks. Although pyrene is often found in 
high abundance in PAH mixtures, the composition of the PAH mixture in different 
environment often varies. As stated earlier in this chapter, mixtures of PAH formed
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are varied by the combustion source, and thus the relative proportion of individual 
PAH in the PAH mixture can vary from time to time and place to place. Therefore the 
specificity of 1-HP as an exposure marker for a PAH mixture is not absolute. And as 
with all PAH exposure analysis techniques, the use of 1 -HP as an exposure marker is 
subject to confounding by the active and passive inhalation of tobacco smoke.
32
Chapter 2 Literature Review
C h a p t e r  2 -  L it e r a t u r e  R e v ie w  
H e a l t h  E ffe c t s  o f  A ir  Pa r t ic u l a t e s
There is a body of scientific evidence regarding the epidemiological relationships 
between the levels of respirable air particulates and cardiorespiratory morbidity and 
mortality which has been well documented in recent years. Studies suggested that 
these particles may lead to both short- and long-term adverse health effects. The scale 
of the effects varies from acute changes in respiratory disease symptoms to increased 
mortality rates due to exacerbations of pre-existing cardiorespiratory disease. Despite 
this overwhelming evidence the exact pathophysiological mechanisms of how air 
particulates may lead to adverse health effects is largely unknown.
The evidence base of population health effect assessment with respirable air 
particulates is extensive. This chapter summaries the key findings based on the 
information found from a number of keyword searches using Scirus, which were 
undertaken at various times to furnish a complete listing of primary research papers 
for review assessment. Scirus is a comprehensive science-specific search engine on 
the Internet. It searches over 250 million science-specific web pages and covers a 
large number of scientific databases such as MEDLINE, Science Direct Online, and 
BioMed Central.
2.1 Evaluation of short-term effects using acute exposure studies
2.1.1 Increased mortality
Since the early 1930s many studies have been carried out to investigate the acute 
effects of air pollution on mortality. The earliest studies were, compared to more 
recent studies, methodologically simple and evaluated the changes in mortality before, 
during, and after pollution episodes that lasted a few days or weeks. Associations 
between increased deaths and severe air pollution were demonstrated by several well- 
known episodes such as the Meuse River valley fog in Belgium in 1930 [Nemery et al 
2001], the Donora smog in Pennsylvania in 1948 [Schrenk et al 1949], and the 
London Smog in 1952 [Ministry of Health 1954]. These studies showed a clear 
linkage between cardiorespiratory mortality and morbidity with episodes of extremely 
elevated concentrations of air particulates and/or other toxic chemicals such as
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sulphur dioxide. Later studies have also shown that less extreme pollution could also 
trigger an increased mortality but with smaller effects. For example, in 1985 a smog 
episode took place in parts of North Rhine-Westfalia, West Germany for 5 days. The 
authors compared mortalities in the effected areas with control areas that were not 
affected by the smog [Wichmann et al 1989]. Maximum 24hr average TSP during the 
episode was 600|ng/m3 in the affected areas, which was 3 times higher than the 
control. Mortality data in the studied areas were collected and a total of 24,000 deaths 
during the episode were recorded. Results showed a larger increase in total mortality 
in the smog areas compared with the control area (8% v 2%). In contrast to an earlier 
study in the same region in 1962, in which a 5-day smog episode with an average TSP 
concentration of 2400pg/m3 has led to an increase of 19% in total mortality [Schmitt 
1986], this 1989 study has demonstrated that less severe episode of air pollution 
would still be able to trigger an increased death rate though at a smaller scale.
In the 1970s and through to the 1980s, various researchers began to adopt time-series 
analysis to investigate the association between daily mortality and air pollution at 
relatively low levels. A time-series is a set of observations being recorded at a specific 
time. When studying air pollution, the dependent and independent variables are 
measured over time to identify the possible short-term changes in mortality related to 
the short-term fluctuations in air pollution levels. In a time-series study, levels of 
pollution within an area of interest serve as indicators of exposure whereas daily 
health data, such as mortality rate, serve as indicator of the effects. Time-series 
studies have the major advantage of being able to provide a large set of observational 
data across a long period of time, rather than a few days before, during, or after an 
episode. This gives the analysis more statistical power to evaluate the mortality 
effects of less extreme levels of pollution episodes. Other environmental factors such 
as meteorological changes or illnesses such as a flu outbreak may confound the results 
and must be taken into account in the analysis. The disadvantages of time-series 
studies are their incapability in estimating the effects of air pollution on a longer-term 
exposure scale. This is because they cannot provide direct information on the loss of 
person-time associated with the extra deaths, and they are unable to demonstrate the 
effects of exposure to transient peaks of air pollution have on long-term disease 
processes. Moreover, exposure data is based on measurements from centrally located
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monitoring stations, which means it lacks a direct link between exposure of the 
pollutant and the resulting health outcome at the individual level. This renders the 
judgement of causality difficult. Nonetheless, time-series studies can compensate for 
these weaknesses by examining a very large population of individuals and their 
responses to the pollutant of interest, thereby gaining an understanding of the public 
health impacts and risks to the population as a whole. Early time-series studies were 
limited by inadequate pollution data and a variety of time-series approach was applied 
to these data that made direct comparison difficult [Holgate et al 1999]. Nevertheless, 
associations between daily mortality counts and air pollution were generally observed.
In the early 1990s, some investigators began to report time-series analysis based on 
Poisson regression modelling, which evaluates the rate or frequency of an outcome 
event in a sample that is followed through time. With the help of sophisticated 
statistical software and computerised records of air pollution, counts of mortality, and 
weather data, researchers were able to analyse more appropriate and complicated 
statistical models of the daily counts of death, particularly in small communities with 
small number of deaths per day. In addition, the widespread use of the same statistical 
method used in the analysis made direct quantitative comparisons of effects estimates 
between studies possible. The following are some of the later time-series studies 
carried out the in the early 1990s.
Pope studied the association between daily mortality and particulate pollution in Utah 
County between April 1985 and December 1989 [Pope 1992]. Poisson regression 
models controlled for weather was used to regress daily death counts on PMio 
pollution levels. During the study period, mean PMio concentration was 47pg/m with 
a maximum 24hr average of 365pg/m3. A total of 4,649 non-accidental deaths were 
recorded, which distributed across 1,736 days and resulted in an average daily death 
of 2.7. Results showed a significant positive assoication between non-accidental 
mortality and PMio concentrations. The strongest association was with 5 day moving 
average PMio levels, including the concurrent day and the preceding 4 days -  for 
every 100pg/m3 increase in PMio concentrations, an increase of 43%, 20%, and 5% 
excess deaths due to respiratory, cardiovascular, and all other causes was observed 
respectively. This is equivalent to 16% excess in total mortality. In addition, relatively
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low levels of SO2, aerosol acidity, and ozone during the study period suggested an 
independent association between mortality and P M i0. Fairley studied the effects of air 
particulates on mortality in the Santa Clara county of California, United States 
[Fairley 1990]. The studied area was characterised by its relatively low level of SO2 
compared with other eastern or midwestem U.S. cities, thus eliminating the combined 
effects of SO2 in the analysis. Daily mortality counts were obtained from the 
California Department of Health Services for the years 1980-1986 and counts of daily 
total non-accidental mortality were extracted. Because PMio levels were not 
monitored at that time, the author used the coefficient of haze (COH) along with NO3 
as an indicator of the level of pollution. Using a Poisson regression model controlled 
for seasons, meteorological variables, and other gaseous pollutants such as ozone, the 
relative risk of non-accidental mortality was 1.05 (p<0.01) per 0.9 units increase in 
COH. In 1999 the author examined all non-accidental deaths as well as respiratory 
deaths and cardiovascular deaths between 1989 and 1996 in the same area, but this 
time included PM io and PM2.5 data. It was found that for every 50pg/m3 increase in 
PM io concentrations, the relative risk (RR) for non-accidental mortality was 1.08 
(p<0.01), and cardiovascular mortality was 1.09 (p<0.05). However, the increased 
risk seen in respiratory deaths was statistically insignificant (RR = 1.11). As for 
PM2.5, for every 28pg/m3 increase in its concentrations, the relative risk of non­
accidental mortality was 1.09 (p<0.05), but no statistically significant associations 
were found between cardiovascular mortality (RR = 1.07) and respiratory mortality 
(RR= 1.13).
Using Poisson regression modelling, Schwartz carried out several individual studies 
in different parts of the United States and identified positive associations between 
exposure to air pollution and increased mortality. In Detroit, all non-accidental deaths 
between 1973 and 1983 were regressed for the levels of TSP in the city. After 
controlling for season, weather, and time trends, a significant correlation (p<0 .01 ) was 
found between predicted TSP and daily mortality, which was independent of SO2 
[Schwartz 1991]. It was found that for each 100pg/m3 increase in TSP there would be 
a 6% increase in mortality. The same research methodology was applied in 
Steubenville, Ohio [Schwartz and Dockery 1992]. All non-accidental deaths were 
studied over an 11-yr period between 1974 and 1984. Being an area with small
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population, the average total number of deaths per day in Steubenville over the study 
period was only about 1% of the deaths in a typical London winter. Despite the 
reduced statistical power, TSP was found to be significantly associated with increased 
daily mortality in Poisson regression analyses controlling for season and temperature. 
For every 100pg/m3 increase in particulate levels there was a 4% increase in mortality 
on the succeeding day, and was independent of SO2. In Birmingham, Alabama, 
mortality was studied from August 1985 through 1988. Poisson regression analyses 
controlled for weather, time trends, day of the week, and year of study, showed a 
significant association between PMio and daily mortality [Schwartz 1993]. For every 
100pg/m3 increase in particulate level there was an increased mortality risk of 1.11 
(95% Cl 1.02-1.20). Following Detroit and Birmingham, Schwartz replicated the 
analysis in Cincinnati, Ohio. Daily TSP concentrations were studied in Cincinnati 
from 1977 to 1982 and were matched to daily counts of non-accidental deaths 
[Schwartz 1994]. Poisson regression analysis controlled for seasonal and monthly 
variations and meteorological variables showed that for every 100pg/m3 increase in 
TSP the estimated relative risk of death was 1.06 (95% Cl 1.03-1.10), and was 
increased even further for the elderly (RR = 1.09; 95% Cl 1.05-1.14) and subjects 
with cardiovascular disease (RR = 1.08; 95% Cl 1.03-1.14). The results obtained in 
this study had a striking similarity to the reported results in Philadelphia -  using data 
extracted between 1973 and 1980, the relative risks for a 100pg/m3 increase in TSP 
were 1.07 (95% Cl 1.04-1.10) for all-cause mortality, 1.10 (95% Cl 1.06-1.13) for 
deaths in the elderly, and 1.10 (95% Cl 1.06-1.14) for cardiovascular deaths 
[Schwartz and Dockery 1992]. At the time when the Philadelphia study was 
published, critics suggested that the authors did not have sufficient controls on the 
time-varying variables [Li and Roth 1995, Moolgavkar et al 1995], despite seasonal 
and meteorological factors such as season, year, previous day's mean temperature, 
dew point, winter temperature, and indicators of hot and humid days had been 
accounted for. In 1999 Neas together with the two original authors carried out a 
reanalysis of the Philadelphia data of 1973 to 1980 [Neas et al 1999]. Using 
conditional logistic regression analysis with a case-crossover design, the researchers 
managed to reproduce very similar results from those estimated in 1992. The case- 
crossover design is an adaptation of the case-control design in which cases serve as 
their own controls, meaning the characteristics of a subject and status of exposure at 
the time of a health event (i.e. case period) are compared with another time period
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when the health event of interest is absent (i.e. control period). The regression model 
which controlled for season and day of week, showed that for a 100pg/m3 increment 
in the 48-hr mean level of TSP was associated with increased all-cause mortality (OR 
= 1.06; 95% Cl 1.03-1.09), increased deaths in the elderly (OR = 1.07; 95% Cl 1.04-
1.11), and increased deaths due to cardiovascular disease (OR = 1.06; 95% Cl 1.02-
1.11). The similarity of the results confirmed the conclusion of the previous Poisson 
regression analysis. In another study, concentrations of PMio and PM2.5 were 
measured in six eastern U.S. cities for eight years and daily mortality for these 
metropolitan areas were combined with particulate air pollution and weather 
measurements [Schwartz et al 1996]. Using Poisson regression models adjusted for 
time trends and weather, both PMio and PM2.5 were each significantly associated with 
increased daily mortality. The strongest association was found in PM2.5, in which for 
every 10pg/m3 increase in two-day mean PM2.5 was associated with a 1.5% (95% Cl
1.1-1.9%) increase in total daily mortality. The risk further increased with deaths 
caused by chronic obstructive pulmonary disease (3.3%) and by ischemic heart 
disease (2.1%). Recently this study was reanalysed by Klemm and colleagues 
[Klemm et al 2000]. The authors used the particulate air pollution data supplied by 
the original investigators, and daily weather and daily counts of total and cause- 
specific deaths were reconstructed from original public records. The reconstructed 
data were consistent with the summaries presented in the original paper except for 
daily counts of deaths, of which the reconstructed data set were lower than in the 
original paper due to restrictions on residence and place of death. Results from the 
reconstructed data resembled those of the original paper. For example, the estimated 
association of a 10pg/m3 increase in 2 -day mean particulate air pollution on total 
mortality was 1.3% (95% Cl 0.9-1.7%) for PM2.5 based on the reconstructed dataset, 
compared to the originally reported association of 1.5% (95% Cl 1.1-1.9%). These 
results from the reconstructed dataset confirmed the validity of the original findings 
and shown that they could be replicated. Using mortality and pollution data obtained 
from St Louis and eastern Tennessee, Dockery together with Schwartz and co­
workers investigated the mortality of all non-accidental deaths in those areas for a 1 - 
yr period from September 1985 through August 1986 [Dockery et al 1992]. Using 
Poisson regression models which controlled for possible meteorological and seasonal 
influences, total mortality in St. Louis was increased by 16% (95% Cl 1-33%) per 
100pg/m3 increase in PMio, and by 17% (95% Cl 12-57%) in eastern Tennessee. No
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statistically significant associations were found with gaseous pollutants including S0 2 , 
NO2, and ozone. Despite the relatively short monitoring period of the study, which 
may have limited its ability to detect associations, it nevertheless generated consistent 
results with other US studies and showed a positive association between air 
particulates pollution and mortality.
Ostro added further evidence of the association between particulate air pollution and 
mortality by studying death counts and PM2.5 in two Southern California counties 
with a population of approximately 2.8 million people [Ostro 1995]. For the years 
1980 through 1986, daily non-accidental death data were collected along with PM2.5 
concentrations, weather, and meteorological information. Poisson regression models 
generated results that showed a positive association between PM2.5 levels and 
mortality, although such relationship was affected by seasons. When the full years’ 
data were included in the model, relationships were found between PM2.5 
concentrations and total mortality (RR = 1.004; 95% Cl 0.99-1.02), respiratory 
mortality (RR = 1.03; 95% Cl 0.99-1.06), cardiovascular mortality (RR = 1.01; 95% 
Cl 0.99-1.02), and mortality in those aged 65 or above (RR = 1.01; 95% Cl 0.99-1.02) 
per 36pg/m3 change in PM2.5 concentrations, although they all marginally failed to 
reach statistical significance. However, when only data from the summer quarters 
were applied to the model, the effects of PM2.5 on total mortality and respiratory 
mortality were increased to 1.03 (95% Cl 1.00-1.05) and 1.08 (95% Cl 1.01-1.14) 
respectively. There were no significant changes for cardiovascular mortality nor 
mortality in individuals aged 65 or above.
The National Mortality, Morbidity and Air Pollution Study (NMMAPS) was a large- 
scale time-series study carried out in 20 major US cities covering a total population of 
50 million people [Samet et al 2000]. Daily mortality rates were obtained from the 
National Centre of Health Statistics between 1987 and 1994, and all deaths due to 
natural causes were classified according to age group (<65yrs, 65-74yrs, and >75yrs) 
and cause of death (cardiorespiratory and other). Weather data and air pollution data 
were obtained from the Environmental Protection Agency. To avoid potential 
consequences of outlying values the highest and lowest 10% of air pollution values 
were excluded in the analysis, and the mean PMio levels throughout the duration of 
the study ranged from 23.8pg/m3 to 46.0pg/m3 across the cities after the 10%
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trimming was applied. Results showed that the levels of PMio had greater effects on 
the rate of deaths from cardiorespiratory causes than all causes. The estimated 
increase risks of death were 0.51% (95% Cl 0.07-0.93) for all causes and 0.68% (95% 
Cl 0.20-1.16) for cardiorespiratory causes per 10pg/m3 increase in PMio. No 
significant differences were seen across different age groups. After adjustment for 
other pollutants including ozone, nitrogen dioxide, sulphur dioxide, and carbon 
monoxide, the effects of PMio on mortality rates did not change considerably, 
suggesting that the findings were not affected by confounding by other pollutants.
Goldberg et al examined the relationships between particulate air pollution and daily 
mortality in Montreal, Quebec [Goldberg et al 2000a]. Between 1984 and 1993, 
140,939 non-accidental deaths occurred in the region along with air pollution data and 
weather data were analysed by Poisson regression models. Amongst all the pollutants 
studied, namely COH, TSP, PMio, and PM2.5, only COH showed significant 
associations with total mortality. For every 1.85 units increase in COH, the mean 
percentage changes in total mortality were 1.44% (95% Cl 0.75-2.14%), 1.12% (95% 
Cl 0.42-1.82%), and 1.98% (95% 1.07-2.90%) for the concurrent day, 1 day 
following an increase in pollution, and 3-day average running mean respectively. For 
cause-specific mortality, the mean percentage changes in death counts from 
respiratory diseases in subjects aged >65 were 4.06% (95% Cl 1.59-6.59%), 4.65% 
(95% Cl 2.24-7.11%), and 6.9% (95% Cl 3.69-10.21%) per 1.85 units increase in 
COH for the concurrent day, 1 day following an increased in air pollution, and 3-day 
moving average respectively [Goldberg et al 2000b]. No statistically significant 
associations were found between cardiovascular disease and COH level.
Studies carried out in Europe also generated consistent results. In Valencia, Spain, 
Ballester et al examined the non-accidental and cause-specific mortality occurred 
between 1991 and 1993 [Ballester et al 1996]. Concentrations of daily black smoke in 
the city were monitored by three stationary monitoring stations and the mean daily 
level in the study was 67.7|ng/m3. Poisson regression models showed significant 
positive associations between black smoke and mortality. The estimated relative risk 
of dying corresponding to a lOpg/m3 increase in mean daily black smoke over the 
whole period was 1.009 (95% Cl 1.003-1.015). For mortality in the group aged >70
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years and for cardiovascular mortality, the relative risks were 1.008 (95% Cl 1.001- 
1.016) and 1.012 (95% Cl 1.003-1.022) respectively. No significant associations were 
found between mortality from respiratory diseases and black smoke. In East Berlin of 
Germany, non-accidental mortality occurred in the winters of 1981-1989 were studied 
[Rahlenbeck and Kahl 1996]. Using regression analysis including daily mean levels of 
suspended particulates controlled for temperature, humidity, day of week, month, and 
year, the authors found that pollution caused by suspended particulates was a 
significant contributor to excess mortality. The strongest association was found for 
mortality 2 days after an increase in particles level. When omitting days with pollutant 
concentrations above 150pg/m , the pollutant-mortality relationship became linear. 
For every 100pg/m3 increase in suspended particulates it was associated with a 6.1% 
increase in mortality 2 days later. When SO2 levels were included in the model, the 
effects of particles on mortality was reduced to 4.6%, suggesting there was a 
combined effect from both pollutants.
A large-scale multi-centre European project, the APHEA project (Air Pollution and 
Health: a European Approach), investigated the effects of particulate matters on daily 
mortality across 12 European cities [Katsouyanni et al 1997]. The length of the study 
period varied between cities, but the overall duration was from 1975 to 1992 covering 
over 23 million populations. Poisson regression modelling was used to analyse the 
effects of particles measured as black smoke as well as PMio, and controlled for 
confounding factors such as seasonal and long term patterns, daily temperature, 
humidity, day of the week, holidays, and influenza epidemics. Because of the 
difference in geography, the participating cities showed a high degree of variation in 
air pollution concentrations, seasonal patterns, and meteorological and climatic 
conditions. Mean winter concentrations of black smoke varied from 10 to 290pg/m3. 
Typical patterns of winter and summer type smog were observed, with some cities 
having particularly high winter type smog, dominated either by sulphur dioxide (e.g. 
Milan, Italy) or particles (e.g. Cracow, Poland), while others had relatively high air 
pollution of both types (e.g. Athens, Greece). Results of each city were pooled into 
two groups namely western European cities and central eastern cities. The estimated 
relative risks associated with a 50pg/m3 change in 24hrs were 1.029 (95% Cl 1.021- 
1.037) for black smoke and 1.021 (95% Cl 1.012-1.030) for PMio in the western 
European cities. In central eastern cities, the relative risks were 1.006 (95% Cl 0.997-
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1.011) for black smoke and 1.043 (95% Cl 1.003-1.085) for PMj0. When results from 
all cities were pooled together, the relative risk of death due to black smoke was 1.013 
(95% Cl 1.009-1.017) and 1.022 (95% Cl 1.013-1.031) due to PMio. All relative risk 
estimates were calculated as the cumulative effects of 24hr moving average. The 
authors commented that, despite the variations between the western European cities, 
the consistency of results supported a causal association between exposure to 
particulate matter and mortality from all causes. As part of the APHEA project Aga 
and colleagues investigated the short-term effects of ambient particles on mortality in 
the elderly aged 65 or above [Aga et al 2003]. Using Poisson regression models and 
pooled data of all cities, results showed an increased relative risk of death in the 
elderly population of 0.8% (95% Cl 0.7-0.9%) and 0.6% (95% Cl 0.5-0.8%) for every 
lOpg/m increase in PMio and black smoke respectively. The estimated effect sizes 
could be modified by the long-term mean level of nitrogen dioxide (higher levels 
were associated with larger effects), temperature (larger effects were observed in 
warmer countries), and by the proportion of elderly in each city (a larger proportion 
was associated with higher effects).
Results of a meta-analysis carried out by the WHO to evaluate the health effects of 
particulate air pollution was published in 2004 [Anderson et al 2004]. Estimates of 
all-cause mortality were extracted from 33 European cities and the summary relative 
risk was 1.006 (95% Cl 1.004-1.008) for every 10pg/m3 increase in PMio 
concentrations. For disease-specific mortality, estimates were pooled from 17 and 18 
European cities for cardiovascular and respiratory deaths respectively, and the 
corresponding summary relative risks were 1.009 (95% 1.005-1.013) and 1.013 (95% 
Cl 1.005-1.020) per every lOpg/m increase in PMio levels. The estimate for all-cause 
mortality was very similar to those obtained in the NMMAPS carried out in 20 major 
US cities (RR = 1.005 for every 10pg/m3 increase in PMio).
For all of the studies reviewed so far none of them have shown a particular threshold 
of effect, and the estimated relative risk of mortality always increased monotonically 
with particulate concentrations and usually in an almost linear fashion. Results from 
these time-series studies were controversial, partly due to the fact that the lack of 
biological mechanisms to explain the observed mortality, especially at low levels of 
particulate air pollution. Some suggested that the observed associations might be due
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to the selection of modelling technique, or due to confounding by other factors such 
as season, weather, other pollutants, or some other unknown factors [Lipfert and 
Wyzga 1995, Moolgavkar and Luebeck 1996].
2.1.2 Changes in respiratory symptoms in children
In comparison with the number of studies investigating how air particulates increase 
mortality in short-term, relatively few studies have been carried out to demonstrate 
how disease symptoms change prior to, during, and after an air pollution episode. 
Most of these studies were panel-based and involved small groups of participants, 
with the majority of them carried out in children. Symptoms of respiratory or other 
diseases are recorded using daily diaries, which is an easy and inexpensive way to 
evaluate acute changes in respiratory health studies. While some studies focused on 
asthmatics and exacerbation of asthma symptoms caused by air pollution, many 
followed non-asthmatics and evaluate changes in acute respiratory health status more 
generally. Reported symptoms were often divided into upper respiratory illness (URI) 
including runny or stuffy nose, sinusitis, sore throat, wet cough, and irritated eyes, and 
lower respiratory illness (LRI) including wheezing, dry cough, phlegm, shortness of 
breath, and chest discomfort or pain. In addition to these, cough was the most 
frequently reported symptom and was often analysed separately. Often, small if 
statistically significant associations were observed between particulate air pollution 
and respiratory symptoms.
One of the earliest studies investigating the acute effects on children’s respiratory 
symptoms was carried out by Vedal and colleagues in 1987 [Vedal et al 1987]. The 
study location was the Chestnut Ridge region of western Pennsylvania of the United 
States, where air pollution was generated from a large number of coal-fired power 
plants. A panel of 351 school children living in the most polluted areas in the region 
were recruited into the study. However, throughout the 8-month study period only 128 
participated in the completion of symptoms diary recording daily changes in 
respiratory symptoms. The pollutant of interest was the CoH measured by a single 
monitoring station within the study region. Using multiple regression models which 
controlled for temperature and other gaseous pollutants, no statistically significant 
associations were found between CoH levels and URI and wheeze. Although other 
LRI excluding wheeze showed stronger associations with CoH, the relationships
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found were statistically insignificant. For every 0.5 units increase in CoH, the odds 
ratios of the occurrence of URI, wheeze, and LRI excluding wheeze on days with 
higher levels of pollution were 0.9 (95% Cl 0.76-1.07), 1.0 (95% Cl 0.97-1.06), and
1.3 (95% Cl 0.93-1.82) respectively.
Most respiratory symptoms studies were undertaken in the 1990s and they provided 
evidence that air particulates were capable of triggering acute respiratory symptoms. 
Again in Pennsylvania, United States, Neas and colleagues recruited 108 children and 
asked their parents to complete diaries twice daily of their children’s symptoms and 
hours spent outdoors [Neas et al 1996]. Regression models showed that for a 20pg/m3 
increment in 24-hour mean respirable particles, there was an increase in the incidence 
of cough episodes that evening or the subsequent morning (OR = 1.37; 95% Cl 1.13- 
1.66). Increased incidence of cold episodes on the same evening or the subsequent 
morning was found for 12-hour day time levels of particles with strong acidity (OR = 
1.35; 95% Cl 1.14-1.61). Similarly in northern Mexico City, Mexico, 71 children 
aged 5-7yrs with mild asthma were enrolled in a study to find out the relationship 
between air pollution and exacerbation of childhood asthma [Romieu et al 1996]. 
Daily changes in symptoms including cough, phlegm production, wheezing, and 
difficulties in breathing were recorded in daily diaries. Regression analysis showed 
that an increase of 20pg/m3 in 24-hour average PMio was related to an 8% (95% Cl 
4%-15%) increase in LRI on the same day, and an increase of 20pg/m3 in the weekly 
mean PM2.5 was related to a 21% (95% Cl 8%-35%) increase in LRI.
Yu et al observed a panel of 133 children aged 5-13yrs with asthma residing in 
Seattle, United States [Yu et al 2000]. Between 1993 and 1995, information on 
respiratory symptoms the children experienced were obtained via daily symptoms 
diary. The average number of days of diary data provided by each child was 58, with 
a range of 28-112 days. Daily levels of PM10 and PMi were monitored by 3 different 
sites in the greater Seattle area. In addition, meteorological data were also collected. 
Logistic regression models were used for the analysis which were controlled for age, 
sex, race, baseline height, and other potential time-dependent factors such as day of 
week, season, and temperature 2 days after an air pollution episode. Results showed 
significant associations between the levels of air particulates and exacerbation of
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asthma symptoms. For a 10pg/m3 increase in PMj0 level, the odds ratios of short-term 
asthma symptoms were 1.09 (95% Cl 1.01-1.18), 1.11 (95% Cl 1.03-1.20), and 1.08 
(95% Cl 1.01-1.17) for the same day, 1 day after, and 2 days after an air pollution 
episode respectively. As for PMi, the odds ratios were 1.18 (95% Cl 1.05-1.33), 1.17 
(95% Cl 1.04-1.33), and 1.09 (95% Cl 0.98-1.21) per 10pg/m3 increase in its level. 
Vedal at al studied the health effects of particulate air pollution on 200 school 
children aged 6-13yrs from Port Albemi, Canada [Vedal et al 1998]. Due to the 
geographical location of the area it is frequently subjected to thermal inversions that 
trap air pollutants in the atmosphere, particularly during winter. The main sources of 
air particulates were the boilers of a local pulp mill and residential wood burning. 
Data were recorded daily by respiratory symptoms diaries for up to 18 months 
between 1990 and 1992, during which time when ambient PMio concentrations were 
monitored by an automated monitoring site located to the north of the pulp mill. 
Throughout the study period, the 24hr average concentration of PMio was 22.1pg/m3, 
with a maximum of 159pg/m . Logistic regression analysis controlled for 
meteorological factors showed associations between PMio and a range of respiratory 
symptoms in the children. For every 10pg/m3 increase in PMio above the mean daily 
concentration of 27.3 pg/m3, the odds ratios were 1.07 (95% Cl 1.02-1.11) for cough, 
1.07 (95% Cl 1.00-1.13) for phlegm production, 1.04 (95% Cl 1.00-1.08) for nose 
symptoms, 1.06 (95% Cl 1.01-1.11) for throat soreness, and 1.06 (95% Cl 1.02-1.10) 
for both cough and phlegm. These odds ratios were calculated using cumulative 
estimates of l-4days following an air pollution episode. In addition, positive but 
statistically insignificant associations were also found between PMio and other 
symptoms including those of the eyes (OR = 1.05; 95% Cl 0.97-1.13), wheeze (OR = 
1.03; 95% Cl 0.96-1.10), chest tightness (OR = 1.06; 95% Cl 0.97-1.16), and 
dyspnoea (OR = 1.01; 95% Cl 0.94-1.08).
Studies carried out in Europe also generated results that were consistent to their 
American counterparts, van der Zee and co-workers investigated the effects of air 
particulates on acute respiratory symptoms in children in the Dutch cities Rotterdam 
and Amsterdam [van der Zee et al 1999]. Rotterdam is an industrialised city with 
about 600,000 inhabitants at the time of the study; in contrast, Amsterdam with a 
population of 720,000 has few industrial developments and local air pollution was
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caused primarily by emissions from motor traffic. Three non-urban areas close to 
Rotterdam and Amsterdam were selected as control areas, which had no major traffic 
emissions, no large industrial sources, and had sufficient size to select enough 
children. Groups of children from urban and non-urban areas were further divided 
into two groups depending on whether or not they suffer from chronic respiratory 
symptoms. Throughout the study period between 1993 and 1995, parents of 630 
children aged 7-1 lyrs old completed daily respiratory symptoms diaries and provided 
the data for analysis. Symptoms included in the diary were cough, phlegm, runny or 
stuffed nose, eye irritations, sore throat, woken up with breathing problems, shortness 
of breathe, wheeze, and attacks of shortness of breathe with wheeze and fever. 
Information on medication use were also collected. Twenty-four hour-measurements 
of PMio, black smoke, gaseous pollutants, and meteorological data of all study areas 
were obtained through fixed monitoring sites. Regression analysis showed positive 
associations between air particulates and acute respiratory symptoms in both the 
exposed and control groups, but the effects were greater in those already suffering 
from chronic symptoms. For example, children residing in urban areas were more 
likely to report LRI than their non-urban counterparts (OR = 1.48 v 1.04, per 
100pg/m3 increase in PMio in the day after an air pollution episode). In addition, 
children from urban areas also reported a higher usage of bronchodilator (OR = 1.29 v 
0.82, per 100pg/m3 increase in PMio on the day of an air pollution episode), and that 
residing in non-urban areas seemed to have a protective effect. No associations were 
found between pollution level and acute cough and URI in either group. For children 
without chronic symptoms, they appeared to be less affected by air pollution than 
symptomatic children, and neither URI nor cough were shown to have any 
associations with PMio levels. The only exception was cough in non-urban children, 
with an odds ratio of 0.88 (95% Cl 0.80-0.97) per 100pg/m3 increase in PMio in the 
day after an air pollution episode, suggesting a protective effect of living in non-urban 
areas. Finally, children who suffered from chronic respiratory symptoms were also 
compared based on whether or not they use any medications for their conditions. 
Children on medication for asthma residing in urban areas were more likely to suffer 
from LRI than any other children in the study (OR = 1.80, 95% Cl 1.17-2.75, per 
100pg/m3 increase in PMio on the day of an air pollution episode), suggesting that
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children with severe underlying respiratory conditions were particularly vulnerable to 
the acute effects of air particulates.
Peters et al studied a small panel of 89 school children for 7 months between 1991 
and 1992 in the Czech Republic [Peters et al 1997a]. The city of Sokolov was chosen 
for the study because of its large coal-fired power plant. The wide use of brown coal 
or lignite with high sulphur and ash content, for both domestic heating and small scale 
industries further contributed to the high levels of air pollution. The children 
participated in the study were aged 6-14yrs, and were either asthmatics or suffered 
from chronic respiratory disease who regularly attended outpatient clinics. Pollutants 
including TSP, PMio, and particles with strong acidity together with meteorological 
variables were routinely measured at one central site in the city. Throughout the study 
period the average TSP and PMio concentrations were 88|ng/m3 and 55pg/m3 
respectively. For particles with strong acidity, the levels were below the minimum 
detection limit on 79% of the days despite high SO2 concentrations. Regression 
models adjusted for temperature, day of week, and other gaseous pollutants have 
shown significant associations between respiratory symptoms reported in the children 
and various air pollutants. For TSP, every 70|ng/m increase in concentration was 
associated with a 6% increase (95% Cl 1%-11%) in phlegm production on the same 
day, and the effect was larger with PMio with a 9% increase (95% Cl 3%-16%) in 
odds per 45pg/m3 increase in its level. Associations were also found between TSP and 
dyspnoea (OR = 1.01; 95% Cl 0.96-1.07) as well as PMio and cough (OR = 1.01; 
95% Cl 0.97-1.06), and runny nose (OR = 1.03; 95% Cl 0.99-1.07) on the same day 
of an air pollution episode, although the results marginally failed to reach statistical 
significance. Increased use of asthma medication was also found to be associated with 
TSP, with an odds ratio of 1.14 (95% Cl 1.02-1.28) on the same day.
In Paris, France, Just et al followed a panel of 82 medically diagnosed asthmatic 
children for 3 months from April to June 1996 [Just et al 2002]. These children were 
recruited from an outpatient clinic of a local children’s hospital and their age range 
was 7-15yrs. Parents of the children kept daily symptoms diary during the study 
period, and at the end of each day they were to record the presence or absence of 
asthma attacks, upper or lower respiratory infections with fever, and the frequency of
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medication use of their children. Daily black smoke and PM 13 concentrations were 
collected from 5 monitoring stations within the city together with meteorological 
information and pollen counts. Logistic regression models adjusted for other factors 
such as meteorological variables, levels of pollens and other gaseous pollutants were 
used in the analysis. Results showed that for every 1 Opg/m3 increase in black smoke, 
the odds ratios of developing nocturnal cough in a child who had been free from any 
asthma symptoms the day before an air pollution episode, were 1.22 (95% Cl 0.99- 
1.51) and 1.36 (95% Cl 1.00-1.86) on the day and within 2 days of an air pollution 
episode respectively. For respiratory infections, the odds were larger at 1.96 (95% Cl 
1.35-2.84) and 2.08 (95% Cl 1.03-4.21) on the day and within 2 days of an air 
pollution episode respectively. No associations were found between black smoke and 
asthma attacks, nor PM 13 and any of the studied symptoms.
So far the reviewed studies have shown some evidence suggesting associations 
between exacerbation of respiratory symptoms and air particulates pollution, even 
though the effects were often small, and sometimes only marginally significant. 
However, not all studies have yielded positive findings. For example, Hoek and 
Brunekreef recruited 1,000 children from 3 Dutch non-industrial communities and 
followed them from 1987 to 1990 [Hoek and Brunekreef 1992]. They found no 
associations between PMio and any of the respiratory symptoms studied including 
cough (OR = 1.10; 95% Cl 0.67-1.79), LRI (OR = 0.88; 95% Cl 0.40-1.91) and URI 
(OR = 1.06; 95% Cl 0.71-1.57). Similarly in Sydney, Australia, 125 children were 
studied for 11 months in 1994 and no associations were found between pollution and 
symptoms [Jalaludin et al 2002]. For every 12pg/m3 increase in daytime ambient 
PMio concentration, the odds ratios were 1.01 (95% Cl 0.99-1.03), 1.00 (95% Cl 
0.98-1.03), 1.01 (95% Cl 0.99-1.04), and 0.99 (95% Cl 0.98-1.01) for wheeze, dry 
cough, wet cough, and increased medication use on the day of an air pollution episode 
respectively. Although it is arguable that the odds ratios of wheeze and wet cough 
were only statistically marginally insignificant, the fact that the effects were so small 
in such a small group of children (n = 125) it is doubtful whether the associations 
were real or were found by chance.
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2.1.3 Changes in respiratory and cardiovascular symptoms in adults
Short-term changes in cardiorespiratory symptoms caused by particulate air pollution 
have also been studied in adults, although the number of studies available for 
reference is fewer compared with those carried out in children. In Southern California, 
United States, Ostro and colleagues followed 321 non-smoking adults over 6-month 
period [Ostro et al 1993]. The participants were asked to fill in daily symptoms 
diaries, which were then used in logistic regression analysis to find out the 
associations between symptoms and ambient sulfates and CoH. Significant 
association was found between ambient sulfates and LRI, with an odds ratio of 1.30 
(95% Cl 1.09-1.54) per 10pg/m3 change in the concentration. However for CoH, 
which is a more general measure of particulates, the authors have found no 
associations with any of the symptoms reported.
Changes in respiratory symptoms in adults were also examined in the Dutch study by 
van der Zee as discussed previously [van der Zee et al 2000]. For the adult study, the 
authors recruited a total of 489 participants aged 50-75yrs from the same regions as 
the children study. Since the two studies were carried out simultaneously, therefore all 
air pollution and meteorological data were identical to one another. In symptomatic 
adults, the effects of PMio in URI were greater in urban adults, although regression 
analysis marginally failed to show statistical significant associations. For every 
100pg/m3 increase in PMio, the odds ratios of developing URI on the same day was 
1.09 (95% Cl 0.93-1.29) in urban adults and 0.99 (95% Cl 0.85-1.14) for non-urban 
adults. Black smoke however, showed a stronger effect than PMio. For example, the 
odds ratio of developing URI on the same day was 1.18 (95% Cl 1.01-1.38) for urban 
adults, and 0.96 (95% Cl 0.82-1.12) for non-urban adults. There were no significant 
evidence linking particulate air pollution to LRI or increased use of bronchodilator in 
any of the subject groups, and no associations were found between URI and air 
pollution in healthy adults without chronic respiratory symptoms.
Another study carried out in Paris, France, selected a panel of 60 adults with severe 
asthma that required frequent medical consultations [Desqueyroux et al 2002]. They 
were followed for 13 months between 1995 and 1996, during which time the levels of 
PMio and other gaseous pollutants were recorded through a network of urban
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background monitoring stations. Every time when the subjects visited their 
physicians, whether it was regularly scheduled or an emergency, the physicians noted 
if the patients were enduring an asthma attack as well as other information such as 
medication use. In addition, the patients also kept a symptom dairy that included 
information such as the presences of an infection, stress, exposure to allergen etc, 
which could help to explain the unusual cause of an attack. Logistic regression models 
were used to estimate the effects of air particulates pollution on asthma symptoms, 
and the results showed that for every lOpg/m increase in ambient PMio levels, the 
odds ratio of severe asthma attacks in the patients was 1.21 (95% Cl 1.04-1.40) over a 
period between 3 to 5 days after an air pollution episode. No figures suggested any 
effects on asthma patients one (OR = 0.87; 95% Cl 0.71-1.06) or two days (OR = 
0.93, 95% Cl 0.80-1.08) after an air pollution episode.
One possible way to examine the acute cardiovascular effects of particulate air 
pollution is by studying the occurrence of ventricular arrhythmias detected by 
implantable cardioverter defibrillators (ICD) and ambient air pollution concentrations 
in the hours immediately before the arrhythmia. ICD devices continuously monitor for 
ventricular arrhythmias and record the date and time of each detected arrhythmia, 
which can then be linked to air pollution data to identify any associations between the 
two. Rich et al studied 203 patients with an ICD in Boston, United States [Rich et al 
2005]. During the follow-up period, 798 ventricular arrhythmias were confirmed in 84 
subjects. By matching with the 24-hour average concentrations of ambient PM2.5, it 
was found that for a 7.8pg/m3 increase in PM2.5, the odds ratios of ventricular 
arrhythmia were 1.08 (95% Cl 0.95-1.21), 1.11 (95% Cl 0.98-.126), and 1.19 (95% Cl
1.02-1.38) within 2hrs, 6hrs, and 23hrs after an air pollution episode respectively. In 
contrast, Peters et al followed 100 cardiac patients with ICD devices in eastern 
Massachusetts, United States for over 3 years but did not find any significant 
associations between the levels of PM2.5 and cardiac arrhythmia [Peters et al 2000].
2.2 Evaluation of long-term effects using chronic exposure studies
While results from time-series studies showed evidence of the acute effects of 
exposure to increased levels of air particulates, little information is provided as to how 
particles effect mortality rates in longer-term nor their ability to induce chronic
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diseases that may lead to increased mortality. When studying long-term effects, 
exposure classification uses spatial differences in air pollution as their outcome across 
communities and neighbourhoods with different levels of air pollution. These studies 
use longer-term pollution data which varies from a year to decades. Chronic exposure 
studies allow the examination of the long-term effects of constant exposures to low or 
moderate level of air particulates over a long period of time, as well as the cumulative 
effects of repeated exposure to elevated levels of pollution.
2.2.1 Increased mortality
Based on several historic events of severe air pollution such as the 1942 Donora smog 
and 1952 London smog, a temporal correlation between air pollution and acute 
increases in mortality was well established. However, subsequent epidemiological 
studies have reported adverse health effects even at a much lower level of particulate 
air pollution [Pope and Dockery 1999]. Three large-scale cohort studies all carried out 
in the United States have shown that prolonged exposure to air particulates increased 
mortality rate in the long-term. Although most epidemiological studies were focused 
on short-term effects, results from these long-term studies provided information that 
exposure to air particulates over a long period of time may be more important in terms 
of overall public health. Of the three long-term exposure studies the earliest one was 
the Harvard Six-Cities Study [Dockery et al 1993]. Random samples of adults were 
selected from six US communities, first started from Watertown in Massachusetts in 
1974 and gradually including other communities in the subsequent years until 1977. A 
total sample of 8,000 white subjects aged 25 to 74yrs at enrolment was recruited. 
Information on vital status were collected from all subjects each year until June 1991. 
The total duration of follow up was 14 to 16 years, which was equivalent to 111,076 
person-years. Death certificates were obtained for 1,401 subjects who died throughout 
the course of the study, of which 8.4% were due to lung cancer and 53.1% were due 
to cardiorespiratory disease. Air pollution data were collected from central monitoring 
stations which measured PM2.5 and PMio and other gaseous pollutants. The average 
concentrations of ambient particulates recorded for the cities ranged from 11.0 to 
29.6pg/m3 and 18.2 to 46.5pg/m3 for PM2.5 and PMio respectively. Cox proportional 
hazards models adjusted for age, sex, smoking, education and body-mass index were 
used for the analysis and examined the adjusted mortality rates across the range of
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exposure for each pollutant among the six cities. The Cox proportional hazards model 
is a regression model commonly used for analysing survival data, and allows the 
estimation of survival curves in the presence of covariates. Using PM2.5 as an 
indicator of air pollution, results showed increased risk of death (RR = 1.37; 95% Cl 
1.11-1.68) due to cardiopulmonary causes in communities with the highest levels of 
pollution. Results also showed higher risks of lung cancer deaths (RR = 1.37; 95% Cl 
0.81-2.31) and all other deaths (RR = 1.01; 95% Cl 0.79-1.30) but were both 
statistically insignificant. Similar results were generated when PMio concentrations 
were studied instead of PM2.5. The authors concluded that because the six cities were 
chosen as representative range of particulate air pollution in the United States, these 
ratios should therefore roughly represent the relative risk associated with that range.
A second large-scale American cohort study on the time line was the Adventist Health 
Study of Smog (AHSMOG Study). In 1977 a total sample of 6,338 non-smoking 
white adults were recruited into the study [Abbey et al 1999]. The participants, aged 
between 27 and 95yrs at enrolment were residents of the Seventh-day Adventists 
(SDAs) of California. The study consisted of relatively old subjects, with a mean age 
of 58.5 years for men and 59.2 years for women. The cohort was followed-up through 
to 1992 in which information on respiratory symptoms, lifestyle, and housing 
characteristics were obtained periodically to classify individuals according to their 
health status as well as estimates of exposures to both ambient and indoor air 
pollution. Concentrations of PM 10 prior to 1987 were estimated using site- and 
season-specific regressions based on TSP. Since 1987 PMio had replaced TSP as the 
particulate pollutant monitored throughout California, so monitored PMio levels were 
available in the following years. Air pollution exposures were estimated based on the 
level of TSP / PMio concentrations recorded in nearby monitoring stations not more 
than 50km away from the residences’ zip code centroids. The monthly mean PMio 
concentration throughout the study was 51.2pg/m3 with the maximum recorded value 
of 83.9pg/m3 and an interquartile range of 24.1 jug/m3. During the follow-up period,
1,628 deaths were identified through record linkage with the state and national death 
certificate files, as well as the authors’ own tracing through the church records. Sex- 
specific adjusted mortality relative risks were estimated using Cox proportional 
hazard models adjusted for exposure to passive smoking, education, occupation, and
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body mass index. Since air pollution data were not available prior to 1973, the authors 
had to omit the first 3 years of cancer deaths (1977-1979) in the analysis to allow the 
relatively long latency period between exposure and cancer development. In the 
single-pollutant analysis, results showed for men only an increased exposure of 
43days/yr to PMio concentrations exceeded 100pg/m3, the relative risks of death were 
1.12 (95% Cl 1.01-1.24) for all natural causes, 1.28 (95% Cl 1.03-1.57) for non- 
malignant respiratory diseases, and 2.38 (95% Cl 1.42-3.97) for lung cancer. 
Increased risk of death from cardiorespiratory diseases was also seen but marginally 
failed to achieve statistical significance (RR = 1.09; 95% Cl 0.95-1.24). In contrast, 
no statistically significant associations were found in women for all natural causes 
(RR = 0.94; 95% Cl 0.86-1.03), cardiopulmonary diseases (RR = 0.90; 95% Cl 0.80- 
1.01), non-malignant respiratory diseases (RR = 1.10; 95% Cl 0.91-1.33), and lung 
cancer (RR = 1.08; 95% Cl 0.55-2.13). As part of the AHSMOG study, McDonnell 
et al studied a subset of samples of 3,700 males who resided near airports. However, 
this time no statistically significant associations were found between particulate air 
pollution and mortality of all natural causes, lung cancer, and respiratory disease 
[McDonnell et al 2000].
The third large-scale cohort study was carried out based on data collected by the 
American Cancer Society (ACS) Cancer Prevention Study (CPS-II), involving 
approximately 1.2 million adults [Pope et al 2002]. Recruitment of subjects was 
carried out with the assistance of 77,000 ACS volunteers in 1982 from all 50 US 
states, the District of Colombia, and Puerto Rico, and were generally their relatives, 
friends, neighbours, or acquaintances [Thun et al 2000]. Enrolment was restricted to 
individuals who were 30yrs of age or above and who were members of households 
with at least one individual aged 45yrs or older. Basic background information of the 
participants such as demographic characteristics and disease history were obtained 
through the completion of a self-administered questionnaire. Deaths were recorded 
via a linkage to the US National Death Index as well as reports from relatives and 
friends of the deceased individuals. The analysis of the relationship between mortality 
and air pollution was restricted to a subset of adults where pollution data were 
available in their areas of residence. As a result the authors included only 295,000 
adults in the final analysis. Estimated concentrations of PM2.5 based on the levels of
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TSP and PMio were used in the analysis, because PM2.5 was not monitored in the 
United States until 1999 as a consequence of the new air particulates monitoring 
standard. Between the period of 1979 and 1983, daily concentrations of PM2 5 were 
estimated to be 21.1pg/m3. A total of 20,765 deaths were recorded in this sub-sample 
and death certificates were obtained for 96% of the total deaths. Using Cox 
proportional hazard models stratified by sex, race, and 5-year age groups, risk ratios 
of all-cause and cause-specific mortality were estimated after adjusting for smoking, 
education, body mass index, alcohol consumption, and occupational exposure to a 
number of substances. Results showed that for all cause mortality due to exposure to 
PM2.5 between 1979 and 1983, the adjusted relative risk associated with a lOjug/m3 
change in PM2.5 was 1.04 (95% Cl 1.01-1.08). The relative risks of death were 1.06 
(95% Cl 1.02-1.10) for cardiorespiratory diseases and 1.08 (95% Cl 1.01-1.16) for 
lung cancer. No association was found for all other causes (RR = 1.01; 95% Cl 0.97- 
1.05).
In 2000, the Health Effects Institute (HEI) of the United States commissioned a 
reanalysis of the Harvard Six-cities study and the ACS study [Krewski et al 2003]. 
Raw data of the Harvard study and the regenerated data of the ACS study were 
audited. A few minor errors were discovered but once corrections were made they did 
not have any marked effects on the original results. The reanalysis also extended to 
cover some key questions raised when the results were first published, including 
physical activity, lung function, population mobility, martial status, measures of 
income, unemployment, maximum temperature, hospital beds per unit of population, 
water hardness, and a more detailed examination of smoking, occupation, education 
and age, but no confounders were discovered that would otherwise significantly 
change the associations found. The reanalysis also found that when age group was 
stratified the risk per unit measurement of particulate matter did not vary markedly 
between the <50, 50-65 and >65 years old, nor in subjects with pre-existing heart or 
lung diseases or in smokers and non-smokers.
After the HEI reanalysis was published, the Institute of Occupational Medicine (IOM) 
developed a methodology for quantifying the long-term effects of air pollution in the 
UK [COMEAP 2000, COMEAP 2001]. The analysis linked the result of the US
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cohort studies and adapted it with the age and mortality characteristics of the UK 
population. This allowed an estimate of the possible life loss due to long-term 
exposure to particles. Based on the population of England and Wales alive in 2000, 
COMEAP made the following estimations; if a 10pg/m3 reduction in PMio was 
maintained for the rest of the lives of this population, then the population would gain 
between 4 and 26 million life years with a mid-estimate of 7.5 to 17.5 million life 
years, which is equivalent to about 1 to 6 months per person; if the 10pg/m3 reduction 
was maintained for 5 years, the population would gain 10,000 to 350,000 life years 
with a mid-estimate of 20,000 to 240,000 life years, which can be expressed in 
another way as a reduction of 1,500 to 48,000 deaths over 5 years. However, it should 
be noted that the gains in life expectancy are unlikely to be equally distributed 
amongst the whole population. The benefits of reduction in PMio have also been 
calculated in the APHEIS study (Air Pollution and Health: A European Information 
System) [Medina et al 2002]. For long-term risks, it was estimated that a decrease of 
5pg/m3 in ambient PMio levels with other factors unchanged in 9 French cities would 
prevent 1,561 anticipated deaths. When the same scenario is applied in 19 European 
cities with a total population of 32 million people, 5,547 deaths would be prevented. 
Finally if the annual PMio limit of 20pg/m3 set by the European Commission were 
achieved in those 19 European cities, a total of 11,855 deaths would be prevented.
A European study carried out in the Netherlands investigated the long-term 
consequences of exposure to traffic-related air pollution in a cohort of 5,000 people 
aged 55 to 69yrs [Hoek et al 2001, Hoek et al 2002]. Subjects were chosen from the 
full cohort of the Netherlands Cohort Study on Diet and Cancer (NLCS) started in 
1986 and involved 120,000 participants aged 55-69 years at enrolment. Exposure to 
traffic-related black smoke was estimated based on the subjects' areas of residences 
and the regional and urban background concentration. The authors estimated that local 
motor traffic emissions would lead to spatial variations between areas resulting in a 
higher concentration of pollutants at short distances from major road. As a result 
geographic information system (GIS), which is a computer system for managing 
spatial data, was used to classify participants living within a 100m distance from a 
freeway or 50m from a major road as exposed. The mean level of exposure to outdoor 
air pollution in long-term was calculated as a function of the regional background
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pollution, pollution from urban sources (urban background), and pollution from 
nearby sources (nearby streets/roads). Both regional background and urban 
background were estimated using the black smoke data obtained from the National 
Air Quality Monitoring Network. As for local sources, the authors used measurement 
data from two Dutch traffic studies. On the basis of the data, living within 100m of a 
freeway resulted in exposure to black smoke concentration of 4.4pg/m3, and for 
people living within 50m of a major inner-city road they were estimated to be exposed 
to 13pg/m of black smoke concentration. These estimates were assigned to each 
exposed address independent of the actual distance to the road. After adjusting for 
confounders such as smoking habit, exposure to passive smoking, occupation, and 
alcohol consumption, results showed a relative risk of 1.95 (95% Cl 1.09-3.51) for 
cardiopulmonary mortality amongst those who were living close to major roads. No 
relationships were found between exposure to black smoke and respiratory diseases or 
lung cancer. This study used a different approach from the two American cohort 
studies mentioned previously, in which exposure to air pollutants were based on the 
proximity of the residences from any major freeways or urban roads. In contrast, the 
American studies used an ecological indicator of exposure and assumed the same 
level of exposure across the same geographical area.
While increased mortality as a response to particulate air pollution was observed in 
adults, studies have shown similar effects in infants in their postneonatal period which 
appeared to be specific to respiratory causes. In the Czech Republic, Bobak and Leon 
studied 2,500 infant deaths between 1989 and 1991 and the possible association with 
TSP exposure in a case-control study [Bobak and Leon 1999]. After adjusting for 
maternal socioeconomic status, birth weight, birth length, and gestational age, the 
authors found a strong effect of TSP on postneonatal mortality from respiratory 
causes with an odds ratio of 1.74 (95% Cl 1.01-2.98) per 50pg/m3 increase in the 
pollutant’s concentration. The effects seen were independent of socioeconomic factors 
and were not mediated by birth weight or gestational age. Results of this study 
confirmed Bobak and Leon’s earlier findings, in which a relative risk of postneonatal 
mortality of 2.41 (95% Cl 1.10-5.28) was observed in neonates who were exposed to 
the highest quintile of TSP compared with those exposed to the lowest quintile 
[Bobak and Leon 1992]. Woodruff et al analysed the association between early
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postneonatal mortality and PMio levels in approximately 4 million infants bom 
between 1989 and 1991 in the United States [Wooddruff et al 1997]. The subjects 
were formed into different categories of high, medium, and low according to their 
levels of exposure to ambient PMi0. The overall mortality rates per 1,000 births were
3.1 among infants with low PMio exposures, 3.5 among infants with medium PMio 
exposures, and 3.7 among infants with high exposures. The effects were then 
examined by logistic regression controlled for demographic and environmental 
factors. The odds ratio of total postneontal mortality for the high exposure versus low 
exposure groups was 1.1 (95% Cl 1.04-1.16). In infants with normal birth weight, 
exposure to high levels of PMio was associated with respiratory deaths (RR = 1.4; 
95% Cl 1.05-1.85) and sudden infant death syndrome (RR = 1.26; 95% Cl 1.14-1.39). 
No statistically significant results were found in infants with low birth weight.
2.2.2 Increased cancer incidence and mortality
Evidence showing an increasing incidence of lung cancer in the United States and 
Western Europe has led researchers to examine the possible role of air pollution on 
cancer development. In industrialised urban areas, known human carcinogens such as 
benzo[a]pyrene can be found in the outdoor air attached onto the surfaces of 
carbonaceous particles of the respirable range. Combustion of fossil fuels also 
releases carcinogenic particles into the air - diesel exhausts have been classified as a 
probable human carcinogen by the IARC [IARC 1989]. Few studies have been carried 
out to answer the question as to whether particulate air pollution causes lung cancer. 
The methods used were usually population-based cohort study design or case-control 
study design. Nonetheless they have both produced consistent results, showing 
positive relationships between particulate air pollution and cancer.
In Italy, Barbone et al conducted a case-control study to examine the relationships 
between lung cancer mortality and exposure to particulate air pollution [Barbone et al
1995]. From 1979 to 1981 and from 1985 to 1986 the levels of exposure to TSP of 
1,510 deceased individuals were studied, of which half died of lung cancer and the 
other half died from other causes. After controlling for age, smoking, and occupation, 
the odds ratios of lung cancer deaths were 1.5 (95% Cl 1.0-2.2) for residents of the 
city area, 1.4 (95% Cl 1.0-2.1) for residents of the industrial area, and 0.6 (95% Cl 
0.4-1.0) for residents of the rural area. In Poland, Jedrychowski et al studied 2,100
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individuals and compared their exposures to TSP [Jedrychowski et al 1990]. After 
adjusting for age, smoking, and occupation, the odds ratio of developing lung cancer 
amongst men living in highly polluted areas was 1.5 (95% Cl 1.1-2.0) compare with 
those living in areas with low pollution levels.
In the United States, Vena studied 1,100 individuals residing in different areas within 
the Erie County of New York between 1957 and 1965 [Vena 1982]. Mean TSP levels 
ranged from 80 to 200pg/m across towns. Results showed that for men exposed more 
than 50yrs to high levels of particulate air pollution, the odds ratio of lung cancer 
development was 1.7 (95% Cl 1.0-2.9) after adjusting for age, smoking, and 
occupation. In Canada, a study of 96 women showed when residing in large urban 
areas the odds ratio of developing lung cancer was 2.3 times higher than those 
residing in small town or the countryside [Holowaty et al 1991]. Using data extracted 
from the cohort of the AHSMOG study, Beeston et al calculated that for an increase 
of 24pg/m in PMio concentrations, the relative risk of developing lung cancer was 
5.21 (95% Cl 1.94-13.99) among men. In contrast no statistically significant 
associations were observed in women. The authors explained the differences seen 
could be due to gender differences in exposure. Sanasuttipun et al studied 1,400 cases 
of lung cancer and 1,800 controls from the regions of Connecticut and Utah / Idaho, 
United States, retrospectively [Sanasuttipun et al 2002]. Among the regions, 
Connecticut had a relatively lower annual TSP level. Adjustments were made for age, 
sex, and cigarette consumption in the analysis and the selection probabilities used in 
randomised recruitment were also accounted for. Results showed that the odds ratios 
of lung cancer per 10pg/m3 increase in TSP was 2.4 (95% Cl 2.0-3.0) for 
Connecticut, and 1.3 (95% Cl 1.1-1.5) for Utah / Idaho. Connecticut showed higher 
odds of lung cancer despite its relatively lower level of annual TSP. The authors 
proposed that this could be due to differences in the physical and chemical 
compositions between the areas.
2.2.3 Effects on birth outcome
Studying the effects of air pollution on birth outcome has become an important 
emerging field in environmental epidemiology. Birth outcomes serve as indicators of 
the health of the newborns and infants, and complications such as low birth weight
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and prematurity are known to influence the subsequent health status of the individual. 
These include increased mortality and morbidity in childhood and an elevated risk of 
hypertension, coronary heart disease, and non-insulin-dependent diabetes in adulthood 
[Barker 1995, Osmond and Baker 2000]. For foetuses, due to their developing organ 
systems, physiological immaturity, and high rates of cell proliferation are particularly 
vulnerable to environmental pollutants [Perera et al 1999, Sram 1999] -  a concept 
being similar to the association between maternal active and passive smoking and 
impaired reproductive outcomes. In a population-based case-control study carried out 
in the United States, Rogers et al analysed the combine effect on very low birth 
weight (<l,500g) of SO2 and TSP levels, using annual exposure estimates [Rogers et 
al 2000]. Results showed that for babies bom to mothers who were exposed to 
concentrations of the combined pollutants above the 95% percentile of the exposure 
distribution (56.8pg/m3), the relative risk of low birth rate was 2.88 (95% Cl 1.16- 
7.13). Another study carried out in the United States has found similar result -  the 
authors examined the association between PMio and birth weight in northern Nevada 
between 1991 and 1999, and found that a 10pg/m3 increase in mean PM 10 
concentrations during the third trimester of pregnancy was associated with a reduction 
in birth weight of 1 lg (95% Cl 2.3-19.8) [Chen et al 2002]. A European study carried 
out in the Czech Republic examined the relationship between low birth rate, 
premature birth, and ambient TSP during each trimester in 108,000 singleton live 
births [Bobak 2000]. The effects of these adverse birth outcomes were marginally 
stronger for exposures during the first trimester. For a 50pg/m3 increase in TSP, the 
odds ratios of low birth rate and prematurity were 1.15 (95% Cl 1.07-1.24) and 1.18 
(95% Cl 1.05-1.31) respectively. In China, Wang et al examined the effects of TSP on 
birth weight in four highly polluted areas of Beijing [Wang et 1997]. A cohort of 
75,000 newborns was followed from early pregnancy until delivery. Regression 
models adjusted for gestational age, residence, year of birth, maternal age, and infant 
gender found that the mean birth weight was reduced by 6.1g for each lOOpg/m 
increase in TSP. The relative risk of low birth rate in association with a lOOpg/m 
increase TSP was 1.10 (95% Cl 1.05-1.14). In another study carried out in Asia, Ha 
and colleagues examined 277,000 full-term births for a 2-year period in Seoul, South 
Korea [Ha et al 2001]. Results showed an increased risk of 4% (RR = 1.04; 95% Cl 
1.00-1.08) for low birth rate, and a 6.09g (95% Cl 3.85-8.27) reduction in birth weight
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for a 14.3 jig/m3 increase in prenatal exposure to TSP. The authors proposed that the 
adverse outcome maybe attributable to the production of free radicals induced by 
PMio which resulted in an inflammatory response and enhanced blood viscosity. In 
contrast both Landgren, who studied the effects of air pollution on delivery of 38,000 
Swedish women in 1985-1990 [Landgren 1996], and Maisonet et al, who studied the 
effects of PMio in live births bom in six northeastern cities of the United States 
[Maisonet et al 2001] showed results with no indication of any positive associations 
between prenatal exposure to particulate air pollution and low birth weight.
2.2.4 Changes in respiratory symptoms in adults
Studies have revealed significant associations between prolonged exposures to 
ambient air pollution and increased prevalence or incidence of varies respiratory 
symptoms in adults. In the United States, Schwartz used data collected from the first 
US National Health and Nutrition Examination Survey (NHANES I) to investigate the 
health effects of long-term exposure to particulate air pollution [Schwartz 1993]. A 
total of 3,800 adults aged between 30 and 74yrs were recruited from 53 urban areas 
across the country where TSP data were available. The frequency and severity of 
respiratory symptoms were recorded by symptoms questionnaires as well as through 
diagnosis by physicians, and the data were modelled in logistic regression controlled 
for age, sex, ethnicity, and smoking. The average concentration of TSP during the 
study period was 85.5jag/m3. For every 10pg/m3 increase in annual TSP concentration 
it was found to be significantly associated with chronic bronchitis (OR = 1.07; 95% 
Cl 1.02-1.12) and respiratory illnesses diagnosed by a physician (OR = 1.06; 95% Cl 
1.02-1.10). No associations were found between TSP and the prevalence of asthma or 
dyspnoea. When smokers were completely removed from the model, the odds ratio 
for chronic bronchitis was increased to 1.11 (95% Cl 1.02-1.21). However, TSP was 
only marginally significant as a predictor for respiratory illnesses diagnosed by a 
physician (OR= 1.07; 95% Cl 1.00-1.15).
Data extracted from the AHSMOG study has also shown positive associations 
between the development of chronic respiratory symptoms and long-term exposure to 
particulate air pollution. Results published in 1987 using a subset of 7,400 non­
smoking participants aged >25yrs showed a 22% increased risk of developing chronic
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obstructive pulmonary disease symptoms when exposed to TSP levels above 
200pg/m3 for 750hrs per year [Euler et al 1987]. Other results from the AHSMOG 
study had also been published. One included a subset of 1,800 participants resided in 
the vicinity of nine airports throughout California and found that long-term exposure 
to ambient concentrations of PM2.5 in excess of 20pg/m3 were associated with the 
development of chronic bronchitis symptoms [Abbey et al 1995a]. In addition, the 
mean concentration of PM2.5 was also associated with the increasing severity of 
respiratory symptoms relating to chronic obstructive pulmonary disease, chronic 
bronchitis, and asthma. Another study involved a subset of 3,900 participants and the 
authors found that the relative risks associated with exposure to concentrations of 
PMio that exceeded 100pg/m3 for l,000hrs per year were 1.17 (95% Cl 1.02-1.33) for 
airway obstructive disease, 1.21 (95% Cl 1.02-1.44) for productive cough, and 1.30 
(95% Cl 0.97-1.73) for asthma symptoms [Abbey et al 1995b]. The risk was further 
increased to 1.66 (95% Cl 1.15-2.33) in individuals with airway obstructive disease as 
a child.
In Europe, Heinrich and colleagues carried out a cross-sectional survey in Germany to 
investigate the possible relationships between respiratory health and local traffic 
[Heinrich et al 2004]. A cohort of 6,900 participants aged between 18 and 79yrs from 
the German Health Survey 1998 took part in the study. Self-administered 
questionnaires were given to the cohort to collect information on traffic intensity 
within their areas of residence. In addition, the European Community Respiratory 
Health Survey (ECRHS) questionnaire was used for collecting data on respiratory 
health. Logistic regression model was used to assess the relationship between traffic 
exposure and various health outcomes. Of the total study population, 64.5% were 
residing in areas with low traffic, 11.6% in areas with moderate traffic, and 23.9% in 
areas with high traffic. After adjusting for age, gender, education, community size, 
and smoking, results showed that living on busy roads compared with low-trafficked 
areas was significantly associated with chronic bronchitis (OR = 1.36; 95% Cl 1.01- 
1.83). In addition, increased odds of nocturnal cough (OR = 1.24; 95% Cl 0.98-1.57) 
and wheeze (OR = 1.21; 95% Cl 0.93-1.57) were also observed, although both figures 
were statistically insignificant. In Switzerland, the SAPALDIA (Swiss Study on Air 
Pollution and Lung Diseases in Adults) study investigated health effects of air
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particulates in a cross-sectional survey involving a random sample of 9,600 adults 
between the age of 18 and 60yrs from 8 different areas representing a range of air 
pollution exposure, urbanisation, altitude, and meteorological conditions [Zemp et al 
1999]. Respiratory health data were collected using the European Community 
Respiratory Health Survey (ECRHS) questionnaire as well as assessments through 
spirometry, bronchial challenge tests, and allergy tests. Logistic regression models 
controlled for potential confounders such as age, body mass index, gender, and 
parental asthma and atopy showed that the odds for a 10pg/m3 increase in the annual 
mean concentration of PMio was 1.35 (95% Cl 1.11-1.65) for chronic phlegm 
production, 1.27 (95% Cl 1.08-1.50) for chronic cough, 1.33 (95% Cl 1.14-1.55) for 
breathlessness, and 1.32 (95% Cl 1.18-1.46) for dyspnoea on exertion. The study also 
showed that a 10pg/m3 difference in PMio levels between different zones led to a 41% 
difference in the frequency of dyspnoea and a 31% difference in the prevalence of 
bronchitis. Lung functions were also shown to be worse in the most polluted regions 
in the study. Since the annual mean PMio concentration in the study areas was 
21.2pg/m3 (range 10.1-33.4pg/m3), thus this study provided evidence that long-term 
exposure to even moderate levels of air particulates was associated with higher 
prevalence of respiratory symptoms in adults.
2.2.5 Changes in respiratory symptoms and lung functions in children
The effects of particulate air pollution on children warrant a separate section of 
review from those of the adults. Exposure to air pollution in children is a special 
concern because their immune system and lungs are not fully developed when 
exposure begins, and thus they may have different responses than those seen in adults. 
Children are physically different from adults because the human lungs are not well 
formed at birth until approximately 6yrs of age, when full functionality develops 
[Schwartz 2004]. For example, the number of alveoli in the human lung increases 
from 24 million at birth to 257 million at age 4 [Dunnil 1962]. Moreover, their lung 
epithelium is not fully developed, resulting in greater permeability of the epithelial 
layer [Schwartz 2004]. Children also have a larger lung surface area per kilogram of 
body weight than adults, and under normal breathing they will breathe 50% more air 
per kilogram of body weight than adults [Schwartz 2004]. In addition, exposure to air 
pollutants is higher in children because they tend to spend more time outdoors,
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particularly in the summer and in the late afternoon [EPA 1997], although this may 
vary between children and the country / area they reside. One hypothesis suggests that 
preadolescent children with decreased level of lung function growth may be more 
susceptible to respiratory infections and environmental pollutants in their childhood, 
and this may subsequently lead to the development of chronic airflow obstruction in 
adult life [Jedrychowski 1999].
In a case-control study conducted in New York, Lin et al studied 400 children aged 0- 
14yrs who were admitted to the hospital for asthma [Lin et al 2000]. The group was 
compared with 400 age-matched controls who were admitted for non-respiratory 
conditions. Exposure assessments were carried out by linking the children’s 
residential addresses to traffic information regarding vehicle miles travelled on their 
streets. Results showed that after adjusting for age and poverty, children hospitalised 
for asthma were more likely to live on roads with the highest tertile of vehicle miles 
travelled within 200m of their residence (OR = 1.93; 95% Cl 1.13-3.29) and were 
more likely to have trucks and trailers passing by within 200m of their residence 
compared to the controls (OR = 1.43; 95% Cl 1.03-1.99). However, no associations 
were found between hospital admission and annual vehicle miles travelled within 
500m, nor whether trucks or trailers passed by within 500m. These suggested that 
local traffic within proximity of the children’s residences have larger impact on their 
respiratory health than those that are further away. A Dutch cross-sectional study 
examined whether motor vehicle exhaust fumes from nearby freeways had any effects 
on respiratory health of children [van Vilet et al 1996]. The study was conducted in 
six residential areas with a large number of homes located within 300m of a major 
freeway which carried 80,000 to 150,000 vehicles per day. A total of 1,500 children 
aged between 7 and 12yrs took part in the study and questionnaires on respiratory 
symptoms were completed by their parents. Chronic cough (OR = 1.64; 95% Cl 0.98- 
2.74) and wheeze (OR = 2.00; 95% Cl 0.99-4.03) were found to be related, but 
marginally failed to reach statistical significance, to children living within 100m of a 
freeway. When stratified by sex, the associations have become statistically significant 
in girls with an OR of 2.45 (95% Cl 1.16-5.56) for chronic cough and 3.05 (95% Cl 
1.11-8.41) for wheeze. For boys, the effects on chronic cough (OR = 1.05, 95% Cl 
0.50-2.22) and wheeze (OR = 1.29, 95% Cl 0.45-3.68) were reduced and remained 
statistically insi gnificant. Braun -Fahrlander and other members of the SCARPOL
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team (Swiss Study on Childhood Allergy and Respiratory Symptoms with Respect to 
Air Pollution, Climate and Pollen) investigated the impact of long-term exposure to 
air pollution on 4,400 schoolchildren living in 10 different communities in 
Switzerland [Braun-Fahrlander et al 1997]. The team studied the levels of PMio and 
other gaseous pollutants in each community and the reported respiratory symptoms 
rates from children. Results showed that between the least and most polluted 
communities the levels of PMio were associated with chronic coughs (OR = 3.07; 
95% Cl 1.62-56.81), nocturnal dry cough (OR = 2.88; 95% Cl 1.69-4.89), and 
bronchitis (OR = 2.17; 95% Cl 1.21-4.89). However, no relationships were found 
between long-term exposure to air pollution and asthmatic or allergic symptoms and 
illnesses.
A large-scale multi-centre cross-sectional survey carried out in 24 communities in the 
United Sates and Canada examined the effects of exposure to acidic air pollution in 
children [Dockery et al 1996, Raizenne et al 1996]. Regions of the eastern United 
States and Southern Canada experienced the greatest levels of particles with strong 
acidity, sulphate, and particle mass concentrations during the spring and summer 
months [Spengler et al 1996]. A total of 13,300 white children aged 8-12yrs were 
recruited from 24 communities which varied in acid aerosols levels. Information on 
respiratory symptoms were collected via questionnaires and lung function tests were 
also performed. After adjusting for confounders such as sex, history of allergies, 
parental asthma, parental education, and exposure to passive smoking, logistic 
regression models found positive associations between levels of fine particulates with 
strong acidity and bronchitis (OR = 1.65; 95% Cl 1.12-2.42). In addition, results also 
shown that a 52nmol/m3 difference in annual mean particles with strong acidity was 
associated with a 3.5% (95% Cl 2.0-4.9) decrement in forced vital capacity (FVC) 
and a 3.1% (95% Cl 1.6-4.6) decrement in forced expiratory volume in 1 second 
(FEVj). FVC measures the total amount of air that can be forcibly blown out after full 
inspiration, and in contrast FEVi only measures the amount of air that can be forcibly 
blown out in one second. These tests are considered as the primary indicators of lung 
functions. Despite the relationships found between ambient particles and declined 
lung functions, the authors found no associations between exposure and wheeze, 
cough, and phlegm.
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A prospective cohort study involving 1,700 children showed relationships between 
reduced lung growth in children and particulate air pollution [Gauderman et al 2004]. 
The study known as the Children’s Health Study, followed the cohort of 10-yr old 
children from 12 southern California communities from 1993 to 2001, by then all had 
reached the age of 18. Details on lung functions and other baseline characteristics 
were collected through annual questionnaires and spirometric testing of the children. 
Levels of PMio and both mass and chemical makeup of PM2.5 were monitored by air- 
pollution-monitoring stations established in the 12 studied communities. Results 
generated by regression models adjusted for height, body-mass index, race, asthma, 
smoking habit, passive smoking, and respiratory illness on the day of the test, showed 
that lung development from the ages of 10 to 18yrs was reduced in children exposed 
to higher levels of ambient air pollution. For example, comparing the average growth 
of FEVj in children from the least and the most polluted communities, there was a 
79.7ml difference (95% Cl 6.4-153.0) for PM2.5 and an 87.9ml difference (95% Cl 
29.4-146.4) for elemental carbon particles. However, no association was found 
between lung development and PM 10. In addition, during the last year of follow-up 
the authors have selected a subgroup of children with clinically significant deficit in 
attained FEV1 to determine whether this was associated with exposure to air pollution. 
Such condition was defined as an attained FEVi below 80% of the predicted value, 
which is a criterion commonly used in clinical settings to identify persons who are at 
risk of adverse respiratory conditions. Across the 12 communities, clinically low 
FEVi was positively correlated with the levels of PMio (P<0.01), PM2.5 (P<0.01), and 
elemental carbon particles (p<0.01). For example, the estimated proportion of 
children with low FEVi was 1.6% at the lowest level of exposure and 7.9% at the 
highest level of exposure to PM2.5. The authors continued to comment that those with 
clinically significant deficits in lung development in the study were unlikely to 
reverse as they complete the transition into adulthood. This was based on the fact that 
lung development are more or less completed in humans at the age of 18, and 
although boys will continue to develop until their early 2 0s, the much reduced rate of 
development will not lead to any significant changes in their conditions.
Decreased respiratory functions associated with long-term exposure to road traffic 
have been found in a cross-sectional study in Munich which examined 6,500 children 
aged 9-llyrs [Wjst et al 1993]. Density of motor traffic in the children’s school
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districts ranged from 7,000 to 125,000 cars per day. Respiratory symptoms collected 
by questionnaires and lung function tests results were analysed by regression models. 
Peak expiratory flow, which measures the speed of air moving out of the lungs at the 
beginning of the expiration, showed a significant decrease by 0.71% (95% Cl 1.08%- 
0.33%) per increase of 25,000 cars per day passing through the school district on the 
main road. Forced Expiratory Flow 25-75%, which measures the average flow of air 
coming out of the lungs during the middle portion of the expiration, was decreased by 
0.68% (95% Cl 1.11%-0.25%). In addition, the prevalence of recurrent wheezing (OR 
= 1.08; 95% Cl 1.01-1.16) and recurrent dyspnoea (OR = 1.10; 95% Cl 1.00-1.20) 
with the same exposure were also increased. Since the unification of Germany in 1990 
reduction in air pollution levels was seen in the former East Germany. Frye et al used 
this opportunity to demonstrate the benefits of such reduction in newer generations of 
children with improved lung functions [Frye et al 2002]. Three consecutive cross- 
sectional surveys were carried in 1992/1993, 1995/1996, and 1998/1999, in which 
lung function tests were performed in 2,500 children aged 11-14 from three 
communities in East Germany in each of the surveys. During the duration of the three 
surveys the annual mean of TSP declined from 79pg/m3 to 25 pg/m3, and the mean 
FVC of the three different generations of children increased from 1992/1993 to 
1998/1999. The adjusted change of FVC was 4.7% (95% Cl 0.2%-9.5%) per 
50 pg/m3 decrease in TSP. The significance of this study is not merely the 
demonstration of an association but that an intervention, i.e. the reduction of TSP 
produced improvements in health.
One thousand 9-year old children from two areas in Poland were recruited in a 2-year 
prospective cohort study to investigate the effects of black smoke and SO2 on lung 
function growth [Jedrychowski 1999]. Daily concentrations of the pollutants of 
interest were obtained from the city network of 17 air monitoring stations. The 
children were assigned into either a high exposure group or a low exposure group 
depending on the levels of pollutants within the areas of their schools and residences. 
Lung function tests were performed on all children in 1995 and information on the 
children’s household characteristics and respiratory health were collected from their 
parents. The same tests were performed 2 years later in 1997 and the results were 
compared. It was found that there were significant differences in lung function growth 
in children between the two groups, and larger increments for both FVC (0.517L v
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0.497L in boys, 0.412L v 0.394L in girls) and FEVi (0.517L v 0.455L in boys, 
0.434L v 0.394L in girls) were seen in children from the low exposure group 
regardless of gender. Results from a subset of children with slow lung function 
growth were also analysed. Slow lung function growth was defined by the authors as 
the lowest quintile of distribution of a given spirometric test. Using logistic regression 
models controlled for confounders such as environmental tobacco smoke, home 
heating, the presence of moulds in the household, and parental education, in boys the 
odds ratios were both 2.1 for the occurrence of slow lung function growth as 
measured by FVC (95% Cl 1.27-3.46), and FEVi (95% Cl 1.27-3.48). However, no 
significant effects were observed in girls. Similarly in Austria, 1,000 children in 
grades 2-3 were recruited from 8 areas in the region of lower Austria and were 
followed up between 1994 and 1997 [Horak Jr et al 2002]. Data on respiratory 
symptoms of the children were collected annually through questionnaires completed 
by their parents, and lung function tests were performed on the children twice a year. 
Collection of PMio data was carried out using Harvard Impactors with an air flow of 
4L/min set up at the children’s schools. Pre-weighed Teflon filters were used to 
collect PMio samples which were changed at 2-weekly intervals and reweighed. 
Results controlled for sex, atopy, passive smoking, height, initial height, and initial 
lung functions showed that an increase of summer PMio by 10pg/m3 was associated 
with an 84ml/yr decrease in FEVi growth. In addition, mid-expiratory flow between 
25 and 75% of the forced vital capacity (MEF25-75), which is a lung function proxy for 
the development of small airways, showed a decrement of 329ml/s/yr for an increase 
of summer PMio by lOpg/m .
2.3 Mechanisms of adverse health effects caused by air particulates
While the health effects of respirable air particulates have been recognised little is 
known about the exact mechanism of damage. Most of the studies that examined the 
effects of particles on biological systems were often laboratory-based and carried out 
in cell lines or animal models. Currently the research is still in its early stages but 
several possible mechanisms have been suggested.
2.3.1 Effects on the card iovascular system
Blood circulation in the body relies on correctly functioning control mechanisms. 
Cardiac death is the consequence of a complex interaction between the autonomic
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nervous system, the current state of the myocardium, and the constant endogenous 
and exogenous stimuli the myocardium experienced which may predispose it to an 
adverse cardiac outcome. Usually the presence of a single condition is not sufficient 
to trigger cardiac events but sometimes a biological or psychological stress can induce 
a cascade of event leading to cardiac complications and even cardiac death [Zareba et 
al 2001]. Air pollution may be a stress factor sufficient to trigger this chain of events, 
especially in compromised individuals such as the elderly and patients with pre­
existing cardiorespiratory conditions. The epidemiological evidence associated with 
increased cardiovascular morbidity and mortality with air pollution indicated several 
possible mechanisms by which air pollution may affect cardiovascular health. This 
includes neural mechanisms related to the response of the autonomic nervous system 
and changes in cardiac vulnerability.
Changes in the autonomic nervous system
The autonomic nervous system has important influences on cardiac health and 
disease, and one of the ways to assess this is by measuring heart rate variability 
(HRV). Heart rate variability refers to the beat-to-beat alterations in heart rate. Studies 
have shown that reduced HRV predicts sudden death in patients with myocardial 
infarction, and it also appears to be a marker of fatal ventricular arrhythmia [Kawachi 
et al 1995]. Several recent studies have shown relationships between increased levels 
of respirable air particulates and decreased HRV; Magari and colleagues found a 
small decrease in HRV when a group of 20 healthy individuals were exposed to 
respirable air particles [Magari et al 2002]. Such negative relationship has also been 
found in several other studies involved healthy elderly [Delvin et al 2003, Creason et 
al 2001, Gold et al 2000, Pope et al 1999a], and it was even stronger in those who 
were hypertensive [Liao et al 2004, Holguin et al 2003]. However, in an earlier study 
by Liao et al the effects were only observed in elderly people with pre-existing 
cardiovascular disease [Liao et al 1999]. In contrast to the negative associations 
found, Routledge and co-workers did not find any significant changes in HRV when 
healthy volunteers were exposed to carbon particles in a double-blinded human 
challenge study [Routledge et al 2003]. It may be possible that the effects seen with 
ambient air pollution is contributed by the reactive species on the particle surface 
rather than the particle itself. Changes in heart rate during an air pollution episode can 
also serve as a biomarker for altered autonomic activity. According to the
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Framingham Study that spanned across 36 years involving 5,000 participants, 
elevated heart rate was a strong predictor of death and fatal heart disease amongst 
those with hypertension [Gillman et al 1993]. However the evidence of associations 
between exposure to air particulates and increased heart rate lacked consistency. For 
example, a significant increase in heart rate in response to increased ambient 
particulate levels was measured in a group of elderly in the Utah Valley, United States 
[Pope et al 1999b], and a smaller increase in the MONICA study carried out in 
Augsburg, Germany with young healthy volunteers [Peters et al 1999]. In contrast, 
decreased heart rate in response to higher concentrations of ambient particles were 
reported in both human [Ibald-Mulli et al 2004] and animal studies [Nadziejko et al 
2002a, Nadziejko et al 2002b, Cheng et al 2003]. In addition to HRV and heart rate, 
blood pressure is also known to be a physiological parameter that can be used to 
assess the autonomic controls of the heart. However, studies on blood pressure had 
again generated mixed results; while blood pressure was found to be positively 
associated with air particulates concentration in two separate human studies [Linn et 
al 1999, Ibald-Mulli et al 2001], other studies with humans [Ibald-Mulli et al 2004] 
and animal models [Cheng et al 2003] generated opposite results.
Increase in myocardial vulnerability
The myocardium is under constant influence of both internal and external stimuli, and 
susceptibility to an adverse cardiac event varies between individuals depending upon 
their myocardial vulnerability, which may predispose them to conditions such as 
arrhythmias and ischemias. Measurements using electrocardiograms (ECG) of T- 
wave altemans and ST-segment changes, which are markers of electrical instability 
and myocardial ischemia respectively, as well as measuring the frequency and 
complexity of ventricular arrhythmias are some of the ways to determine the risk of 
cardiac death. Using these detection methods it has been found that different levels of 
myocardial vulnerability were induced when animal models were exposed to 
particulates [Lovett et al 1999] and oil fly ash [Watkinson et al 1998, Wellenius et
2003], which is a known a contributor to PM2.5. In a study of patients with cardiac 
defibrillator implants, data on frequency of defibrillator discharges were used as an 
indictor of significant cardiac arrhythmias. Associations were found between air 
particulates level and increased defibrillator discharges [Peters et al 2000]. In another 
study led by the same researcher, increased risk of myocardial infarction onset was
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associated with increased air particulates levels 2hrs prior to the attack [Peters 2001 et 
at].
2.3.2 Changes in blood rheology and coagulability
One hypothesised pathway was suggested by Seaton and co-workers that fine 
particulates may provoke alveolar inflammation, resulting in the release of potentially 
harmful cytokines [Seaton et al 1995]. Fibrinogen and C-reactive proteins (CRP) are 
part of the acute phase response mediated by the cytokines released during 
inflammatory reactions, and they can be used as indicators of tissue damage and 
inflammation. Increased levels of any proteins involved in the clotting cascade may 
trigger systemic increases in blood coagulability. In fact, increased fibrinogen levels 
and neutrophil counts were found to be associated with coronary heart disease and 
myocardial infarction [Dinerman et al 1990, Jousilahti et al 2001, Luc et al 2003, 
Lawlor et al 2005]. In addition, elevation of fibrinogen levels, which is a sign of 
inflammation, was found to be associated neutrophil activation [Rubel et al 2001].
Peters et al reported an increase in blood viscosity, as measured by fibrinogen and 
plasma proteins, in healthy volunteers when exposure to TSP was increased [Peters et 
al 1997b]. In addition to increased fibrinogen, Schwartz also found an increased 
platelet and white cell counts in respond to increased particle concentrations 
[Schwartz 2001]. Similar results were found in several other human studies using 
diesel exhaust fumes [Salvi et al 1999] and concentrated air particulates [Ghio et al 
2000, Huang et al 2003], as well as in animal models when exposed to oil fly ash 
[Gardner et al 2000] and concentrated air particulates [Gordon et al 1998, Lei et al
2004]. However, one study showed an increase in only neutrophils but not fibrinogen 
when exposing animal models to ultrafine particles [Gilmour et al 2004]. 
Interestingly, Seaton et al who proposed the hypothesis of altered blood coagulability 
by air particles, obtained results that did not support their original hypothesis [Seaton 
et al 1999]. They found that the fibrinogen and platelet levels in the study subjects 
had actually fallen with increased air particulate concentrations, despite the levels of 
CRP were increased. Copolla et al had also found negative associations between both 
fibrinogen and platelet levels and gasoline exhaust fumes [Coppola et al 1989], whilst 
others found no changes at all [Hazell et al 1999, Clarke et al 2000, Nadziejko et al 
2002]. Nevertheless, Seaton proposed a new hypothesis that the actions of particles on
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the pulmonary endothelium was capable of altering the adhesive properties of the 
passing red cells and make them more likely to adhere to systemic capillaries. Hence 
the fallen fibrinogen level and platelet counts may indicate that they were being 
consumed for the coagulation of blood, which would increase the risk of ischaemic 
damage in individuals with compromised cardiovascular health. Further research is 
needed to support this hypothesis.
2.3.3 The role of oxidative stress
One of the potential mechanisms of cardiorespiratory injury caused by air particulates 
is through oxidative stress, which occurs when cells have lost control of their 
regulatory systems and results in a highly oxidised cellular environment. The 
oxidative capacity of these particles is primarily dependent upon their transition metal 
contents, which typically include iron, vanadium, chromium, manganese, cobalt, 
nickel, copper, zinc, and titanium [Prahalad et al 1999, Clarke et al 2000]. Some of 
these metals are capable of generating reactive oxygen species (ROS) [Stohs and 
Bagchi 1995]. ROS such as superoxide radicals, hydrogen peroxide, nitric oxide, and 
hydroxyl radicals are by-products of normal metabolic processes in cells. They are 
classified into two categories: free radicals and non-radical derivatives. Being 
chemically unstable, free radicals will quickly react with other molecules or radicals 
to achieve a stable configuration - this makes them more reactive than the non-radical 
derivatives. ROS can be found in several cells including macrophages and vascular 
smooth muscle cells. At low concentrations they act as physiological mediators of 
cellular responses, whereas higher concentrations may cause cell damage. ROS can 
exert oxidative stress on the cellular system, which can in turn trigger the release of 
redox sensitive transcription factors such as nuclear factor kappa B (NF-kB) [MacNee 
and Donaldson 2003] and activator protein 1 (AP-1) [Donaldson and MacNee 2001]. 
Oxidative stress will result in the depletion of reduced glutathione (GSH) in exchange 
of a rise in oxidized glutathione (GSSG), which leads to a drop in the intracellular 
GSH/GSSG ratio [Rahman et al 1999]. Oxidative stress can be considered as a 
biological emergency that would trigger a range of cellular responses. This can vary 
from protective to harmful effects depending on the level of oxidative stress. Li et al 
proposed that at lower levels of oxidative stress, antioxidant enzymes would be 
released in an attempt to restore the oxidant/antioxidant balance [Li et al 2003]. At an
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intermediate level, induction of inflammatory response would occur through NF-kB 
and AP-1 activation and leads to the release of cytokines. At high level of oxidative 
stress, the completely overwhelmed cellular regulatory system would result in cell 
apoptosis. Oxidative injury to the pulmonary epithelium is prevented by a thin layer 
of fluid known as the respiratory tract lining fluid (RTLF). It is known that during the 
aging process there will be changes in the functions of leukocytes and reduction in 
antioxidant defences [MacNee and Donaldson 2003], thus their ability to handle 
oxidative stress from air particulates is reduced. If the hypothesis is true, then any 
lowering of the antioxidant defence mechanisms in the elderly may predispose them 
to harmful inflammatory responses.
There is much evidence published to support the theory that particles are capable of 
creating oxidative stress and triggers inflammatory processes. For example, 
instillation of urban PMio samples into rat lungs produced inflammation as measured 
by bronchoalveolar lavage levels of neutrophils, and this was accompanied by a 
reduced level of GSH and an increased level of GSSG [Li et al 1996]. When rat heart 
microvessel endothelial cells were exposed to organic extracts of diesel exhaust 
particles and urban fine particles, mRNA levels of antioxidant enzymes were found to 
be positively associated with the dosage [Hirano et al 2003]. Carter et al showed that 
cells treated in vitro with PMio activated both NF-kB and AP-1 which are important 
in controlling the expression of pro-inflammatory mediators [Carter et al 1997]. 
Finally the most direct evidence was the generation of hydrogen peroxide detected in 
vivo over the lungs of rats exposed to concentrated ambient particles [Gurgueira et al 
2002].
2.3.4 Inhibition of phagocytosis and reduced clearance rate
Phagocytosis is the ingestion and destruction by individual cells of foreign particles. 
One of the phagocytic cells is the macrophage, which are large white cells that engulf 
and digest microorganisms and other antigenic particles. Macrophages are initially 
produced in the bone marrow as monocytes and they circulate in the blood for 24hrs 
before settling in tissues where they develop into macrophages. Specialised 
macrophages found in the lungs are known as alveolar macrophages. Macrophages 
are versatile and play many roles. As scavengers, they remove microbes, worn-out 
cells and other debris by engulfing and breaking them down into substances for
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excretion or reutilisation. They also function as antigen-presenting cells for T cells 
activation. As secretory cells, macrophages are vital to the regulation of immune 
responses and the development of inflammation. Alveolar macrophages in the 
alveolar space are among the first cells to respond to the inhaled particles. They play a 
key role in the clearance of particles in the lung by phagocytosis. However, when 
deposition rate of inhaled particles is greater than clearance rate, macrophages can 
become overloaded and their ability to clear particles will be impaired or even 
inhibited. This will result in particles being deposited unphagocytosed in the lungs, 
which may lead to exacerbation of cardiorespiratory conditions by triggering 
inflammations of the epithelial cells and releasing harmful cytokines. Particles may 
also gain access to the pulmonary interstitium to create further damage.
Morrow proposed that clearance mechanisms would be affected as soon as the 
phagocytosed particle burden reached 6 % of the internal volume of the alveolar 
macrophages, and would completely cease when it reached 60% [Morrow 1988]. In 
support of Morrow’s theory, laboratory experiments showed that cytoskeletons of 
alveolar macrophages were affected when the particle burden reached 7-8% [Dorries 
and Valberg 1992], and almost a complete inhibition was observed when the 
phagocytic load occupied 60% of the total internal cell volume in vitro [Lenhert 1990, 
Oberdoster et al 1992]. The ability of particles to inhibit phagocytosis by alveolar 
macrophages depends not only on the number of particles present but also depends 
upon the size of the particles, with the optimum size around 1.5-3pm [Holma 1967]. 
Using titanium dioxide particles, Renwick and colleagues showed that ultrafine 
particles have greater abilities to inhibit phagocytosis than fine particles [Renwick et 
al 2001].
2.3.5 Effect of particle size
Scientists are increasingly focused onto the part ultrafine particles play in causing 
adverse health effects, as evidence to date suggested that they may be able to create 
more harm than their coarse and fine counterparts. The deposition of inhaled particles 
in the respiratory tract is influenced by their physical properties such as size and 
shape, and is also determined by the efficiency of the host’s dust clearance defence 
mechanisms. As discussed in chapter 1, coarse particles are primarily deposited in the 
upper respiratory tract where they will be cleared away by the mucociliary clearance
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mechanism of the body. Finer particles however are able to penetrate deep into the 
lungs into the terminal bronchioles and alveoli. Within the alveoli, soluble particles 
such as sulphates are dissolved into the lung lining fluid and their various 
constituents, whereas insoluble particles such as carbon may remain longer and may 
overcome the natural defence mechanism. Particles can also be translocated from the 
lungs into the circulation and be deposited in other organs. In a study carried out by 
Nemmar and colleagues, healthy volunteers were asked to inhale radioactive labelled 
ultrafine carbon particles [Nemmar et al 2002]. While radioactivity was detected in 
the lungs, it was also detected in the liver and the bladder at a later time. In addition, 
blood was drawn at regular intervals and at 1 minute radioactivity was already 
detected in the blood, reached a maximum between 10 and 20 minutes, and remained 
at this level up to 60 minutes. Another study using animal model led by the same 
researcher yielded similar results [Nemmar et al 2001]. Although the exact 
mechanism is yet to be established, its rapidity suggested that phagocytosis by 
macrophages and endocytosis by epithelial and endothelial cells were unlikely.
The main characteristic of ultrafine particles is their very large surface area and 
particle number per unit mass. For example, to obtain lOpg/m of 2pm diameter fine 
particles would require 1.2 particles per ml of air and the total surface area of particles 
would be 24pm2/ml. However, to obtain the same airborne mass concentration with 
particles of 0.02pm in diameter would require 2.4 million particles and the total 
surface area would be 3,016pm2/ml [Kelly FJ, unpublished data]. It is highly likely 
that the lung would respond quite differently to 2.4 million particles with a large total 
surface area than to a relatively smaller number of larger particles with significantly 
smaller total surface area. Studies comparing healthy individuals with those suffering 
from asthma and chronic obstructive pulmonary disease (COPD) showed an increased 
deposition of inhaled ultrafine particles in their respiratory tracts [Anderson et al 
1990, Brown et al 2002, Chalupa et al 2003]. This indicated that people with such 
underlying medical conditions have a higher deposition rate and deposition dosage of 
particles in their body for a given exposure, which may in addition to their depleted 
antioxidant defences contribute to their increased susceptibility to the health effects of 
air pollution.
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2.4 Concluding remarks
Evidence from epidemiological studies has demonstrated the negative health effects 
of respirable air particulates on human health in both the short-term and long-term 
such as increased number of deaths and cancer incidence, exacerbation of 
cardiorespiratory symptoms in chronically ill individuals, increased incidence of 
respiratory tract irritations, decreased lung functions, as well as adverse birth 
outcome. While the effects found were often small they were nevertheless statistically 
significant. In the case of large-scale longitudinal studies and time-series studies, the 
odds/risks were estimated from large sample sizes often involving the whole 
population of one or more major cities. It is important to realise that when applying 
the small level of odds/risks in a huge population, the health burden of respirable air 
particulates is still substantial.
Currently the mechanisms of damage caused by respirable air particulates are still 
largely unknown. In fact, the study of air pollution on health as a branch of 
environmental epidemiology is still a relatively new research topic compared with 
other areas of medical sciences. Development in technology as well as research 
methods in the past few decades have improved our understanding about air 
particulates and its relationship to health in human beings. Therefore in the 
foreseeable future we should be able to answer questions that are not fully understood 
nowadays with regard the health effects and biological mechanisms of air particulates.
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C h a p t e r  3 -  M e t h o d o l o g y  
Sec t io n  1 
E x p o su r e  C o m pa r iso n  St u d y
Traffic concentrations may give rise to microenvironments in which the levels of 
respirable air particulates may be higher than that measured from a fixed central site. 
Thus in theory, anyone residing within close proximity to heavy traffic will be exposed 
to higher levels of respirable particulate air pollution, compared with those residing in 
an urban area but distant from major traffic flow. This was investigated by measuring 
the levels of respirable particles in the environment and by examining markers of 
exposure in a group of healthy volunteers who reside in various trafficked and non­
trafficked areas in the city of Cardiff.
3.1.1 Selection of study area
Like most developed cities in the UK, the city of Cardiff has a mixture of residential 
areas located in built-up areas close to the city centre with frequent traffic congestion, 
as well as areas in the suburbs where traffic density is minimal. In this study 
individual streets were selected based on their traffic flow densities and the number of 
houses present, and they were subsequently allocated into either the exposed or 
control group. A street was defined as exposed if it was a major A or B road with high 
traffic flow. On the other hand, a street was defined as control if it was a minor road 
or a cul-de-sac with low traffic volume, and that it was at least 750m away from the 
city centre and any major urban roads defined as exposed. In addition, both exposed 
and control streets must have a sufficient number of houses along it. These definitions 
are summarised in table 3.1.
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Exposed Control
Major A or B road Minor roads, cu l-de-sacs
High traffic flow Low traffic flow
Have sufficient num ber of 
hou ses  presen t
Have sufficient num ber of 
h ou ses  presen t
/
At least 750m aw ay from the 
city centre and any major 
urban roads defined a s  exposed
Table 3.1: Selection criteria of the exposed and control areas. 
Exposed areas
Although traffic flow data were not routinely collected in Cardiff at the time when the 
study commenced, traffic flow data were available in a small number of streets and 
such information was obtained from the Cardiff Council. Based on the traffic flow 
information 10 streets with sufficient number of houses along them were chosen from 
the list and classified as exposed areas. Extra streets were chosen based on long-term 
local knowledge of traffic queues and flow in certain areas of Cardiff city, where 
traffic volumes were high with residential areas within close distances.
Control areas
When choosing control areas for the study, the fact that no traffic data were available 
had again led to the use of long-term local knowledge. Several control areas were 
chosen based on the fact that they were both considerably far away from the city 
centre within an isolated residential area or community, and that the roads that lead to 
those areas were mainly consisted of small roads and cul-de-sacs. Careful 
considerations were also taken to avoid selecting streets from the control areas which 
had the possibility of being used as short-cuts by road users to gain access into 
another area rather than the local community itself. A whole area rather than 
individual streets were chosen for the controls because streets in the suburbs were 
often small with only a few houses. Groups of neighbouring streets from within an 
isolated area were chosen and referred by the name of that area instead of individual 
street names. Table 3.2 shows all the streets and areas that were chosen for the study. 
Those that are highlighted in red are areas which traffic flow data were available from 
the Cardiff Council. A map showing the locations of the studied areas can be found in 
Pg370.
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Exposed areas Control areas
Cowbridge Road East Cathedral Road Fairwater
Cowbridge Road W est Manor Way Llanedeym
Fidlas Road Park Road Llanishen
Llandaff Road Pencisely Road Marshfield
Mackintosh Place Richmond Road Michaelston-Super-Ely
Moorland Road Tudor Street St Mellons
Ninian Road Western Avenue
Penwyallt Road Whitchurch Road
The Philog
Ty-Glas Road
Table 3.2: List of streets/areas included in the study. Those with traffic flow data are
highlighted in red.
3.1.2 Selection criteria of the participating subjects
Although the main objective of the study was to examine uptake rather than the 
effects of air particulates, it was thought that the use of only healthy individuals 
would reduce the variability between subjects in terms of daily activities and other 
unforeseen characteristics that may confound the results. The health status of each 
potential participant was determined by whether or not they had a history of 
cardiovascular disease or chronic obstructive pulmonary disease. Only one permanent 
resident was recruited from each participating household located in one of the target 
streets. In order to be chosen subjects were restricted to the male sex and aged 50 to 
70 years of age, again for the purpose of reducing variability within the sampled 
population. Smoking, exposure to environmental tobacco smoke, and occupational 
exposure to air particulates and chemicals are considered as confounding factors that 
could lead to the overestimation of exposure to traffic-generated particulate matters. 
Therefore, all participating subjects must be non-smokers for at least 5 years with no 
frequent exposure to air particulates and chemicals, such as individuals who are 
employed in the transport or engineering businesses. In addition, the participating 
household must be a smoke-free home. All the selection criteria are summarised in 
table 3.3.
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Selection Criteria
• Male
• 50-70yrs of age
• Perm anent resident of the sam pled house
• Non-sm oker in the past 5yrs
• R eside in a non-smoking household
• No occupational exposure to air particles / chem icals
• No history of cardiovascular d isease
• No history of chronic obstructive pulmonary d isease
Table 3.3: Selection criteria of study subjects, Exposure Comparison Study.
3.1.3 Ethical approval
Prior to the commencing of recruitment it was essential that ethical approval was 
obtained from an appropriate governing body. An application together with an outline 
of the study proposal were sent to the Bro Taf Local Research Ethics Committee. 
Approval was granted subjected to the stipulation that all participants were provided 
with details of the study and be given opportunity to ask questions. In addition, the
participants were required to sign a consent form which indicated that they fully
understood what might involve in the study and that they were willing to take part 
voluntarily.
3.1.4 Recruitment of participating subjects
Recruitment of study subjects was carried out by sending letters addressed to the 
residents of each residential address along the 24 streets/areas of interest. All 
residential addresses were obtained through Royal Mail address finder, which were 
then extracted to a Microsoft Access® database. A universal letter template was used, 
and with the help of the mail merge function in Microsoft Word® thousands of letters 
addressed to different households were printed. In order to examine the effectiveness 
of such recruitment method, the first batch of letters were only sent to 3 streets from 
the exposed group, namely Mackintosh Place, Ninian Road, and Ty-Glas Road. 
Included in the mail was a brief covering letter providing basic information of the 
proposed study, as well as a short questionnaire with simple yes/no answers for the 
residents to express any likely interest in participation and to provide information
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regarding their eligibility (appendix 1). A freepost return envelope was included in the 
letter for sending back the completed questionnaire. Those who were eligible and 
indicated possible interest in taking part were contacted via the phone, where they 
were asked further questions regarding their eligibilities. In addition, they were also 
given further information about the study and were given the opportunity to ask 
questions. Finally, interviews at the participating households were arranged with 
residents who were willing to take part in the study.
3.1.5 The interview
On the interview day the participants were visited by the researcher and the levels of 
both indoor and outdoor PM5 concentrations were measured, and biological samples 
including hair and urine were collected. In addition, a customised questionnaire 
administered by the researcher was used to obtain information regarding the subjects’ 
previous day’s activities, travelling history in the past month, and the architectural 
design of the house. A copy of the questionnaire can be found in appendix 2. The 
participants were also given the opportunity to ask questions, and they were asked to 
sign a consent form stating their willingness to participate in the study voluntarily. A 
copy of the consent form is listed in appendix 3.
3.1.6 Measuring the levels of indoor and outdoor air particulates 
Equipment
In this study one of the main objectives was to obtain information on the ambient 
levels of air particulates in different exposure areas. This monitoring work was carried 
out using a Quartz Crystal Microbalance (QCM) Mass Monitor produced by Booker 
Systems Ltd, UK (figure 3.1). It was connected to a cyclone head with a cut-off size 
of 5 pm and had been calibrated by the manufacturer before the study commenced. 
This battery-powered equipment was capable of determining the amount of PM 5 
collected on a second-by-second basis with a capacity of up to 4hrs. The QCM utilises 
a crystal as a sensitive microbalance, which has a precisely defined natural frequency 
at which it oscillates. When P M 5 particles extracted from the air are deposited onto 
the crystal via a small electrostatic precipitator, the mass load on its surface decreases 
its natural frequency. Thus, the particulate mass collected on the crystal can be 
determined by measuring the change in the natural frequency of the crystal. As the
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QCM measures absolute mass, no correction factors for the particle shape or optical 
properties were required.
Figure 3.1: A Quartz Crystal Microbalance (QCM) Mass Monitor 
produced by Sensors Inc. under the licence of Booker Systems Ltd.
(Source: www. news.thomasnet.com)
Measuring indoor PM5 levels
Levels of PM5 were measured in each participating household during the interview. 
The duration of sampling was determined by the time needed to conduct the 
interview, but nevertheless set to be at least 20mins at anytime between 9am and 6pm, 
Monday to Friday. The measurements were taken by the QCM from the centre of the 
room that was facing towards the main road where possible. In the case where access 
to that room was restricted an alternative spot closest to it was used instead. Residents 
were asked not to purposely open or close any windows or doors during sampling so 
that the monitoring work was performed in a stable state for that house, with 
conditions unchanged during the monitoring period. It is well known that a number of 
indoor sources such as gas appliances would contribute toward the particle 
concentrations in an indoor environment. Therefore the researcher would ask the 
participants if such activities were performed within 2 hours prior to sampling, and an 
alternative sampling date would be arranged if so.
Measuring outdoor PM5 levels
Outdoor measurements of PM 5 were conducted immediately after the interview when 
indoor PM5 levels were recorded. Measurements were carried out using the QCM 
outside the participating households. The equipment was placed on the pavement of
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the road of interest no further than 2m away from the traffic. Additional outdoor PM5 
measurements that followed the same sampling procedures were also made on 
separate occasions.
3.1.7 Collecting environmental samples 
Equipment
In addition to the quantitative measurements of PM5 levels in the environment, air 
particulate samples were also collected for the analysis of trace elements. This was 
carried out by a high volume air-sampler (JD Technical, UK) attached to a PMio 
selective inlet head in the form of a horizontal elutriator (C30 Classifier, Negretti, 
UK) as shown in figure 3.2. Air at a rate of 30L/min was drawn by the pump through 
the inlet head, where particles less than 10pm were separated and collected onto a 
47mm polycarbonate membrane filter (Millipore, UK).
air
tamplcT
Figure 3.2: The monitoring equipment used for the collection of PMi0.
(a) Schematic representation of the equipment.
(b) Actual equipment.
(Courtesy o f Dr T Jones, Cardiff University)
Collecting environmental PM 10 samples
The samplings took place outside the houses of a sub-group of participants. The 
device was setup in the selected households with the pumps located inside the house, 
both for drawing power from the mains, and for safety reasons because they were not 
waterproof. The elutriator were connected to the pump via a rubber tube and placed 
outside the house facing the front towards the main road. A camera stand was used to 
support the elutriator and the tube so that the air samples were taken from
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approximately lm from the ground. Due to security reasons, the elutriator were only 
placed within the premises of the participants and thus the distance from the main 
road varied between samples. The sampling period was 24hrs, on any day between 
Monday and Friday. When collection was completed these filters were analysed by 
inductively coupled plasma mass spectrometry (ICP-MS) for the presence of any trace 
elements that may be attached on the particle surface. The analyses were carried out 
by Dr Tim Jones of the School of Earth, Ocean, and Planetary Sciences, Cardiff 
University.
Collecting environmental PAH samples
Additional PMio samples were collected for the analysis of PAH attached on the 
surfaces of air particulates. The procedures and equipment used were identical to 
those used for the collection of PMio for trace element analysis. The only exception 
was that Teflon coated glass fibre filters (SKC, USA) were used instead of 
polycarbonate filters. Once the samples were collected they were kept in cold dark 
conditions until analysis by high-pressure liquid chromatography (HPLC), carried out by 
Dr. Alun Hutchings of the Therapeutics and Toxicology Centre, Llandough Hospital.
Collecting indoor dust samples
A petri dish was also placed inside each participating households to collect dust. They 
were left inside rooms that were facing toward the main road for a period of 6months, 
which were then collected for trace element analysis by ICP-MS.
3.1.8 Collecting biological samples
In addition to recording data on indoor and outdoor P M 5 concentrations, biological 
samples were also collected during the interview that would allow comparisons 
between the levels of various exposure makers of respirable air particulates found in 
different exposure groups. The participants were asked to donate hair, urine, and 
blood samples on two occasions which were 6 months apart.
Hair samples
Hair samples were collected for the analysis of trace elements by neutron activation 
analysis (NAA), which was carried out in collaboration with the Medical Physics 
group of the University of Surrey, making use of the University of London reactor
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centre. In order to maintain consistency, each time approximately 20-30 hair strands 
were cut off from the nape of the participants’ necks which were 2-3mm from the 
scalp. The samples were then collected into resealable plastic bags for storage. Prior 
to NAA the collected samples were treated in accordance with the International 
Atomic Energy Agency (IAEA) recommended protocol [IAEA 1992]. The samples 
were washed in acetone and thrice in double deionised water followed by a second 
acetone wash. They were then agitated in acetone for a period of lOmins and were 
allowed to air-dry overnight at room temperature in a clean laminar flow unit. Once 
dried the samples were then loaded into pre-weighted pre-washed polyethylene 
capsules for weighting and transport. Due to the relatively slow speed of growth of 
the human hair, any markers found inside the hair would serve as indicators of long­
term exposure to particulate air pollution. Because of this, hair samples were only 
collected from participants who had been residing in their residences for at least 20 
days in the month prior to the interview, and the others were collected at a later date 
when such criterion was fulfilled.
Urine samples
Urine samples were also collected during the interview. Standard universal bottles for 
the collection of urine samples were sent to the participants in advance. They were 
asked to prepare the sample the night before the scheduled interview in order to assess 
exposure during the day. In the interview the participants were asked to provide 
information of their activities on the previous day, and they were asked to produce a 
replacement sample some other time if any unusual activities such as prolonged travel 
in motor vehicles were reported. Once collected the samples were freeze-stored until 
analysis by HPLC and ICP-MS for the detection of 1-hydroxpyrene and platinum 
respectively. Urine samples that were analysed by HPLC were carried out by Dr. 
Wolfgang Will of the Medizinisches Labor Bremen, Germany, and all samples 
analysed by ICP-MS were carried out by Dr. Steve Smith, Dept of Medical 
Biochemistry, University Hospital of Wales.
Blood samples
The participants were also asked to attend the Phlebotomy clinic at the University 
Hospital of Wales for a qualified phlebotomist to extract a small amount of blood for 
trace element analysis by ICP-MS, which was carried out by Dr. Steve Smith of the
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Dept of Medical Biochemistry, University Hospital of Wales. Any exposure markers 
found in the blood would indicate the amount of exposure to air particulates in a long 
term. Because it was uncertain as to how long the markers would remain in the system 
before being excreted, therefore the participants were advised not to provide a blood 
sample immediately if they had been away from their residences overnight for more 
than 10 days in the last month prior to the interview. To ensure smooth operations as 
well as to facilitate the process, each participant was given a card attached with labels 
that contained their initials, date of birth, and unique ID number. They were asked to 
present this card to the phlebotomist, who then attached the labels onto the samples 
drawn from the participants, thus minimising the chances of mislabelling and mis- 
sorting. These cards were later returned to the researcher and any discrepancies found 
between the records and the actual number of blood samples received were followed- 
up. A flow chart that summarises the recruitment process of participants and the 
sampling procedures of the Exposure Comparison Study is shown in figure 3.3.
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Contacted by phone
Schedule appointment + 
send out urine sample bottles
Return in 6months time
IneligibleEligible
ResponsesRefusals / Non-respondents
Eligible and 
agreed to take part
Sending out 
recruitment letters
Ineligible or 
unwilling to take part
Second measurement of indoor and outdoor PM5 
levels.
Collect second hair, and urine samples.
Complete questionnaires.
Pick up petri dish from house.
Ask subject to give a second blood sample.
Measure indoor and outdoor PM 5  levels. 
Collect hair and urine samples. 
Complete questionnaires.
Leave perti dish in house.
Ask subject to give blood.
Acquire signature for consent form.
Sam pling com pleted for subject
Figure 3.3: Flow chart of recruitment and sampling procedures, Exposure Comparison 
Study.
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Sec t io n  2 
Sy m pt o m s  C o m pa r iso n  St u d y
Results from time-series studies carried out in the past showed that short-term 
increase in the levels of ambient air particles led to the premature deaths of 
compromised individuals with chronic underlying medical conditions. While majority 
of studies investigated the short-term rise in mortality caused by excursions of 
ambient particle levels, relatively few of them focused on symptoms change. Since 
short-term increases in PMio levels are associated with elevated death rates, it is 
therefore likely that such increase can also lead to the exacerbation of less severe 
symptoms. The objective of this questionnaire-based study is to investigate how 
sudden changes in the levels of PMio, as measured from stationary central monitoring 
stations in South Wales, affect disease symptoms in compromised individuals. 
Disease-specific questionnaires were used to detect changes in symptoms, medication 
use, and the psychological well-being between different episodes of particulate air 
pollution.
3.2.1 Selection of study area
At the time of the study, within the region of South Wales there were a total of 6 
stationary monitoring stations that collect data on PMio concentrations continuously 
over 24hrs. Real time levels of PMio recorded in these sites were accessible via 
databases on the Internet at http://www.welshairquality.co.uk. These stations are 
located in Cardiff (two stations: Cardiff Centre and Cardiff Briardene), Cwmbran, 
Narberth, Neath Port Talbot, and Swansea. Together with other monitoring sites set 
up in other locations of Wales, they are known as the Welsh Automatic Urban 
Pollution Monitoring network. Data from all but two stations were used in the study -  
Cardiff Centre was excluded due to large-scale construction works being carried out 
within close distance to the site at that time; and Narberth was excluded because it 
was located in a rural area with very few residential areas nearby. Further details 
regarding the site information of Cardiff Briardene, Cwmbran, Neath Port Talbot, and 
Swansea can be found in appendix 4. With PMio data readily available from the 
selected sites, recruitment was therefore focused on those areas.
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3.2.2 Selection criteria of the participating subjects
The research method used in the study was case-crossover study design, in which only 
case subjects were studied and each subject acted as his or her own control. The 
disease status of each participant was self-reported and according to the information 
provided they were then allocated into one of the three appropriate disease groups 
including asthma, respiratory disease excluding asthma, and cardiovascular disease 
group. In addition to their underlying conditions, each individual must also fulfil all of 
the following selection criteria:
Selection Criteria
• Aged 50-70yrs for respiratory and cardiovascular d isea se  groups
• Aged 18-70yrs for asthm a group
• N on-sm oker in the past 5yrs
• R eside in a non-smoking household
• No occupational exposure to air particles / chem icals
• Residing within 10miles from their local stationary air monitoring
stations
3.2.3 Ethical Approval
Applications along with copies of the research outline and questionnaires were sent to 
the Swansea Local Research Ethics Committee and the Gwent Local Research Ethics 
Committee. Ethical approvals for the study were granted by the panel.
3.2.4 Recruitment of participating subjects
The recruitment of study subjects was carried out via cardiology and respiratory 
hospital outpatient clinics located in South Wales, namely Cardiff, Swansea, Newport, 
and Neath Port Talbot. All medical consultants were contacted by mail for 
permissions to recruit volunteers from their clinics (appendix 5). Patients visiting 
those clinics were given an information sheet with brief information of the study and 
how they could help (appendix 6). They were asked to complete a “reply card” to 
indicate their possible interest in participating in the study together with their name, 
phone number, date of birth, and their consultant’s name. Upon completion the cards 
were then collected by the clinic staff and sent back to the researcher every fortnight. 
A preliminary screen was carried out on all the cards and those who were eligible
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were contacted via the phone. During the telephone conversation the researcher 
obtained details on the patient’s medical conditions, as well as other information 
regarding their eligibility. In addition, the patients were also given the opportunity to 
ask questions and provide further information which they think were relevant to the 
study. All eligible individuals who wished to take part were assigned a unique 
identifying number and they were asked to sign and return a consent form (appendix 
7) which were sent out following the phone call.
3.2.5 Questionnaire design
Three sets of disease-specific questionnaires were designed for the study and they 
were the Asthma Symptoms Questionnaire, the Heart Symptoms Questionnaire, and 
the Respiratory Symptoms Questionnaire. A copy of the questionnaires can be found 
in appendix 8.1, 8.2, and 8.3. These questionnaires were based on validated 
instruments including the Asthma Quality of Life Questionnaire, the Kansas City 
Cardiomyopathy Questionnaire, the MacNew Heart Disease Health-Related Quality 
of Life Questionnaire, the Seattle Angina Questionnaire, and the St George’s 
Respiratory Questionnaire. Permission to use them had been granted from the authors. 
All disease-specific questionnaires include items that can be categorised, which focus 
on disease symptoms, medication use, and emotional well-being. In addition “check 
questions” were also included to identify the existence of any factors that may 
confound the results. The questions within each questionnaire were then randomised.
3.2.6 Data collection
Throughout the study period levels of PMio in South Wales were monitored daily 
through databases via the Internet. Each individual were asked to complete a disease- 
specific questionnaire on 4 occasions in which two of these were subsequent to 
episodes of high pollution and two subsequent to normal pollution episode, which are 
defined as below:
• High pollution episode -  Any 4hrs with a PMio concentration above 50pg/m3 
within a 16-hour period between 6am and 10pm.
• Normal pollution episode -  24hr mean with a PMio concentration below 
25pg/m , with no readings above 30pg/m .
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The questionnaires collected symptoms data from the participants throughout a 7-day 
period following an air pollution episode that matched the pre-set criteria. Such period 
was referred as “the week of interest” in the questionnaire. There were no specific 
rules as to how widely spread between each questionnaire has to be sent out, but there 
must be at least a 3-week gap between each questionnaire. The definitions of these 
pollution episodes were judged based on real PMio data observed in Cardiff between 
2000 and 2003. The defined level of normal pollution episodes resembled the average 
PMio concentrations seen in Cardiff, and is thus the representation of the levels of 
particulate pollution each individual would normally experience.
3.2.7 Dispatching the questionnaires
The question as to when to dispatch the questionnaires was regarded as crucial in the 
study. A questionnaire that arrives either too late or too early may have affects on its 
accuracy. Eventually, it was scheduled to be sent out on the fourth day after the 
pollution episode of interest has occurred, which also provided sufficient amount of 
time for the preparation of questionnaires. At last, these questionnaires were 
dispatched via Royal Mail 2nd class delivery with an estimated arrival time of 2 
working days. According to the plan, the questionnaires will arrive around the sixth 
day of the week of interest and can be filled in within 1-2 days (figure 3.4).
Number of days within the “week of interest”
DayO 1 2 3 4  5 6 7
“Day 
when £ 
episode
”, i.e. 
e lution 
?ntified
Dispatching the Questionnaires
questionnaires arrived
Preparing the 
questionnaires
Participants start 
filling in the 
questionnaire
Figure 3.4: Flow chart showing the scheduled timing of dispatching the questionnaires.
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3.2.8 Checking the returned questionnaires
Participants were encouraged to fill in the questionnaires promptly on the last day of 
the week of interest and to return the completed questionnaires at their earliest 
convenience. All returned questionnaires were checked and any incomplete 
questionnaires were subsequently filled in by contacting the participants on the phone. 
Within the questionnaires there were some “check questions” that concerned about 
various confounding factors that may lead to the under- or overestimation of the 
effects of PMio on symptoms. The completed questionnaire would be automatically 
voided if the participants have experienced any of the followings during the week of 
interest:
• Had a chest infection.
• Had been exposed to other people’s tobacco smoke for a prolong period.
• Had been away from their residences overnight for more than 3 days.
In addition, a questionnaire would also be invalidated if any unusual changes in PMio 
levels were observed during the week of interest. For example, a sudden increase in 
PMio occurred after questionnaires were sent out during the week of interest of a 
normal pollution episode. A flow chart that summarises the recruitment process of 
participants and the sampling procedures of the Symptoms Comparison Study is 
shown in figure 3.5.
3.2.9 Method of analysis
Each answer given by the participants in the completed questionnaires corresponded 
to a symptoms score. This symptoms score was used to examine the influence of air 
pollution at high levels relative to episodes of normal air pollution levels. Furthermore, 
certain responses which were believed to be more indicative of more severe asthma, 
respiratory, and cardiovascular disease symptoms were analysed as a separate 
category.
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Contacted by phone
Pollution episode
IneligibleEligible
Responses
Send out questionnaires
Refusals / Non-respondents
Valid
questionnaires
Ineligible or 
unwilling to take part
Eligible and agreed 
to take part
Handing out 
invitation letters 
in hospital clinics
Invalid questionnaires (voided) 
or non-respondents
Loop continues until 4 sets of valid 
questionnaires are completed from 
each participant.
Figure 3.5: Flow chart of recruitment and sampling procedures, Symptoms Comparison 
Study.
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C h a pt e r  4 -  R e su l t s  
Sec tio n  1 
E x p o su r e  C o m pa r iso n  St u d y
Compared with other large cities in the UK such as London and Birmingham, the 
absolute levels of PMio as measured by stationary air quality monitoring stations are 
relatively low in Cardiff. However, there is a marked variation in traffic flow between 
the central urban areas and the sub-urban areas on the outskirt of the city. This section 
reports the levels of air particulates in microenvironments within Cardiff city with 
different traffic volumes, and also whether biomarkers of personal exposure to traffic 
particulates were elevated in more trafficked areas. Houses were chosen on streets 
with dense traffic flows and also in sub-urban areas where motor traffic was minimal. 
Outdoor and indoor measurements were made on the same occasion at each location 
and individual residents provided blood, urine, and hair samples for analysis of trace 
elements which may act as biomarkers of exposure to air particulates from motor 
vehicles.
4.1 Analysis of PM5 air particulates in the environment
Recruitment
Recruitment first started in spring 2003, when approximately 500 letters were sent out 
to houses located in three exposed areas namely Mackintosh Place, Ninian Road and 
Ty-Glas Road. Recruitment was then expanded to other targeted areas. Over the study 
period recruitment was a continuous process, first concentrated on exposed areas then 
eventually switched to control areas when the numbers of participants in the exposed 
group reached 70. The last group of residents were recruited in spring 2005 as 
recruitment beyond that date would have left insufficient time for the analysis of 
biological samples and revisits 6 months later.
Outcome rates
Outcome rates of the study were presented as the response rate, which is expressed as 
a percentage and refers to the ratio of number of people who participated in the study 
divided by the number of eligible individuals ever contacted. Table 4.1 shows the 
breakdown of responses to the recruitment letters sent out. A total of 8,319 invitation
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letters were sent out over the study period between 2003 and 2005, of which 4,043 
were to the exposed areas and 4,276 to the control areas. Response received from the 
exposed area was slightly higher than those from the control areas. Ninety of the 250 
responses received from residents residing in exposed areas were eligible for the 
study, and out of that 73 agreed to take part. In the control areas, 189 responses were 
received, of which 68 of them were eligible and eventually 50 took part in the study. 
The response rates were 81% and 74% for the exposed and control groups 
respectively.
Total number (n) Exposed Control
Letters sent out 4043 4276
Response received 250 189
Eligible response received 90 68
Respondents who agreed 
to take part 73 50
Table 4.1: Breakdown of responses to recruitment letters, exposed v control.
4.1.1 Ambient air particulate levels in the environment
Sampling durations were 20 minutes each time and were carried out between 9am and 
6pm Monday to Friday. In order to get an overall picture of the PM5 concentrations 
throughout the year, samplings took place in all seasons and under different weather 
conditions. Each time, outdoor levels of P M 5 were measured immediately after indoor 
measurements made during the interviews with the participants were completed. 
Additional outdoor measurements took place at random times again between 9am and 
6pm Monday to Friday to collect extra P M 5 data that helped to determine the typical 
ambient particulate levels of the targeted streets.
Levels o f PM5 in the environment
Throughout the study a total of 373 ambient P M 5 measurements have been made in all 
areas. At least 10 random measurements were made in each target street, with the 
highest number of measurements made in the control area Michaelston-Super-Ely (29
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times) and the lowest number in the exposed area Tudor Street (10 times). Figure 4.1 
shows boxplots of the distribution of PM5 levels in each studied street and figure 4.2 
defines the structure of a boxplot. Table 4.2 shows the descriptive statistics of the 
measured PM5 concentrations. The mean levels of PM5 concentrations of the exposed 
streets ranged from 15.4pg/m3 to 21.1 pg/m3, with Cowbridge Road West having the 
highest mean PM5 concentration (21.1 pg/m3), followed by Cowbridge Road East 
(20.9pg/m ) and Western Avenue (20.1 pg/m ). On the other hand, Mackintosh Place 
has the lowest mean PM5 concentration (15.4pg/m3), followed by Pencisely Road 
(15.7pg/m3) and Ty-Glas Road (15.8pg/m3). Amongst the control areas, Llanishen 
has the highest mean PM5 concentration (13.2pg/m ) and Marshfield has the lowest 
(10.4pg/m3). The standard error of mean (SE) for each individual street was also 
examined and was expressed as a percentage of the mean [(SE / mean) x 100%], 
known as “SE%”. The larger the SE% the more imprecise was the estimate of the 
mean. Results showed that Cowbridge Road West has the highest SE% (10.9%) and 
the lowest was Richmond Road (4.4%). In the control areas the SE% was highest in 
Marshfield (12.0%) and lowest in Llanishen (6.1%).
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Extreme value -  more than
* 1 3  <--------  3 box-lengths above the
box. The number is the 
identifier.
Largest value which 
is not an outlier or 
extreme value
Median
Smallest value which 
is not an outlier or 
extreme value
012 <- Outlier value -  more than 1.5 box-lengths above the box
75th percentile
25th percentile
Q0  A  Outlier v a lu e -m o r e  than 1.5
box-lengths below the box
* 4  <  Extreme value -  more than
3 box-lengths below the 
box.
Figure 4.2: Structure of a boxplot.
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Mean Max Min N u m b er  of  
m e a s u r e m e n t s  
m a d e
SE SE%
(n g /m 3) ( | i g /m3) (jig/m3)
Exposed Group
Cowbridge Rd 
West 21.1 41 .7 8.2 15 2.30 10.9
Cowbridge Rd 
East 20.9 30.4 15.9 13 1.13 5.4
Western Ave 20.1 31.1 7.4 17 1.58 7.9
Ninian Rd 19.4 28.3 11.9 13 1.57 8.1
Cathedral Rd 18.8 33.3 12.1 13 1.74 9.2
Manor Way 18.1 34.3 6.2 22 1.46 8.1
Llandaff Rd 17.4 24 .7 7.8 13 1.44 8.3
Park Rd 17.1 27 .8 11.1 13 1.47 8.6
Tudor St 17.1 21 .4 13.0 10 0.91 5.3
Moorland Rd 16.8 34 .6 8.9 18 1.58 9.4
The Philog 16.6 37.5 8.0 17 1.70 10.3
Whitchurch Rd 16.6 24.5 11.0 13 1.12 6.8
Pendwyallt Rd 16.4 24.2 4.9 16 1.36 8.3
Richmond Rd 16.0 20.0 12.5 12 0.71 4.4
Fidlas Rd 16.0 22.4 9.7 15 1.56 9.7
Ty-Glas Rd 16.8 26.6 8.9 18 1.34 8.5
Pencisely Rd 15.7 23.3 7.9 20 0.96 6.1
Mackintosh
Place 15.4 23 .0 7.7 13 1.38 9.0
Control Group
Llanishen 13.2 17.8 4.1 17 0.80 6.1
Michaelston-
Super-Ely 12.3 23 .6 3.6 29 1.27 10.3
Fairwater 12.1 18.7 7.1 13 1.01 8.4
St Mellons 12.1 23.0 6.7 14 1.28 10.7
Llanedeyrn 11.9 17.8 8.0 16 0.72 6.1
Marshfield 10.4 18.5 3.2 13 1.25 12.0
Table 4.2: Environmental PM5 measurements of all study areas.
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Defining the control group
Initially, the allocation of participants into either the exposed or control group was 
dependent on the proximity of their houses to an urban road with high volumes of 
traffic. A total of six areas were selected for the study as controls, which consisted of 
minor roads and cul-de-sacs that were at least 750m away from the city centre or any 
urban roads with high volumes of traffic flow. According to the measurements made 
in the control areas, the difference between the means of the highest and lowest PM5 
concentrations was only 2.8pg/m3. If it could be proved that the mean PM5 levels 
observed in each area were not significantly different from each other, it was possible 
to combine the measurements made in all control areas and form into one large 
control group. Doing so would increase the statistical power of the information 
collected due to the increased number of measurements that can be included in the 
statistical analysis at one time. For this purpose, a statistical test called Analysis of 
Variance (ANOVA) was chosen. In brief, ANOVA is a statistical method for making 
simultaneous comparisons between the means of two or more groups. It produces a 
value that can be tested to determine whether the relation observed between the 
variables is statistically significant. However, since ANOVA assumes the data being 
analysed were normally distributed, therefore it is essential to check for the 
distribution and identify any abnormalities in the data set. This can be done by 
constructing boxplots, which allows the visual examination of the data set and the 
identification of any extreme values as demonstrated in figure 4.2. If any extreme 
values were present, it is necessary to consider whether or not to remove them before 
engaging in further analysis.
In this case, ANOVA tested the null hypothesis (H0) that the mean P M 5 
concentrations observed in the 6 different control areas were not different from each 
other. Results from the ANOVA test yielded a large p-value (F = 0.48; p = 0.79), 
meaning the differences observed were likely to be by chance and thus H0 was 
accepted. Boxplots (figure 4.3) also confirmed the distributions of the data and there 
were no extreme values present. With the help of boxplots and ANOVA test, the 
decision of combining all of the six control areas into one large control group was 
justified. The new control group now consisted of 102 measurements in total, with a 
mean and median of 11.8pg/m and 11.5pg/m respectively (table 4.3).
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Defining the exposed group
In the study all eligible individuals who agreed to take part were allocated into the 
exposed group if they resided within 20m of an urban road with high traffic flow. The 
mean environmental PM5 concentration of all the exposed areas was 17.5pg/m3 with a 
median value of 16.7pg/m3, which were both approximately 50% higher than the 
mean and median PM5 levels observed in the control group (table 4.3). Apart from the 
presence of several outlying values toward the upper end, the distribution of the data 
was more or less normal, as shown in figure 4.3.
Exposed Control
N 271 1 0 2
Mean (pg/m3) 17.5 1 1 . 8
Median (pg/m3) 16.7 11.5
Minimum (pg/m3) 4.9 3.2
Maximum (pg/m3) 41.7 23.5
Percentiles 25th (pg/m3) 13.3 8.9
75th (pg/m3) 2 0 . 6 14.4
Table 4.3: Descriptive statistics of environmental PM5 concentrations, 
exposed v control.
50
0>9
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N * 271 102
exposed control
Figure 4.3: Concentrations of environmental PM5, exposed v control.
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Testing the difference in mean PM5 levels between the exposed and control groups
The difference in means of the two groups were analysed by the Independent-Samples 
T-Test, which is a statistical method for comparing the means of two independent 
groups of samples. Results showed that the means of the two exposure groups were 
statistically different from each other (t(372) = 8.40; p<0.01). In addition, the 
differences in medians between the two exposure groups were also compared. For this 
purpose the non-parametric statistical test Mann-Whitney test was used, which 
examines the medians of two independent sets of samples. In this case, the Ho is that 
both the samples from the exposed and control groups were drawn from a single 
population, and there is no difference between the medians of the two groups. Results 
showed that the difference observed was highly significant at the 1% significance 
level (z = -8.45; p<0.01), and thus the Ho was rejected.
Redefining the exposed group
It was apparent after the outdoor PM5 measurements were made that significant 
variations in terms of mean PM5 concentrations between individual streets within the 
exposed group existed. For example, Cowbridge Road West has the highest mean 
PM5 concentration recorded in the study and was 37% higher than the mean 
concentration of Mackintosh Place, which was the lowest amongst all the exposed 
streets. This observation indicated that the group defined as exposed may usefully be 
further sub-classified into a medium exposure group and a high exposure group. This 
would also allow investigation of any dose response relationship that may exist 
between exposure and various markers of exposure. The exposure concentration 
chosen as a “boundary” between the medium and high exposure group is to a certain 
extent arbitrary. A sensible cut-off point would satisfy the criteria of a) ensuring that 
there are sufficient numbers of measurements in each group and b) that there is a 
difference between the mean exposure concentrations in each group.
At first the cut-off point was chosen for Manor Way due to the more marked increase 
in mean PM5 level from Llandaff Road (figure 4.4). However, when using this point it 
largely reduced the number of measurements made in the high exposure group -  only 
93 measurements in the high exposure group and 178 in the medium exposure group. 
As a result a second choice was sought and Moorland Road was considered as a more 
favourable alternative. This was because Moorland Road was situated close to the
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centre point when all streets were arranged in an ascending order according to their 
mean PM5 concentrations. Also it would increase the number of measurements in the 
high exposure group to 147 and reduce the size of the medium exposure group to 124. 
Moreover, the mean PM5 concentrations were also compared; if the cut-off point was 
made at Manor Way the mean PM5 levels would be 19.7pg/m3 for the high exposure 
group and 16.4jjg/m for the medium exposure group. On the other hand, if the cut-off 
point was made at Moorland Road instead, the mean PM5 concentrations would be 
18.7pg/m3 for the high exposure group and 16.1 pg/m3 for the medium exposure 
group. Since the differences between the means of PM5 levels were small when the 
two cut-off points were compared, and the number of measurements would be more 
evenly distributed if the cut-off point was chosen at Moorland Road, therefore that 
was finally decided to be the point where the two groups would split. A summary of 
these figures is shown in table 4.4 below. According to figure 4.4, the medium 
exposure group consisted of streets from Mackintosh Place to The Philog inclusive, 
and the high exposure group consisted of all streets from Moorland Road onwards.
Cut-off point Number of measurements
Mean PM5 levels 
(ng/m3)
High
exposure
Medium
exposure
High Medium 
exposure exposure
Manor Way 93 178 19.7 16.4
Moorland Road 147 124 18.7 16.1
Table 4.4: Differences in the number of measurements and mean PM5 levels of the two
different cut-off points.
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Testing the differences between high and medium exposure and control groups
Now that three different exposure groups were defined, namely high exposure group, 
medium exposure group, and control group. Table 4.5 and figure 4.5 show the 
descriptive statistics and boxplots of the PM5 measurements of the three exposure 
groups. A linear trend was seen across the groups with the controls having the lowest 
mean PM5 concentration (11.8pg/m3) and the high exposure group the highest 
(18.7pg/m3). Both the mean and the median of the high exposure group were 
approximately 60% higher than the control group. ANOVA test was carried out in 
order to show that the means of each exposure group were significantly different from 
each other. The results generated a very small p-value, thus rejecting the null 
hypothesis that the three groups were identical (F = 44.51; p<0.01). In addition, 
Tukey’s test was also used to test the mean of each group against the mean of each 
other group, i.e. intra-group difference, and showed no significant similarities 
between the means of any of the three groups (p<0.01). To complete the analysis, 
medians of the three exposure groups were also compared. An increasing trend was 
seen across the three groups, with the control group (11 .5 pg/m ) being the lowest, 
followed by the medium exposure group (15.5pg/m ) and the high exposure group 
(17.8pg/m ). Kruskal-Wallis test, which tests for the differences in medians in 3 or 
more groups, showed that the medians were significantly different from each other (x
(2 ) = 81.16; p<0 .01).
Due to the similarities in sample sizes, and the statistical significance seen in the 
differences between the means and medians of the high and medium exposure groups, 
it was therefore valid to consider them as three distinct groups with respect to 
exposure. The process of classifying various target streets into 3 different exposure 
groups is summarised in figure 4.6.
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High
exposure
Medium
exposure Control
N 147 124 1 0 2
Mean (ng/m3) 18.7 16.1 1 1 . 8
Median (/ig/m3) 17.8 15.5 11.5
Minimum (ng/m3) 6 . 2 4.9 3.2
Maximum (fig/m3) 41.7 37.5 23.5
Percentiles 25th (ng/m3) 14.5 1 2 . 8 8.9
75th (ng/m3) 2 1 . 6 19.2 14.4
Table 4.5: Descriptive statistics of environmental PM5 concentrations, high 
exposure v medium exposure v control.
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Figure 4.5: Concentrations of environmental PM5, high exposure 
v medium exposure v control.
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4.1.2 Indoor air particulate levels in the sampled households
In addition to the outdoor sampling work carried out, P M 5 measurements were also 
made in indoors on the same occasion as outdoors. Doing so would allow the 
comparisons between indoor air qualities in houses located in different exposure 
areas, as well as the examination of any correlations that may exist between indoor 
and outdoor P M 5 levels. Obviously the architectural design of the house will influence 
the indoor levels of particle concentrations, this will be dealt with in section 4.1.4. 
Throughout the study period each participating household was sampled twice 6 
months apart for indoor P M 5 concentrations, the figures were then combined to form a 
mean P M 5 level that represents the house. A total of 73 houses were sampled in the 
exposed areas and 50 in the control areas. Due to the skewness of the data, medians 
instead of means of the two groups were compared. This was done by the non- 
parametric statistical methods Mann-Whitney and Kruskal-Wallis tests.
Differences in exposed and control groups
Houses in the exposed group (13.2pg/m3) had a higher median indoor PM5 
concentration than the control group (9.4pg/m ). The range of the values in both 
groups were high, especially in the exposed group where the maximum PM5 
concentration was more than six-fold higher than the minimum concentration 
recorded (32.2|iig/m v 5.0pg/m ). Although one extreme value was present in the 
exposed group, its removal did not alter the medians significantly (figure 4.7). A 
summary of the statistics can be found in table 4.6. The median of the exposed group 
was 40% higher than the control group, and when the medians were tested by Mann- 
Whitney test it was found that the difference observed was statistically significant (z = 
8.64; p<0.01).
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Exposed Control
N 73 50
Median (pg/m3) 13.2 9.4
Minimum (pg/m3) 5.0 3.0
Maximum (pg/m3) 32.2 21.8
Percentiles 25th (pg/m3) 11.7 7.1
75th (pg/m3) 16.2 12.1
Table 4.6: Descriptive statistics of indoor PM5 concentrations, 
exposed v control.
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Figure 4.7: Boxplots of indoor PM5 concentrations, exposed v control.
Differences in high exposure, medium exposure, and control groups
The exposed group was subdivided into high exposure group with 39 measurements, 
and medium exposure group with 34 measurements. The median indoor PM5 
concentrations were compared, and despite the division a decreasing trend can still be 
seen across the three exposure groups. Although both the high and medium exposure 
groups had medians that were higher than the control group, the difference between 
the high and medium exposure group was actually quite small (13.8pg/m3 v 
13.0jjg/m3). The median of the high exposure group was 47% higher than the control 
group. Table 4.7 and figure 4.8 show the statistics and distribution of the data of the 
different exposure groups. Kruskal-Wallis test was performed and showed that the
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medians were significantly different from each other {y2 (2) = 78.49; p<0.01). In 
addition, differences between each group were also analysed by Mann-Whitney test 
including high exposure group v medium exposure group, high exposure group v 
control group, and medium exposure group v control group. All results were found to 
be statistically significant at the 1% level.
High
exposure
Medium
exposure Control
N 39 34 50
Median (/ig/m3) 13.8 13.0 9.4
Minimum (ytg/m3) 5.0 6.7 3.0
Maximum (/ug/m3) 32.2 24.9 21.8
Percentiles 25th (^ig/m3) 11.9 10.2 7.1
75th (fig/m3) 16.2 15.9 12.1
Table 4.7: Descriptive statistics of indoor PM5 concentrations, high exposure v 
medium exposure v control.
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Figure 4.8: Boxplots of indoor PMS concentrations, high exposure v 
medium exposure v control.
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4.1.3 Correlations between indoor and outdoor PM 5 concentrations
Correlations between indoor and outdoor PM5 levels in different exposure areas were 
examined. In this section the Pearson (r) was used to measure the strength of the 
correlation coefficient between indoor and outdoor PM 5 levels. The correlation 
coefficient is defined as a statistic devised to measure the degree of a supposed linear 
association between two variables [Kinnear & Gray 2000]. The Pearson correlation 
can only be in a range from -1 to +1 inclusive, and the stronger the association, the 
greater the absolute value. A positive association is indicated by a positive r and a 
negative association by a negative r. A perfect correlation arises when the values of 
one variable can be exactly predicted from the other variable, then r takes a value of 
±1. Oppositely, when there is no association between two variables whatsoever r will 
become zero.
Firstly all PM 5 data obtained through environmental surveys were included in the 
analysis, and the indoor and outdoor measurements were found to be moderately 
correlated as shown in figure 4.9. The correlation coefficient was 0.64 with a p-value 
of <0.01, meaning r was statistically significant at the 1% level (r = 0.64; n = 123; 
p<0.01). However, the presence of an outlying value (sample 108) may have led to 
the overestimation of the correlation coefficient, therefore the pair was removed from 
the analysis and the test reran (figure 4.10). New results showed that the value of r 
was slightly reduced to 0.57 but remained statistically highly significant (r = 0.57; n = 
122; p<0.01). Similarly when only data from the exposed group were studied r had a 
value of 0.63 but was reduced to 0.53 when sample 108 was removed (r = 0.53; n = 
72; p<0.01) (figure 4.11). In contrast, when only data from the control cases were 
examined, a weaker but still statistically significant correlation was observed between 
indoor and outdoor PM 5 concentrations (r = 0.36; n = 50; p = 0.01) (figure 4.12). 
Figure 4.13 shows a scatterplot two separate linear regression lines for the exposed 
group and the controls. The correlation coefficient of the exposed group was 47% 
higher than that of the controls.
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Figure 4.9: Scatterplot showing correlations between indoor and outdoor PM5 
concentrations of all areas.
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Figure 4.10: Scatterplot showing correlations between indoor and outdoor PM5 
concentrations of all areas, with outlier “sample 108” removed.
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Figure 4.11: Scatterplot showing correlations between indoor and outdoor PM5 
concentrations of all exposed areas, outlier “sample 108” was removed from the figure 
on the right.
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Figure 4.12: Scatterplot showing correlations between indoor and outdoor PM5  
concentrations of all control areas.
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Figure 4.13: Scatterplot showing correlations between indoor and outdoor PM5 
concentrations separated into exposed and control areas.
f
4.14 Associations between indoor PM5 levels and the architectural design of the 
house
This section examines whether the architectural design of a house can determine how 
much of a barrier it is in reducing the levels of outdoor PM5 entering the indoor 
environment. During the interviews with the participants, they were asked to provide 
basic information regarding the architectural designs of the house. Details collected 
were 1) how many sheltered sides does the house have; 2) how many windows were 
there in the house and how many were routinely opened; 3) whether the windows 
were single- or double-glazed; and 4) how many doors were there in the house. These 
data were then fed into a multiple regression model to examine if levels of indoor PM5 
could be influenced by the design of the house. The model takes into account of the 
independent variables, in this case the design of the house, and estimates the 
coefficient of a linear equation that best predicts the value of the dependent variable, 
which in this case is the level of indoor PM5. A total of 114 participants provided 
details of the house, in which 37 of them were from the high exposure group, 28 from 
the medium exposure group, and 49 from the control group. Seven refused to provide 
any details.
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Number of sheltered sides
This information provides details of how many sides the house was sheltered, i.e. 
directly connected to an adjacent building or wall but excludes the ceiling. For 
example, a detached house will have 0 sheltered sides, and a semi-detached house will 
have 1 because it is connected to another building on one side. The majority (53%) of 
the houses sampled had 1 sheltered side, meaning most of them were either semi­
detached or at the end of a terrace. The others were detached (26%) with 0 sheltered 
sides, terrace (17%) with 2 sheltered sides, or flats (4%) with 3 sheltered sides.
Number o f windows
The number of windows in each house varied greatly in the study, from as few as 3 in 
a flat, to as many as 32 in a 3-storey detached house. The mean number of windows
tli tKrecorded was 14, with a 25 and 75 percentile of 9 and 18 respectively.
Number o f routinely opened windows
Participants were asked about how many windows were routinely opened in their 
houses in daytime, during the period when the interviews were conducted. The same 
questions were asked once again in the second interview six months later. The 
answers were then combined to form a single value that represent the frequency of 
windows being opened in the house and expressed as a percentage. On average 28%
i L  f.l_
of the windows were regularly opened, with a 25 and 75 percentile of 11% and 
36% respectively. In addition, 17% of the households never had windows opened 
routinely, and 5% had always opened all their windows on a daily basis.
Glazing
Most of the houses sampled had double-glazing (84%) and the rest with single­
glazing. In houses where a mixture of both was present, the type of glazing installed 
was determined by their proportions and were allocated into the group that was larger.
Number of external doors
Information of the number of external doors that opens to the outside was collected. 
Those that opened to the garage and garage doors were excluded, and a set of patio 
doors was counted as one. Approximately 61% of the houses had 3 to 4 external 
doors, and 33% had 1 to 2. A small proportion (6%) had no external doors because
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their main front doors were opened to a public hallway within a building that led to 
another main door to the outside.
The multiple regression model
Before the variables could be fed into the regression model they must be checked for 
normality. This applies to all continuous variables including the percentage of 
windows that were routinely opened in the house, and the indoor and outdoor PM5 
levels of each house. Using P-P plots the distributions of these variables were 
examined, in which the points would cluster around a straight line if normal 
distributions were observed. Any skewness present in the data can be fixed by taking 
the logio of the values, although this method does not fully eliminate the problem. 
Figures 4 .1 4 -4 .1 6  show the P-P plots of all the continuous variables in the model 
before and after adjustments made by taking log 10. It appeared that the distributions of 
the three variables were all skewed, as shown on the P-P plots on the left of the 
figures. Both variables “% of windows routinely opened” and “outdoor PM5 levels” 
partially restored normality after adjustment by taking logio- In contrast, the variable 
“indoor PM5” appeared to be less skewed before adjustment and was therefore 
unchanged.
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Figure 4.14: Normal P-P plots of the variable “% of windows routinely opened”, before 
(left) and after taking log]0of the values.
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Figure 4.15: Normal P-P plots of the variable “indoor PM5 levels”, before (left) and after 
taking logi0of the values.
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Figure 4.16: Normal P-P plots of the variable “outdoor PM5 levels”, before (left) and 
after taking logi0of the values.
All variables were included in the regression model, with the levels of indoor PM5 as 
the dependent variable. The model generated an R squared of 0.70 and an adjusted R 
squared of 0.49. Both are indicators of how well the model fits and are always in the 
range from 0 to 1. The higher the value the better the model fits. The value of R 
squared represents the proportion of variation in the dependent variable explained by 
the model, and tends to optimistically estimate how well the model fits. In contrast, 
the adjusted R square will correct the R squared so that it will more closely reflect the 
goodness of fit of the model. This explains why the value of adjusted R squared is
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always smaller among the two. An output of the regression model is shown in figure 
4.17. Although there is a lot of information provided in the output the most important 
ones are the beta coefficients as indicated by “B ” , the t statistics as indicated by “t”, 
and the significance level as indicated by “Sig”. The model showed that none of the 
independent variables except outdoor PM 5 levels could explain the variability of the 
indoor P M 5 levels observed, due to the fact that outdoor P M 5 was the only variable 
that achieved statistical significance. In this case, the estimated regression model can 
be expressed as the equation [indoor P M 5 = constant + Boutdoor pms x  outdoor P M 5]. 
Using this model the level of indoor P M 5 can be estimated if the level of outdoor PM 5 
is known. For example, if the corresponding outdoor P M 5 concentration of a house is 
20pg/m3, using the regression model the predicted indoor P M 5 would therefore be 
[-7.704 + logl5.179 x 20] = 15.92pg/m3. The t statistics helps to determine the 
relative importance of each variable in the model, and useful predictors are usually 
below -2 or above +2. As a result, outdoor P M 5 concentrations can be considered as a 
useful predictor for the indoor levels of PM 5 .
C oefficients3
Unstandardized
Coefficients
Standardized
Coefficients
Model B Std. Error Beta t Sig.
1 (Constant) -7.704 5.384 -1.431 .157
No. of sheltered sides .884 .730 .138 1.211 .230
No. of windows -.002 .078 -.002 -.022 .983
Glazing 1.243 1.320 .092 .942 .350
No. of external doors .823 .570 .153 1.444 .154
Outdoor PM5 
concentrations 15.179 2.760 .607 5.500 .000
% of windows 
routinely opened -1.078 1.708 -.063 -.631 .530
Exposure group -1.088 1.143 -.111 -.952 .345
a- Dependent Variable: Indoor PM5 concentrations 
Figure 4.17: Output of multiple regression model.
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4.1.5 Trace elements in outdoor ambient air samples
Apart from monitoring the concentrations of air particulates in the environment, PMio 
samples were also collected to examine the elemental contents of the particles in the 
air. A total of 19 outdoor ambient air samples were taken within a 6-week period. 
Nine of the samples were from exposed areas and 10 were from control areas. 
Presence of trace elements in these environmental samples collected on polycarbonate 
filters were detected by neutron activation analysis. A set of control blanks were also 
analysed and the mean concentrations of each trace element found on these filters 
were deducted from the results obtained from the environmental samples. Seventeen 
different elements including sodium (Na), magnesium (Mg), aluminium (Al), sulphur 
(S), chlorine (Cl), potassium (K), calcium (Ca), titanium (Ti), vanadium (V), cobalt 
(Co), manganese (Mn), copper (Cu), bromine (Br), antimony (Sb), tin (Sn), iodine (I), 
and holmium (Ho) were quantified, with V, Cu, Br, and Sb as the main elements of 
interest. When comparing the levels of trace elements between different exposure 
groups, the use of medians were thought to be more appropriate due to the skewness 
of the data. The difference in medians was examined by the non-parametric Mann- 
Whitney test. When the concentrations of some elements in a sample fell under the 
minimum detection limits, they were treated as zero. Ideally the value of the minimum 
detection limit should be quoted instead, but due to the fact that the detection limits of 
certain elements were unknown, thus zero was used throughout the results section to 
maintain consistency. Furthermore, since median was calculated instead of mean, the 
decision of whether to use zero or the value of the minimum detection limit would 
have no effects on the results at all. On the other hand, any extreme values present in 
the data were still being included in the analysis.
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Vanadium (V)
Table 4.8 shows the descriptive statistics of vanadium concentrations in ambient air 
samples. One sample from the exposed group contained undetectable amount of 
vanadium and there were no outlying values in the dataset (figure 4.18). Median 
concentration of vanadium found in the exposed areas was almost half of the level 
seen in the control areas. The median concentration for exposed area was 0.07ng per 
m3 of air sampled and 0.12ng/m3 for control areas. Mann-Whitney test showed that 
the different medians observed in the two exposure groups was statistically significant 
(z = 2.25; p = 0.03).
Exposed Control
N 9 10
Median (ng/m3) 0.07 0.12
Minimum (ng/m3) 0.00 0.06
Maximum (ng/m3) 0.14 0.21
Percentiles 25th (ng/m3) 0.03 0.07
75th (ng/m3) 0.11 0.15
Table 4.8: Vanadium concentrations in ambient air samples, 
exposed v control.
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Figure 4.18: Vanadium concentrations in ambient air samples, 
exposed v control.
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Copper (Cu)
Table 4.8 shows the descriptive statistics of copper concentrations in ambient air 
samples. All samples contained detectable amount of copper. Although two extreme 
values were found in the exposed group, their existence had no significant effects in 
the median (figure 4.19). The exposed group has a higher median copper 
concentration than the control group by 41% (1.21ng/m3 v 0.86ng/m3). Mann-Whitney 
test showed that it was not statistically different from the median of the control group 
(z = 1.72; p = 0.1).
Exposed Control
N 9 10
Median (ng/m3) 1.21 0.86
Minimum (ng/m3) 0.30
r
0.06
Maximum (ng/m3) 2.06 1.41
Percentiles 25th (ng/m3) 1.10 0.55
75th (ng/m3) 1.46 1.29
Table 4.9: Copper concentrations in ambient air samples, 
exposed v control.
2.5 T--------------------------------------------------------------------------------------------  2.5
exposed control exposed control
Figure 4.19: Copper concentrations in ambient air samples, exposed v control. Extreme 
values “1” and “2” were removed from the figure on the right.
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Bromine (Br)
Table 4.10 shows the descriptive statistics of bromine concentrations in ambient air 
samples. Bromine was not detected in one of the control samples and there were no 
extreme values present in the data. The median bromine concentration of the exposed 
group was 0.47ng/m3, which was approximately 19% lower than the control group 
(0.58ng/m3) as shown in figure 4.20. There was no significant difference between the 
medians of the exposed and control areas as shown by Mann-Whitney test (z = 0.41, p 
= 0.72).
Exposed Control
N 9 10
Median (ng/m3) 0.47 0.58
Minimum (ng/m3) 0.30 0.00
Maximum (ng/m3) 0.83 0.92
Percentiles 25th (ng/m3) 0.41 0.26
75th (ng/m3) 0.74 0.67
Table 4.10: Bromine concentrations in ambient air samples, 
exposed v control.
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Figure 4.20: Bromine concentrations in ambient air samples, exposed v control.
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Antimony (Sb)
Insufficient amount of data were available for the analysis of antimony in the ambient 
air samples.
Others
Amongst all other elements analysed, only sodium (z = 2.29; p = 0.02) and chlorine (z 
= 2.21; p = 0.03) achieved statistical significance when tested by Mann-Whitney test. 
Boxplots of sodium and chlorine concentrations are shown in figures 4.21 and 4.22. 
Both elemental concentrations observed have medians significantly higher in the 
exposed group than the control group. For sodium, the median of the exposed and 
control groups were 50.8ng/m3 and 17.3ng/m3 respectively; for chlorine, the median 
of the exposed and control groups were 24.6ng/m3 and 10.3ng/m3 respectively.
control
Figure 4.21: Sodium concentrations in ambient air samples, 
exposed v control.
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Figure 4.22: Chlorine concentrations in ambient air samples, 
exposed v control.
4.1.6 Trace elements in indoor dust samples
Indoor dust samples were collected from 10 exposed houses and 10 control houses, 
and subjected to analysis by ICP-MS for the presence of trace elements. Amongst 
them vanadium (V), manganese (Mn), iron (Fe), copper (Cu), zinc (Zn), barium (Ba), 
cerium (Ce), and lead (Pb) were the main elements of interest, although aluminium 
(Al), titanium (Ti), chromium (Cr), cobalt (Co), nickel (Ni), and tin (Sn) were also 
examined. In addition three sets of procedural control blanks were included and the 
concentrations of elements found on these blanks filters were then averaged and 
deducted from the samples. The median concentrations of each element were 
compared between the exposed and the control groups. Any undetectable elements 
that fell below the minimum detection limits were regarded as zero when analysing 
the data, and any extreme values present were also included in the analysis.
Vanadium (V)
Table 4.11 shows the descriptive statistics of vanadium concentrations in indoor dust 
samples. There were a total of 4 samples from the exposed group and 3 samples from 
the control group that fell below the minimum detection limit. No extreme values 
were found (figure 4.23). Median concentration of vanadium from the exposed group 
was 33% higher than the control. The difference observed was tested by Mann- 
Whitney test but it failed to achieve statistical significance (z = 1.14; p = 0.25).
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Exposed Control
N 10 10
Median (ng/m3) 0.12 0.09
Minimum (ng/m3) 0.00 0.00
Maximum (ng/m3) 0.51 0.33
Percentiles 25th (ng/m3) 0.00 0.00
75th (ng/m3) 0.25 0.21
Table 4.11: Vanadium concentrations in indoor dust samples, 
exposed v control
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Figure 4.23: Boxplots of vanadium concentrations in indoor dust 
samples, exposed v control.
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Manganese (Mn)
Table 4.12 shows the descriptive statistics of manganese concentrations in indoor dust 
samples. All 20 samples were above the detection limit and there were no extreme 
values present (figure 4.24). Median concentration of manganese in the exposed group 
was 56% higher than the control group. Mann-Whitney test was carried out to 
compare the medians observed and they were found to be statistically insignificant (z 
= 1.07; p = 0.29).
Exposed Control
N 10 10
Median (ng/m3) 0.28 0.18
Minimum (ng/m3) 0.07 0.07
Maximum (ng/m3) 1.75 0.49
Percentiles 25th (ng/m3) 0.08 0.07
75th (ng/m3) 0.59 0.29
Table 4.12: Manganese concentrations in indoor dust samples, 
exposed v control.
2.0
1.5
1.0
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N= 10 10
exposed control
Figure 4.24: Boxplots of manganese concentrations in indoor dust 
samples, exposed v control.
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Iron (Fe)
Table 4.13 shows the descriptive statistics of iron concentrations in indoor dust 
samples. All values were above the detection limit and extreme values were not 
present (figure 4.25). Median concentration of iron in the exposed group was 
markedly higher and nearly doubled the median concentration found in the controls. 
Mann-Whitney test was carried out and the difference observed did not reach 
statistical significance (z = 1.63; p = 0.10).
Exposed Control
N 10 10
Median (ng/m3) 15.3 8.8
Minimum (ng/m3) 3.0 2.8
Maximum (ng/m3) 56.5 31.9
Percentiles 25th (ng/m3) 11.1 6.3
75th (ng/m3) 34.1 16.4
Table 4.13: Iron concentrations in indoor dust samples, exposed v control.
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Figure 4.25: Boxplots of iron concentrations in indoor dust samples, 
exposed v control.
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Copper (Cu)
Table 4.14 shows the descriptive statistics of copper concentrations in indoor dust 
samples. None of the samples contained copper that was below the minimum 
detection limit but there were two extreme values present (figure 4.26). The median 
concentration of copper was lower in the exposed group than the control group by 
21%. However, the difference observed was found to be statistically insignificant by 
Mann-Whitney test (z = 0.23; p = 0.82). Note that the range between the 25th and 75th 
percentiles was unusually large.
Exposed Control
N 10 10
Median (ng/m3) 5.5 7.0
Minimum (ng/m3) 0.8 0.7
Maximum (ng/m3) 55.6 10.2
Percentiles 25th (ng/m3) 2.0 1.7
75th (ng/m3) 12.8 10.0
Table 4.14: Copper concentrations in indoor c ust samples, exposed v control.
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Figure 4.26: Boxplots of copper concentrations in indoor dust samples, exposed v
control. Extreme values “7” and “10” were removed from the figure on the right.
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Zinc (Zn)
Table 4.15 shows the descriptive statistics of zinc concentrations in indoor dust 
samples. One sample from the exposed group contained undetectable amount of zinc 
and was therefore treated as 0 in the analysis. No extreme values were present in 
either group (figure 4.27). Median concentration of zinc found in the exposed group 
was significantly higher than the control group more than two-fold. The observed 
difference in medians was test by Mann-Whitney test and was found to be statistically 
insignificant (z = 1.29; p = 0.20).
Exposed Control
N 10 10
Median (ng/m3) 26.1 9.8
Minimum (ng/m3) 0.0 0.2
Maximum (ng/m3) 125.9 28.4
Percentiles 25th (ng/m3) 6.7 4.4
75th (ng/m3) 66.7 23.7
Table 4.15: Zinc concentrations in indoor dust samples, exposed v control.
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Figure 4.27: Boxplots of zinc concentrations in indoor dust samples, 
exposed v control.
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Barium (Ba)
Table 4.16 shows the descriptive statistics of barium concentrations in indoor dust 
samples. All samples contained concentrations of barium that were above the 
detection limits but one extreme value was present in the exposed group (figure 4.28). 
The median concentration of barium in the exposed group was more than 2-fold 
higher than the controls. The observed difference was tested by Mann-Whitney test 
and was found to be statistically insignificant (z = 1.97; p = 0.05).
Exposed Control
N 10 10
Median (ng/m3) 5.6 2.7
Minimum (ng/m3) 1.1 0.6
Maximum (ng/m3) 621.1 5.3
Percentiles 25th (ng/m3) 2.1 1.2
75th (ng/m3) 12.4 3.1
Table 4.16: Barium concentrations in indoor dust samples, exposed v control
N * 10 10 N * 9 10
exposed control exposed control
Figure 4.28: Boxplots of barium concentrations in indoor dust samples, exposed v
control. Extreme value “3” was removed from the figure on the right.
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Cerium (Ce)
Table 4.17 shows the descriptive statistics of cerium concentrations in indoor dust 
samples. All samples contain concentrations of cerium above the minimum detection 
limits but two extreme values were present in the exposed group (figure 4.29). Median 
cerium concentration in samples from the exposed group was 33% higher than those 
from the control group. The observed difference was tested by Mann-Whitney test but 
did not reach statistical significance (z = 0.09; p = 0.36).
Exposed Control
N 10 10
Median (ng/m3) 0.12 0.09
Minimum (ng/m3) 0.03 0.03
Maximum (ng/m3) 0.61 0.31
Percentiles 25th (ng/m3) 0.08 0.04
75th (ng/m3) 0.23 0.15
Table 4.17: Cerium concentrations in indoor dust samples, exposed v control.
exposed exposed
Figure 4.29: Boxplots of cerium concentrations in indoor dust samples, exposed v
control. Extreme values “1” and “10” were removed from the figure on the right.
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Lead (Pb)
Table 4.18 shows the descriptive statistics of lead concentrations in indoor dust 
samples. Lead was detected in all the samples but there were two extreme values in 
the exposed group (figure 4.30). The median lead concentration found in the exposed 
group was 3-fold higher than the controls. However, the observed difference did not 
reach statistical significance when tested by Mann-Whitney test (z = 0.10; p = 0.36).
Exposed Control
N 10 10
Median (ng/m3) 0.60 0.20
Minimum (ng/m3) 0.10 0.10
Maximum (ng/m3) 367.10 1.20
Percentiles 25th (ng/m3) 0.18
r
0.15
75th (ng/m3) 2.48 0.75
Table 4.18: Lead concentrations in indoor dust samples, exposed v control.
400
exposed exposed control
Figure 4.30: Boxplots of lead concentrations in indoor dust samples, exposed v control. 
Extreme values “3” and “10” were removed from the figure on the right.
Others
Median tests were also performed for the remaining elements includeing Al, Ti, Co, 
and Sn. Although the median concentrations of Al, Co, and Sn were higher in samples 
from the exposed group than the controls (figures 4.31 -  4.33), none of them have
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reached statistical significance. Analysis was not carried out for Cr and Ni due to the 
absence of sufficient data that were above the minimum detection limits.
exposed control
Figure 4.31: Boxplots of aluminium concentrations in indoor dust 
samples, exposed v control.
exposed exposed
Figure 4.32: Boxplots of cobalt concentrations in indoor dust samples, exposed v control. 
Extreme values “3”, “7”, “10”, “12”and “15” were removed from the figure on the right.
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exposed control
Figure 4.33: Boxplots of tin concentrations in indoor dust samples, 
exposed v control.
4.1.7 PAH concentrations in environmental air samples
A total of 9 environmental PAH samples were collected throughout the study, of 
which 5 were from exposed areas and 4 were from control areas. Fibreglass filters 
used for sampling were subjected to HPLC for the analysis of 16 PAH compounds 
including napthalene, acenapthylene, acenapthene, fluorene, anthracene, 
phenanthrene, fluoranthene, pyrene, benz[a]anthracene, chrysene, 
benzo[b] fluoranthene, benzo[k]fluoranthene, benzo[a]pyrene, indeno[123cd]pyrene, 
benzo[ghi]perylene, and dibenz[ah]anthracene. The minimum detection limits for 
these compounds were approximately 5ng/ml, which is roughly equivalent to 15ng of 
PAH per filter, although there may be some slight variations depending upon the 
particular compound. Results of the analysis showed that all filters contained 
undetectable levels of PAH compounds.
133
Chapter 4 Results
4.2 Analysis of trace elements and 1-HP in biological samples
This part of the study attempts to answer the question as to whether the concentrations 
of exposure markers differ between individuals residing in different exposure areas. 
Blood, hair, and urine samples were collected from each participant on two occasions 
that were six months apart. The blood samples collected were analysed by ICP-MS 
for the presence of known markers of exposure to motor vehicles including Cu, Fe, 
Zn, and Pb. Hair samples were analysed by NAA for the presence of V, Cu, Br, and 
Sb. Finally the urine samples were analysed for both platinum (Pt) and 1-HP.
4.2.1 Trace elements in blood samples
Throughout the study period a total of 84 participants agreed to donate two blood 
samples that were 6 months apart, of which 53 were from the exposed group and 34 
were from the control group. They were asked to attend the Phlebotomy clinic in the 
University Hospital of Wales where a qualified phlebotomist extracted a small amount 
of blood via a Vacutainer®. Samples of whole blood were then separated and serum 
was used for the analysis of Cu, Fe, Zn, and Pb by ICP-MS. The elemental 
concentrations of the two samples donated by each subject were then combined to 
give a mean concentration. Any elements that fell below the minimum detection limit 
within a sample were treated as zero, and all extreme values were included in the 
analysis. Mann-whitney and Kruskal-Wallis tests were used to find out whether or not 
the differences in medians were significant.
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Differences in exposed and control groups
Copper (Cu)
Table 4.19 shows the descriptive statistics of copper concentrations in blood samples. 
All samples contained concentrations of copper that were above the minimum 
detection limit and there were no extreme values presented (figure 4.34). The medians 
of the exposed group and the control group were very similar (15.6pmol/L v 
15.1 pmol/L) with a difference of only 3%. Mann-Whitney test showed that the 
medians of the two groups were not significantly different from each other (z = 1.63;
p = 0 .10).
Exposed Control
N 53 34
Median (pmol/L) 15.6 15.1
Minimum (pmol/L) 12.8 11.3
Maximum (pmol/L) 21.4 19.5
Percentiles 25th (pmol/L) 14.4 13.4
75th (pmol/L) 17.8 16.7
Table 4.19: Copper concentrations in blood, exposed v control.
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Figure 4.34: Copper concentrations in blood, exposed v control.
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Iron (Fe)
Table 4.20 shows the descriptive statistics of iron concentrations in blood samples. 
Only 52 out of 53 blood samples in the exposed group were available for iron 
detection by ICP-MS. Both the exposed and control groups had one extreme value, 
and all samples had detectable levels of iron (figure 4.35). The medians of the 
exposed and control groups were very similar, with the controls having a slightly 
larger median than the exposed group by 2% (29.4pmol/L v 30.1 pmol/L). The 
observed difference in the medians was found to be statistically insignificant by 
Mann-Whitney test (z = 0.98; p = 0.33).
Exposed Control
N 52 34
Median (/jmot/L) 29.4 30.1
Minimum (/.tmol/L) 9.7 16.1
Maximum (/imol/L) 95.3 102.1
Percentiles 25th (jjmol/L) 22.7 25.7
75th (ftmol/L) 39.4 41.5
Table 4.20: Iron concentrations in blood, exposed v control.
exposed exposed
Figure 4.35: Iron concentrations in blood, exposed v control. Extreme values “2” and
“73” were removed from the figure on the right.
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Zinc (Zn)
Table 4.21 shows the descriptive statistics of zinc concentrations in blood samples. 
One extreme value was present in the control group and zinc was detected in all 
samples (figure 4.36). The median of zinc concentrations were very similar between 
the two groups with less than 1% difference. The exposed group has a median of 
13.2pmol/L, and the control group 13.3pmol/L. Mann-Whitney test showed that the 
difference observed was statistically insignificant (z = 0.51; p = 0.61).
Exposed Control
N 53 34
Median (/.tmol/L) 13.2 13.3
Minimum (/umol/L) 8.7 10.0
Maximum (/jmol/L) 20.8 22.3
Percentiles 25th (/jmol/L) 11.7 12.2
75th (jjmol/L) 14.5 14.3
Table 4.21: Zinc concentrations in blood, exposed v control.
53 34 N » 53 33
exposed control exposed control
Figure 4.36: Zinc concentrations in blood, exposed v control. Extreme value “81” was 
removed from the figure on the right.
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Lead (Pb)
None of the samples contained significant quantity of lead for detection by ICP-MS. 
The minimum detection limit for lead is approximately O.lnmol/L.
Differences in high exposure, medium exposure, and control groups
The exposed group was subdivided into high exposure and medium exposure groups 
according to the criterion set before, so that any dose response relationships that exist 
can be identified. The total number of samples from the high exposure group was 34 
and medium exposure group was 19. Because there were no changes to the control 
group hence the number remained the same at 34.
Copper (Cu)
Table 4.22 shows the descriptive statistics of copper concentrations in blood samples. 
The medians of the three different exposure groups were compared; the highest was in 
the high exposure group at 15.7pmol/L, followed by the medium exposure group and 
controls which were both at 15.1 pmol/L. No extreme values were present that may 
affect the medians (figure 4.37), and all samples contained detectable amount of 
copper. Kruskal-Wallis test showed that the difference observed between the medians 
of each group were statistically insignificant (% (2) = 3.57; p = 0.17).
High
exposure
Medium
exposure Control
N 34 19 34
Median (pmol/L) 15.7 15.1 15.1
Minimum (pmol/L) 13.1 12.8 11.3
Maximum (pmol/L) 21.4 20.2 19.5
Percentiles 25th (pmol/L) 14.6 14.0 13.5
75th (pmol/L) 18.1 17.2 16.8
Table 4.22: Copper concentrations in blood, high exposure v medium exposure v 
control.
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Figure 4.37: Copper concentrations in blood, high exposure 
v medium exposure v control.
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Iron (Fe)
Table 4.23 shows the descriptive statistics of iron concentrations in blood samples. 
There was no particular trend observed in the medians of the three exposure groups 
for iron concentrations. Samples from the medium exposure group have the highest 
median (34.1 pmol/L), followed by the controls (30.1 pmol/L) and the high exposure 
group (27.1 pmol/L). One extreme value was found in the high exposure group and 
one in the control group, although their existence had little effects on the medians 
(figure 4.38). Kruskal-Wallis test showed that none of the differences in medians 
observed within the three groups reached statistical significance (x2 (2) = 3.52; p = 
0.17).
High
exposure
Medium
exposure Control
N 33 19 34
Median (fimol/L) 27.1 34.1 30.1
Minimum (pmol/L) 9.7 15.7 16.1
Maximum (pmol/L) 95.3 55.8 102.1
Percentiles 25th (pmol/L) 21.1 24.8 25.7
75th (pmol/L) 35.2 43.8 41.5
Table 4.23: Iron concentrations in blood, high exposure v medium exposure v control.
A
high exposure medium exposure control high exposure medium exposure
Figure 4.38: Iron concentrations in blood, high exposure v medium exposure v control. 
Extreme values “2” and “73” were removed from the figure on the right.
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Zinc (Zn)
Table 4.24 shows the descriptive statistics of zinc concentrations in blood samples. 
Medians of zinc concentrations found across the three exposure groups did not vary 
greatly despite a slightly increasing trend seen from the high exposure group 
(13.0pmol/L), through the medium exposure group (13.2pmol/L), and to the control 
group (13.3pmol/L). There were two extreme values in the medium exposure group 
and the one in the control group (figure 4.39). Kruskal-Wallis test was performed and 
the differences in medians were found to be statistically insignificant (%2 (2) = 0.28; p 
= 0.87).
High
exposure
Medium
exposure Control
N 34 19 34
Median (j.tmol/L) 13.0 13.2 13.3
Minimum (fjmol/L) 9.8 8.7 10.0
Maximum (fjmol/L) 20.8 20.1 22.3
Percentiles 25th (fimol/L) 11.0 12.3 12.2
75th (iumol/L) 14.8 13.7 14.3
Table 4.24: Zinc concentrations in blood, high exposure v medium exposure v control.
high exposure medium exposure control
c
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high exposure medium exposure
Figure 4.39: Zinc concentrations in blood, high exposure v medium exposure v control. 
Extreme values “35” and “81” were removed from the figure on the right.
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Lead (Pb)
Statistical analysis was not carried out because the level of lead fell below the 
minimum detection limit in all samples.
4.2.2 Trace elements in hair samples
A total of 109 hair samples were collected from the participants, of which 67 were 
from the exposed group and 42 from the control group. Twelve participants were 
unable to provide sufficient amount of hair samples and were therefore excluded. A 
suite of trace elements were analysed by NAA including V, Mn, Cu, Br, and Sb which 
were markers of exposure to motor traffic, and also some other elements including 
Na, Mg, Al, S, Cl, K, Ca, Ti, Co, Sn, I, and Ho. A set of control blanks were also 
analysed and thus the total amount of elements present in the hair samples were equal 
to the results obtained minus the mean concentrations found in the blanks.
Differences in exposed and control groups
Trace elements concentrations in the hair samples were compared between the 
exposed and the control groups. Due to the fact that the distributions of the levels 
were skewed, medians were used in the calculations instead of the means. For 
elements that were below the minimum detection limits and were therefore 
undetectable, they were all treated as zero.
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Vanadium (V)
Table 4.25 shows the descriptive statistics of vanadium concentrations in hair 
samples. Of the 109 hair samples collected, vanadium was detectable in 96 samples. 
The difference in the medians between the two groups was very small. In the exposed 
group the median concentration of vanadium was 0.09pg/g and in the control group 
O.lOpg/g. There were three extreme values found in the exposed group and two in the 
control group (figure 4.40). Mann-Whitney test was used to compare the medians of 
the two groups and found that they were not significantly different from each other (z 
= 0.29; p = 0.82).
Exposed Control
N 67 42
Median (fig/g) 0.09 0.10
Minimum (iig/g) 0.00 0.00
Maximum (/ig/g) 1.00 0.99
Percentiles 25th (iig/g) 0.04 0.05
(Mg/g) 0.17 0.21
Table 4.25: Vanadium concentrations in hair, exposed v control.
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Figure 4.40: Vanadium concentrations in hair, exposed v control. Extreme values “55” 
“56” “72” “101” and “102” were removed from the figure on the right.
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Manganese (Mn)
Table 4.26 shows the descriptive statistics of manganese concentrations in hair 
samples. There were a total of 18 samples with undetectable amount of manganese. A 
large number of extreme values were present in both the exposed and control groups 
(figure 4.41). The median concentration was higher in the exposed than the control 
group by approximately 35% (0.57pg/g v 0.42pg/g). The difference in medians was 
tested by Mann-Whitney test and was found to be statistically insignificant (z = 0.96; 
p = 0.34).
Exposed Control
N 67 42
Median (ng/g) 0.57 0.42
Minimum (jug/g) 0.00 0.00
Maximum (ng/g) 5.77 12.30
Percentiles 25th (fig/g) 0.27 0.30
75th (Mg/g) 0.98 1.13
Table 4.26: Manganese concentrations in hair, exposed v control.
exposed exposed
Figure 4.41: Manganese concentrations in hair, exposed v control. Extreme values “9’
“5 5 ” “56” “72”, “ 1 0 1 ”, “1 0 2 ”, and “ 1 1 2 ” were removed from the figure on the right.
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Copper (Cu)
Table 4.27 shows the descriptive statistics of copper concentrations in hair samples. 
Eight of the 109 hair samples had copper levels that were below the minimum 
detection limit. A large number of extreme values were present in both the exposed 
and control groups (figure 4.42). The median of copper concentration was 18pg/g in 
the exposed group, and 19.1 pg/g in the control group. Mann-Whitney test showed that 
the medians of the two groups were not significantly different from each other (z = 
0.74; p = 0.46).
Exposed Control
N 67 42
Median (pg/g) 18.0 19.1
Minimum (pg/g) 0.0 0.0
Maximum (pg/g) 206.8 182.0
Percentiles 25th (pg/g) 11.0 14.3
25.3 25.2
Table 4.27: Copper concentrations in hair, exposed v control.
300
200
100
•100
42
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N " 57
exposed exposed
Figure 4.42: Copper concentrations in hair, exposed v control. Extreme values “21”, 
“36”, “37”, “51”, “55”, “56”, “71”, “72”, “75”, “76”, “8 6 ”, “101”, “102”, “109” and 
“1 1 2 ” were removed from the figure on the right.
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Bromine (Br)
Table 4.28 shows the descriptive statistics of bromine concentrations in hair samples. 
A total of 101 samples had detectable amount of bromine but the remaining 8 samples 
fell below the minimum detection limit. A larger number of extreme values were 
found in both exposure groups (figure 4.43). The median concentration of bromine 
was 50% higher in the exposed group than the controls. Results from Mann-Whitney 
test showed that the medians of the two groups were not significantly different from 
each other (z = 1.27; p = 0.2).
Exposed Control
N 67 42
Median (/jg/g) 3.7 2.5
Minimum (ng/g) 0.0 0.0
Maximum (ng/g) 97.1 79.5
Percentiles 25th (ng/g) 1.4 1.4
75"’ 6.3 4.1
Table 4.28: Bromine concentrations in hair, exposed v control.
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Figure 4.43: Bromine concentrations in hair, exposed v control. Extreme values “1”, 
“2”, “6 ”, “27”, “28”, “55”, “56”, “71” and “90” were removed from the figure on the 
right.
controlsexposedcontrols
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Antimony (Sb)
Comparison between levels of antimony in the exposed and control groups was not 
possible because antimony was undetectable in 98% of the samples.
Others
Of the remaining elements namely Na, Mg, Al, S, Cl, K, Ca, Ti, Co, Mn, Sn, I, and 
Ho, insufficient data were available for the comparisons of K, Sn, and Ho due to the 
presence of a large amount of measurements below the minimum detection limits. 
Mann-Whitney test was run for each of the remaining elements and none of the results 
suggested significant difference between any of the groups (results not shown). 
Moreover, the median concentrations were always found to be higher in the control 
group than the exposed group -  the only exception being Cl, in which the level found 
in the samples of the exposed group was higher than the controls (0 .68mg/g v 
0.52mg/g), as shown in figure 4.44.
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Figure 4.44: Chlorine concentrations in hair exposed v control. Extreme values “5”, 
“55”, “56”, “71”, “8 8 ”, “102”, “106”, and “107” were removed from the figure on the 
right.
Differences in high exposure, medium exposure, and control groups
Kruskal-Wallis tests were carried out for comparing the medians of each element in 
the hair samples between the three different exposure groups. There were 35 samples 
from the high exposure group, 32 from the medium exposure group, and 42 from the 
control group. In addition, Mann-Whitney tests were also carried out to identify 
possible differences in medians between pairs of groups, i.e. high v medium, high v 
control, and medium v control.
*1 0 7
controlscontrols
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Vanadium (V)
Table 4.29 shows the descriptive statistics of vanadium concentrations in hair 
samples. Extreme values were present in all groups but had no significant effects on 
the medians (figure 4.45). The median concentrations of vanadium were almost the 
same across the three exposure groups although the high exposure group had a 
slightly lower median. Kruskal-Wallis test was performed and showed that there were 
no significant differences in the medians across the three exposure groups (x2 (2) = 
0.05; p = 0.97). Mann-Whitney tests also failed to detect any statistically significant 
differences between pairs of groups.
High
exposure
Medium
exposure Control
N 35 32 42
Median (jig/g) 0.09 0.10 0.10
Minimum (ng/g) 0.00 0.00 0.00
Maximum (ng/g) 1.00 0.99 0.99
Percentiles 25th (/ig/g) 0.05 0.03 0.05
75"’ (f& g) 0.18 0.16 0.21
Table 4.29: Vanadium concentrations in hair, 
control.
ligh exposure v medium exposure v
1.2 
1.0 
.8 
.6 
.4 
.2 
0.0 
-.2
N » 35 32 42 N .  33 31 40
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Figure 4.45 Vanadium concentrations in hair, high exposure v medium exposure v 
control. Extreme values “55”, “56”, “72”, “101” and “102” were removed from the 
figure on the right.
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Manganese (Mn)
Table 4.30 shows the descriptive statistics of manganese concentrations in hair 
samples. A number of extreme values were present in all three groups, but had no 
significant effects on the medians (figure 4.46). No particular trend in the median 
concentrations of manganese was seen across the different exposure groups. The high 
exposure group has a median of 0.56pg/g, medium exposure group 0.29pg/g, and 
control group 0.42pg/g. Kruskal-Wallis test was carried out and found no statistically 
significant difference between the three medians (x (2) = 4.90; p = 0.09). Mann- 
Whitney was also carried out to compare pairs of medians, but again yielded 
insignificant results.
High
exposure
Medium
exposure Control
N 35 32 42
Median (pg/g) 0.56 0.29 0.42
Minimum (pg/g) 0.00 0.00 0.00
Maximum (pg/g) 2.95 1.69 2.36
Percentiles 25th (pg/g) 0.29 0.08 0.26
75th (pg/g) 1.06 0.66 0.85
Table 4.30: Manganese concentrations in hair, high exposure v medium exposure v 
control.
10
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N -  35 32 42
high exp medium exp control high exp medium exp control
Figure 4.46: Manganese concentrations in hair, high exposure v medium exposure v
control. Extreme values “9”, “11”, “40”, “55”, “56”, “101”, “102” and “112” were
removed from the figure on the right.
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Copper (Cu)
Table 4.31 shows the descriptive statistics of copper concentrations in hair samples. 
Large number of extreme values was present in all groups. The median copper 
concentration in the controls was highest amongst the three exposure groups 
(19.1 pg/g), followed by high exposure (18.6pg/g) and medium exposure group 
(18pg/g). Kruskal-Wallis test showed that there were no significant differences 
between the medians across the three exposure groups (x2 (2) = 0.74; p = 0.69) nor 
did Mann-Whitney when comparing pairs of medians.
High
exposure
Medium
exposure Control
N 35 32 42
Median (pg/g) 18.6 18.0 19.1
Minimum (pg/g) 0.00 0.00 0.0
Maximum (pg/g) 91.6 206.8 182.0
Percentiles 25th (pg/g) 10.9 11.0 14.3
26.0 24.3 25.2
Table 4.31: Copper concentrations in hair, hig i exposure v medium exposure v control.
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Figure 4.47: Copper concentrations in hair, high exposure v medium exposure v 
control. Extreme values “55”, “56”, “71”, “72”, “75”, “101”, “102” and “109” were 
removed from the figure on the right.
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Bromine (Br)
Table 4.32 shows the descriptive statistics of bromine concentrations in hair samples. 
A large number of extreme values were present in all groups (figure 4.48). The 
medians of bromine concentrations showed a linear decreasing trend across the three 
exposure groups. The high exposure group has a median of 3.8pg/g, medium 
exposure group 3.1 pg/g, and the control group 2.5pg/g. The differences in medians 
across different exposure groups failed to reach statistical significance when tested by 
Kruskal-Wallis test (x2 (2) = 1.53; p = 0.47) and Mann-Whitney test.
High
e x p o s u r e
Medium
e x p o s u r e
Control
N 35 32 42
Median (fig/g) 3.8 3.1 2.5
Minimum (jug/g) 0.0 0.0 0.0
Maximum (fig/g) 97.1 39.9 79.5
Percentiles 25th (ng/g) 1.5 1.1 1.5
75"’ (pg/g) 5.5 6.1 4.1
Table 4.32: Bromine concentrations in hair, high exposure v medium exposure v control.
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Figure 4.48: Bromine concentrations in hair, high exposure v medium exposure v
control. Extreme values “1”, “2”, “27”, “28”, “44”, “55”, “56”, “71”and “90” were
removed from the figure on the right.
high exposure medium exposure controlhigh exposure medium exposure control
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Antimony (Sb)
Tests were not carried out for antimony because there was insufficient amount of data 
available.
Others
Medians of the three exposure groups were also compared for Na, Mg, Al, S, Cl, Ca, 
Ti, Co, Mn. These data were tested by Kruskal-Wallis test and no statistically 
significant differences were found between the three exposure groups in any of these 
elements. Moreover, none of these elements have shown any linear trends across the 
different exposure groups (results not shown).
4.2.3 Correlation between trace elements concentrations in blood and hair 
samples
Trace elements that were recovered from hair samples were the result of depositions 
of these elements from the blood. Copper was the only element that was both analysed 
in hair and blood samples in the study, and the correlations between its concentrations 
were compared in 80 sets of samples.
Exposed and control groups
Correlations between copper concentrations in hair and blood were tested in all 80 
samples (figure 4.49). Results showed that there was virtually no correlation between 
these samples (r = 0.04; n = 80; p = 0.73), and the correlation remained very low 
when only the exposed group was compared (r = 0.09; n = 51; p = 0.53) (figure 4.50), 
and even lower when the only the control group was compared (r = 0.01; n = 29; p = 
0.95) (figure 4.51). None of these correlations achieved statistical significance.
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Figure 4.49: Scatterplot showing correlations between copper 
concentrations in all hair and blood samples (n=80).
Cu concentrations in blood
Figure 4.50: Scatterplot showing correlations between copper 
concentrations in hair and blood samples from participants 
residing in exposed areas (n=51).
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Cu concentrations in blood
Figure 4.51: Scatterplot showing correlations between copper 
concentrations in hair and blood samples from participants 
residing in control areas (n=29).
High and medium exposure groups
In this section the exposed group was sub-divided into high exposure (n = 25) and 
medium exposure (n = 26) according to the definition discussed previously. When 
only the high exposure group was studied, the correlation between copper 
concentrations in the two sample types yielded a negative value of -0.17 (r = -0.17; n 
= 25; p = 0.42). It was possible that such negative correlation was due to the presence 
of two extreme values (samples 7 and 10) that had very high concentrations of copper 
in hair. Thus, they were removed from the analysis and the test was rerun. After the 
removal of the extreme values as shown in the scatterplot on the right of figure 4.52, 
the correlation was reversed to a positive value of 0.08 (r = 0.08; n = 23; p = 0.71). 
The correlation was found to be relatively stronger when only samples from the 
medium exposure group were studied (figure 4.53), although in overall the correlation 
was still weak (r = 0.21; n = 26; p = 0.3). Nevertheless, all of the correlation 
coefficients found failed to reach statistical significance.
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Figure 4.52: Scatterplot showing correlations between copper concentrations in hair and 
blood samples from participants residing in high exposure areas (n=25). Extreme values 
“7” and “10” were removed from the figure on the right.
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Figure 4.53: Scatterplot showing correlations between copper 
concentrations in hair and blood samples from participants 
residing in medium exposure areas (n=26).
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4.2.4 Platinum in urine samples
Few studies have been carried out to quantify the level of platinum in the general 
population with inconsistent results. Since one of the major sources of platinum in a 
non-occupational environment is motor traffic, therefore it can serve as a biomarker of 
exposure to respirable air particulates arose from road transport. One of the ways to 
quantify the level of platinum in the human body is by measuring its concentration in 
urine via ICP-MS. For this study a small number of 28 urine samples were chosen 
from participants who resided in areas that have high levels of outdoor PM5, such as 
Cowbridge Road West, Cowbridge East, and Manor Way. This was because the 
sensitivity of ICP-MS to detect platinum was unknown, therefore it seemed 
reasonable in the first instance to select samples from individuals residing in more 
polluted areas and assumed that the levels of platinum biomarker should be higher. 
Initially a set of samples from the control group was scheduled to follow once 
samples from the exposed group were analysed, but it was later cancelled due to 
technical problems and time constrains. Table 4.33 shows the descriptive statistics of 
platinum concentrations in the urine samples. The measurements were adjusted for the 
levels of creatinine in the urine and presented as ng/g of creatinine. The lowest level 
of platinum detected in the urine samples was 3.8ng/g creatinine, and the highest level 
that was not an extreme value was 56.5ng/g creatinine. Platinum was not detected in 3 
of the samples. The distribution of the data was highly skewed due to the presence of 
several extreme values toward the upper end as shown in figure 4.54.
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Pt concentration
(ng/g creatinine)
N 28
Mean 150.8
Median 12.0
Minimum 0
Maximum 1411.6
Percentiles 25th 6.0
75th 88.7
Table 4.33: Concentrations of platinum in urine samples.
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Figure 4.54: Platinum concentrations in urine samples. Extreme values “8 ”, “15”, “24”, 
“26”, “22”, and “27” were removed from the figure on the right.
4.2.5 1-hydroxypyrene (1-HP) in urine samples
In this study, urine samples were collected from participants residing in different 
exposure areas and biomarkers of PAH uptake from the environment were compared. 
Throughout the study two urine samples that were 6 months apart were collected from 
each participant. A total of 120 sets of urine samples were received for the analysis of 
1-HP in urine, of which 70 were from the exposed group and 50 were from the control 
group. Biomarkers for the absorbed dose of PAH, which were presented as 1-HP in 
urine, were analysed by HPLC. The concentrations of 1-HP derived from the two 
samples of each subject were averaged for the analysis. Because the data were not 
evenly distributed, therefore medians were tested instead of means, using the non-
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parametric Mann-Whitney test and Kruskal-Wallis tests. Any samples that contained 
insufficient amount of 1 -HP and undetected by HPLC were regarded as zero, and any 
extreme values were included in the analysis.
Differences in exposed and control groups
Table 4.34 shows the descriptive statistics of 1-HP concentrations in urine samples. 
All samples contained detectable levels of 1-HP, the median concentrations were 
calculated and it was found to be higher in the control group (0.21 pg/g of creatinine) 
than the exposed group (0.13pg/g). Three extreme values were present in the exposed 
group (figure 4.55). When tested by Mann-Whitney test the difference in medians 
observed between the two groups was found to be statistically significant at the 1% 
level (z = 4.16; p <0.01).
Exposed Control
N 70 50
Median (pg/g) 0.13 0.21
Minimum (pg/g) 0.05 0.06
Maximum (pg/g) 2.11 1.47
Percentiles 25th (pg/g) 0.09 0.13
(fjg/g) 0.19 0.50
Table 4.34: 1-HP concentrations in urine, exposed v control.
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Figure 4.55: 1-HP concentrations in urine, exposed v control. Extreme values “26”,
“42”and “68” were removed from the figure on the right.
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Differences in high exposure, medium exposure, and control groups
For this analysis the exposed group was divided into high exposure group and 
medium exposure group, with 36 and 34 samples respectively. The control group 
remained unchanged. The high exposure group has a median of 0.16pg/g, the medium 
exposure group 0.06pg/g, and the control group 0.21 pg/g (table 4.35). The median 
levels of 1-HP did not resemble a linear trend across the 3 exposure groups. Three 
extreme values were identified in the high exposure group (figure 4.56). Kruskal- 
Wallis test showed that the medians between the three groups were significantly 
different from each other at the 1% level (x2 (2) = 17.73; p < 0.01). Mann-Whitney 
tests were also carried out to identify possible differences within groups. Results 
showed that the high exposure group was not different from the medium exposure 
group (z = 0.71; p = 0.48) but was significantly different from the control group (z = 
3.10; p < 0.01). Moreover, the difference seen between the medium exposure group 
and the controls was also found to be statistically significant at the 1% level (z = 3.84,
p<0.01).
High
exposure
Medium
exposure Control
N 36 34 50
Median (pg/g) 0.16 0.06 0.21
Minimum (pg/g) 0.05 0.05 0.06
Maximum (pg/g) 2.11 0.40 1.47
Percentiles 25th (pg/g) 0.09 0.09 0.13
75th (t&g) 0.23 0.18 0.50
Table 4.35: 1-HP concentrations in urine, high exposure v medium exposure v control
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Figure 4.56: 1-HP concentrations in urine,high exposure v medium exposure v control. 
Extreme values “26”, “42”and “6 8 ” were removed from the figure on the right.
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Sec tio n  2 
Sy m pt o m s  C o m pa r iso n  St u d y
This section reports the effects of short-term changes in ambient PMio levels on 
disease symptoms. During the 12-month study period daily levels of PMio in Cardiff, 
Swansea, Port Talbot, and Cwmbran as measured by stationary air quality monitoring 
stations were followed, and disease-specific symptoms questionnaires were sent out 
when pollution levels matched the preset criteria. Customised questionnaires with 
items extracted from validated instruments were used to detect acute changes in 
disease symptoms in patients with asthma, chronic respiratory diseases excluding 
asthma, and chronic cardiac diseases that may have been induced by short-term 
changes in PMio levels in their areas. All subjects were acting as their own controls in 
the study and thus allowed comparisons to be made at the individual level.
4.3 Asthma symptoms questionnaire analysis 
Outcome rates
As shown in table 4.36, a total of 200 copies of invitation letters were given out to all 
patients visiting the participating asthma clinics in South Wales. Eighty-three asthma 
patients expressed interests by filling in the cards with their personal and contact 
details, which were then returned to the researcher via the clinics. Further information 
were collected from the patients when they were contacted by phone. At the end 65 
fulfilled the selection criteria of the study and amongst them 44 agreed to take part. 
Approximately half of these patients resided in Cardiff (48%), with the rest from 
Swansea (39%), Port Talbot (7%), and Cwmbran (7%). There were more females than 
males (16 v 28) and the mean age was 57years old, with the youngest 20yrs old and 
the oldest 76yrs old. All subjects survived throughout the duration of the study, and 
all 44 sets of questionnaires were collected that recorded their asthma symptoms 
through different episodes of air pollution with no missing data. The response rate of 
the study was 67.7%.
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N u m b e r  o f  p a r t i c ip a n ts  (n)
Letters handed ou t 2 0 0
R espon se  rece ived 83
Eligible re sp o n se s 65
R espon den ts agreed  
to take part 4 4
C om pleted questionnaires 4 4
Table 4.36: Breakdown of responses to recruitment letters, Asthma
Symptoms Comparison Study.
4.3.1 Changes in asthma symptoms score between high and normal levels of 
PMio
A copy of the asthma symptoms questionnaire is listed in appendix 8.1. The 
questionnaire included items that can be categorised, which focused on disease 
symptoms (questions 4,5, 7, 13 and 14), medication use (10 and 23), and emotional 
well-being (questions 1-3, 8, 9, 11, 16, 18-22, 24 and 25). The remaining questions 
were all “check questions” for the detection of confounding factors that may affect the 
accuracy of the results. For every question the participants were asked to choose an 
option between 1 and 7 to represent how their asthma symptoms had been. The only 
exception was question 23 in which only 4 options were available. The answers they 
had given were then converted into symptoms scores, with option 1 equivalent to a 
score of 1, and option 2 equivalent to a score of 2 and so on. Based on this method, a 
low symptoms score therefore indicated that the patient was experiencing hardship 
from his or her exacerbated asthma symptoms. Table 4.37 shows a summary of the 
mean symptoms scores for each question during different pollution episodes. Using 
the symptoms scores obtained, the influence of air pollution at high levels were 
expressed by calculating the effect size, which was calculated by dividing the 
differences of the mean scores following high and normal pollution episodes by the 
standard deviation (SD) of the results in the corresponding question (figure 4.57). The 
SD indicated how widely spread the symptoms scores were for each question.
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Effect size (%) = [(difference in mean scores) I SD] x 100%
Figure 4.57: Formula for calculating effect size.
Large effect size % represents greater changes observed in the mean symptom scores 
between normal and high pollution episodes in either direction. Paired-Sample T-Test 
was used to find out whether the difference in means observed between the two 
episodes was statistically significant. This statistical method is used for comparing the 
repeated means of a group of individual. In other words, it compares the means of two 
variables for a single group, such as before and after an intervention. In this case the 
mean symptoms scores of the same group of individuals during high and normal 
pollution episodes were compared. All questions in the asthma symptoms 
questionnaire were tested except for question 23, because the answers for that 
question were neither continuous nor categorical, which were not suitable for 
calculating means.
Changes in asthma symptoms
Out of the 5 questions that focused on changes in asthma symptoms, 3 yielded 
positive effect sizes (questions 5, 7, and 14) and 2 yielded negative effect sizes 
(questions 4 and 13). The largest positive effect size was seen in question 7 (+28.3%), 
meaning the participants were more likely to experience wheeze in the chest during 
high levels of PMio- On the other hand, the largest negative effect size was seen in 
question 4 (-10.7%), meaning the participants were suffering from shortness of 
breathe more frequently at normal period than episodes of high PMio pollution. Mean 
symptoms score reported by the participants between different occasions of pollution 
episodes were tested by Paired-Sample T-Test but none of them achieved statistical 
significance.
Changes in medication use
Result for question 10 showed a positive effect size of 7.1%, which reflected the 
increased use of asthma medication in the participants when PMio levels were high.
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However, when the observed difference was tested by Paired-Sample T-Test it was 
found to be statistically insignificant (t (43) = -0.39; p = 0.7).
Changes in emotional well-being
Questions for changes in emotional well-being that yielded positive effect sizes were 
1, 19, 20, 21, and 22, of which question 22 had the highest effect size of 41.6%. When 
results of these 5 questions were tested by Paired-Sample T-Test, only question 22 
reached statistical significance (t (43) = -2.48; p = 0.02), meaning the participants 
were more likely to feel discomfort and distress due to coughing when PMio level was 
high. All the remaining questions (2, 3, 8, 11, 16, 18, 24, and 25) yielded negative 
effect sizes and amongst them the effect was most significant in question 25 (-44.8%), 
meaning the participants were less bothered by heavy breathing during high levels of 
ambient PMio. No changes in overall symptoms score between different episodes of 
particulate pollution were seen in question 9.
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Q u est io n
n um ber E p is o d e Mean s c o r e SD E ffect  s i z e  (%) p-va lue
Symptoms
Pair High 3.27 1.70 -10 .7 0.604 Normal 3.09
Pair High 3.25 1.87 +4 .9 0.795 Normal 3 .34
Pair High 3.02 1.84 + 28 .3 0.137 Normal 3.55
Pair High 3.16 1.79 -10 .2 0 .5913 Normal 2.98
Pair High 2 .98 1.84 + 1 2 .4 0.5114 Normal 3 .20
Medication
Pair High 2.59 1.91 +7.1 0 .7010 Normal 2.73
Erinotional well-beiin g
Pair High 2.52 1.75 +22.1 0.231 Normal 2.91
Pair High 3.30 1.95 -4.7 0 .792 Normal 3 .20
Pair High 3 .55 1.95 -5.8 0.713 Normal 3 .43
Pair High 3.27 2 .02 -9.0 0.618 Normal 3 .09
Pair High 2 .93 1.75 0 1.009 Normal 2 .93
Pair High 3.11 1.72 -6.6 0 .7511 Normal 3 .00
Pair High 3 .66 2 .1 7 -4.2 0.8116 Normal 3 .57
Pair High 3.11 2 .0 3 -20.1 0.1618 Normal 2 .70
Pair High 2.59 1.93 +35.2 0.0919 Normal 3 .27
Pair High 3.18 2.01 +10.2 0.6120 Normal 3.39
Pair High 2.89 1.87 +18 .2 0.3121 Normal 3 .23
Pair High 2 .36 1.86 +41 .6 0.0222 Normal 3 .14
Pair High 3.16 1.96 -16.2 0.4024 Normal 2 .84
Pair High 3.66 1.78 -44 .8 0.0125 Normal 2 .86
Table 4.37: Mean symptoms scores and statistical significance for each question in the 
Asthma Symptoms Questionnaire between two occasions of high and normal air 
pollution levels. Note that question 23 and all “check questions” were omitted.
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Question 23 concerned the frequency of inhaler usage amongst the participants and 
they had 4 options available to choose from. However, because the options were not 
weighted equally, the comparison of neither means nor medians was suitable for its 
analysis. Figure 4.58 shows the distribution of the mean symptoms score reported by 
each participant for question 23, during different episodes of particulate air pollution. 
The graph shows that more participants have obtained lower symptoms score when air 
pollution level was high, as indicated by the distribution of the red bars that skewed to 
the left. In contrast, more participants have obtained higher symptoms score when air 
pollution level was normal, as reflected by the lower number of participants scoring 1 
and 2, and higher number of participants scoring 3 and 4. The hypothesis of this study 
was that during episodes of high particulate air pollution, the symptoms score 
obtained by each participant would be lower in contrast to normal episodes of 
pollution. Thus in an ideal situation when the hypothesis is correct, the distribution of 
the bars in figure 4.58 should resemble those shown in figure 4.59, i.e. the red bars 
which represent high episode of air pollution should skew to the left while the green 
bars which represent normal episodes of air pollution should skew to the right.
Symptoms score
Figure 4.58: Clustered bar chart showing the distribution of symptoms scores for 
question 23 (n=44), between different episodes of particulate air pollution.
2 3 4
Air pollution level
Normal
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Figure 4.59: A hypothetical clustered bar chart showing the distribution of symptoms 
score between different episodes of particulate air pollution.
In addition to knowing the overall changes in symptoms scores, it is also important to 
know the changes at individual levels. This was done by plotting a bar chart as shown 
in figure 4.60. Each bar represents the total number of patients with their change in 
symptoms scores that corresponded to the number on the x-axis. The changes were 
calculated by subtracting an individual’s score for high pollution episode from the 
score for normal episode. Thus zero indicated that there were no changes between 
high and normal pollution levels, a positive figure indicated improvement and a 
negative figure indicated exacerbation of asthma symptoms. For example, if a 
participant answered “ 1” during a high episode and “3” during normal level, then the 
change in symptoms score of this participant is equal to [3 -  1 ]=  2, which means the 
symptoms were less severe when the pollution level is normal.
The bar chart in figure 4.60 shows an evenly distributed pattern and suggested that 
there were no changes in symptoms score between high and normal pollution episodes 
for most participants. Despite the fact that improvements were seen in a number of 
patients (i.e. those with a change of +1, +2, and +3 in symptoms score) when 
changing from high to normal pollution levels, there were roughly the same number 
of patients who suffered from worse asthmatic symptoms (i.e. those with a change of 
-1 and -2  in symptoms score). Overall, improvement was seen in 34% of the subjects
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when pollution level was reverted to normal, 41% showed no changes, and 25% have 
worsened symptoms. If the hypothesis of the study were correct, that is, symptoms 
may be changed by temporary excursions of pollution levels, the overall changes in 
symptom scores should not be normally distributed but instead skewed to the right 
(figure 4.61), i.e. positive changes in symptoms score due to higher symptoms scores 
obtained during the week when PMio levels are normal.
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Changes in symptoms score, question 23
Figure 4.60: Bar chart showing changes in symptoms scores 
for question 23 (n=44), high v normal pollution episode.
.2
Changes in symptoms score
Figure 4.61: A hypothetical bar chart showing changes in 
symptoms score, high v normal pollution episodes.
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4.3.2 Changes in asthma symptoms score amongst the more severe cases 
between high and normal levels of PMio
It is possible that excursions in pollution differentially affect those individuals with 
more severe symptoms. Therefore a more sensitive subgroup of asthmatics who were 
suffering from more severe asthma were chosen from the main group in order to re­
examine the effects of PMio- This subgroup of patients was selected based on whether 
or not they had scored low (options 1 and 2) for questions 4, 7, and 13. These 
questions were chosen because they concerned about symptoms that were strong 
indicators of the disease. A total of 29 patients were identified as having more severe 
asthma based on these criteria. The mean age of the subjects was increased to 59yrs 
old. Paired-Sample T-Tests were rerun for all of the questions except 23. Table 4.38 
shows a summary of the mean symptoms scores for each question during different 
pollution episodes in the more severe asthma cases.
Changes in asthma symptoms
All five questions that concerned asthma symptoms changes yielded positive effects 
sizes, ranged from 15.6% (question 5) to as high as 104.9% (question 7). When tested 
by Paired-Sample T-Test, the difference observed in question 7 was the only one that 
reached statistical significance, meaning the participants were more likely to 
experience wheeze in the chest during episodes of high pollution (t(28) = -3.3; 
p<0.01).
Changes in medication use
Question 10 had yielded a positive effect size of 17.1% between different levels of 
PM io pollution, however it failed to reach statistical significance when tested by 
paired-sample t-test (t(28) = -0.7; p = 0.5).
Changes in emotional well-being
Half of the questions that concerned changes in emotional well-being between 
different levels of air pollution yielded positive effect sizes (questions 1, 2, 9, and 19- 
22) and half yielded negative effect sizes (questions 3, 8, 11, 16, 18, 24, and 25). The 
largest positive effect size was seen in question 22 (89.1%) and for negative effect 
size it was seen in question 25 (-71.6%), both of which were found to be statistically 
significant at the 1% level after being tested by paired-sampled t-test. All remaining
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questions were found to be statistically insignificant, although question 1 was only 
marginally failed to reach significance (t(28) = -1.9; p = 0.06).
Changes in asthma symptoms score between analyses using data from all cases and 
from only severe cases is summarised in table 4.39.
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Question
number E p isode Mean sc o re SD Effect s iz e  (%) p-value
Symptoms
Pair High 2.31 1.44 +28 .7 0 .344 Normal 2.72
Pair High 2.62 1.54 +15 .6 0 .605 Normal 2 . 8 6
Pair High 1.97 1.09 + 104 .9 <0.017 Normal 3.10
Pair High 2.34 1.52 +20 .4 0 .4813 Normal 2 . 6 6
Pair High 2.31 1.58 +28 .3 0.3114 Normal 2.76
Medication use
Pair _ High _ 2.24 1.62 +17.1 0 .5010 Normal 2.52
Emotional well-being
Pair High 1.86 1.09 +69 .4 0 .061 Normal 2.62
Pair High 2.55 1.38 +10 .0 0 .752 Normal 2.69
Pair High 2.93 1.67 -10 .3 0.683 Normal 2.76
Pair High 2.69 1.79 -15 .4 0 .588 Normal 2.41
Pair High 2.28 1.49 +18 .6 0 .549 Normal 2.55
Pair High 2.86 1.64 -10 .5 0 .7011 Normal 2.69
Pair High 3.17 2.02 -10.3 0 .6416 Normal 2.97
Pair High 2.45 1.72 -16 .0 0 .4318 Normal 2.17
Pair High 2.07 1.51 +52 .5 0 .1519 Normal 2.86
Pair High 2.66 1.76 +21 .6 0 .4820 Normal 3.03
Pair High 2.10 1.32 +49 .7 0.1321 Normal 2.76
Pair High 1.66 1.04 +89.1 <0.0122 Normal 2.59
Pair High 2.66 1.90 -32.8 0.1924 Normal 2.03
Pair High 3.10 1.40 -71.6 <0.0125 Normal 2.10
Table 4.38: Mean symptoms scores and statistical significance for each question in 
the Asthma Symptoms Questionnaire amongst the more severe asthma cases, 
between two occasions of high and normal air pollution levels (n=29). Note that 
question 23 and all “check questions" were omitted.
171
Chapter 4 Results
Question 23 was analysed using the method explained earlier. Figure 4.62 showes that 
most of the subjects scored low during both high pollution episodes and normal 
pollution levels, meaning asthma medication use was unlikely to be affected by the 
ambient levels of PMio- At individual levels, as shown in figure 4.63, the symptoms 
scores followed an evenly distributed pattern, with small number of subjects showing 
either improved or worsen symptoms between high and normal pollution levels. 
Overall, improvement in symptoms scores was seen 28% of the patients, while 41% 
of the patients had shown no changes and 31 % were worsened.
Air pollution level
N orm al
Symptoms score
Figure 4.62: Bar chart showing changes in symptoms scores for question 23 (n=29) in 
the more severe cases, high v normal pollution episode.
Changes in symptoms scores in more severe cases, question 23
Figure 4.63: Clustered bar chart showing the distribution of symptoms scores for 
question 23 (n=29) in the more severe cases, high v normal pollution episode.
172
Chapter 4 Results
A ll c a s e s O n ly  s e v e r e  c a s e s
Question
number E p iso d e M ean s c o r e
E ffect s iz e  
(%)
M ean s c o r e E ffect s iz e  
(%)
Symptoms
Pair High 3.27 -10.7 2.31 28.74 Normal 3.09 2.72
Pair High 3.25 4.9 2.62 15.65 Normal 3.34 2.86
Pair High 3.02 28.3 1.97 104.97 Normal 3.55 3.10
Pair High 3.16 -10.2 2.34 20.413 Normal 2.98 2.66
Pair High 2.98 12.4 2.31 28.314 Normal 3.20 2.76
Medication use
Pair High 2.59 7.1 2.24 17.110 Normal 2.73 2.52
Emotional well-being
Pair High 2.52 22.1 1.86 69.41 Normal 2.91 2.62
Pair .....High 3.30 -4.7 2.55 10.02 Normal 3.20 2.69
Pair High 3.55 -5.8 2.93 -10.33 Normal 3.43 2.76
Pair High 3.27 -9.0 2.69 -15.48 Normal 3.09 2.41
Pair High 2.93 0 2.28 18.69 Normal 2.93 2.55
Pair High 3.11 -6.6 2.86 -10.511 Normal 3.00 2.69
Pair High 3.66 -4.2 3.17 -10.316 Normal 3.57 2.97
Pair High 3.11 -20.1 2.45 -16.018 Normal 2.70 2.17
Pair High 2.59 35.2 2.07 52.519 Normal 3.27 2.86
Pair High 3.18 10.2 2.66 21.620 Normal 3.39 3.03
Pair High 2.89 18.2 2.10 49.721 Normal 3.23 2.76
Pair High 2.36 41.6 1.66 89.122 Normal 3.14 2.59
Pair High 3.16 -16.2 2.66 -32.824 Normal 2.84 2.03
Pair High 3.66
-44.8
3.10
-71.6
25 Normal 2.86 2.10
Table 4.39: Changes in asthma symptoms score between analyses using data from all
cases (n=44) and only severe cases (n=29).
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4.4 Cardiac symptoms questionnaire analysis 
Outcome rates
The same research method used for studying symptoms changes in asthma patients 
was applied to this study. The hypothesis was that, short-term increase in ambient 
PMio levels would exacerbate the symptoms of individuals with cardiac disease. A 
total of 207 replies were received from potential participants when 324 invitation 
letters were handed out to patients visiting the participating cardiology outpatient 
clinics in South Wales (table 4.40). All respondents were followed up by phone and 
126 were found to be eligible for the study, of which 84 agreed to take part. However, 
during the course of the study, 13 were withdrawn from the study; 4 due to death and 
7 due to illnesses. At the end a total of 73 complete sets of questionnaires that 
recorded the participants’ cardiac symptoms were collected. Most of the 
questionnaires were successfully completed with some containing missing data, which 
were subsequently filled in by contacting the participants via the phone. The mean age 
of the survived patients was 66years old, and 69% of them were male. Most of the 
subjects resided in Cardiff (55%), and the others were from Cwmbran (33%), 
Swansea (11%), and Port Talbot (1%). Response rate of the study was 67%.
Number of participants (n)
Letters handed out 324
Response received 207
Eligible responses 126
Respondents who 84agreed to take part
Withdrawn due to death 4
Withdrawn due to illness 7
Completed questionnaires 73
Table 4.40: Breakdown of responses to recruitment letters given out to
cardiac patients.
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4.4.1 Changes in cardiac symptoms score between high and normal levels of 
PMio
The cardiac symptoms questionnaire included items that concerned changes in 
symptoms (questions 3, 5, 8, 9, and 12), medication use (question 7), and emotional 
well-being (questions 1, 2, 4, 6, 10, 11, and 13-17). However, the format of the 
cardiac symptoms questionnaire was different from the asthma symptoms 
questionnaire due to the format of the options that the participants could choose. A 
copy of the cardiac symptoms questionnaire is listed in appendix 8.2. For the cardiac 
symptoms questionnaire, because all of the questions contain answers in ordinal 
format that were unsuitable for calculating the mean or median scores, a different 
analytical approach was used. Each individual reported on a particular question, on 
occasions of high pollution episodes and occasions of low pollution episodes. 
Therefore the change in symptoms score (i.e. worse or better) or no change between 
the two occasions was recorded. Then the proportion of participants who changed 
their reports of a particular symptom between different pollution episodes was 
calculated by ignoring those individuals whose reporting was constant between the 
two episodes and calculating a proportional change. The proportion of changes was 
represented by the net improvement (%), which was calculated by the formula below:
(N of “improved” -  N of “worsen”) / N of questionnaires completed) x 100%
Thus with reference to question 1 in table 4.39, 22 participants reported that their 
symptoms had worsened during high pollution episodes, while 20 other reported 
improved cardiac health during the same pollution episodes. In this case the overall 
change in cardiac symptom was [(20-22) / 73 x 100%] = -2.7%.
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S y m p t o m s  s c o r e
Question
num ber W o r s e n I m p r o v e d N e t  c h a n g e  (% )
Symptoms
3 23 27 5 .6
5 21 27 8 .2
8 13 12 -1.4
9 10 18 11.0
12 22 22 0
Medication use
7 14 12 -2.7*
Emotional well-being
1 22 20 -2 .7
2 21 23 2 .7
4 10 21 15.1
6 18 19 1 .4
10 13 16 4.1
11 20 19 -1 .4
13 26 21 -6 .9
14 23 21 -2 .7
15 22 22 0
16 23 19 -5 .5
17 27 14 -1 7 .8
*Only those who were prescribed nitroglycerin were included (n=32).
Table 4.41: Changes in cardiac symptoms between episodes of high and normal air 
pollution levels (n=73).
The calculation of net change only involved individuals who had reported changes in 
their symptoms and excluded those who had reported no changes. In order to 
compensate for this shortfall, the same analytical method used for studying question 
23 of the asthma symptoms questionnaire was used. The breakdown of the answers of 
each question in the cardiac symptoms questionnaire is presented in appendix 9.1, 
figure “a” of figures 1-17. The higher the symptoms score (as shown on the x-axes) 
the better the participants were with regard to their cardiac symptoms. Graphs 
representing the differences in symptoms score were also presented in appendix 9.1, 
figure “b” of figures 1-17. Each bar represents the change in symptoms score and was 
calculated by subtracting the symptoms score obtained during high pollution episodes
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from score obtained during normal pollution episodes. A positive value would 
therefore represent improvement in cardiac symptoms and vice versa, and zero would 
mean that there were no changes between high and normal pollution levels.
Changes in cardiac symptoms
There were five questions that recorded changes in cardiac symptoms, of which 
questions 3, 5, and 9 yielded positive net changes that ranged from 5.5% to 11%. The 
largest positive net change amongst the symptoms questions was seen in question 9, 
meaning the participants had increased frequency of swelling in the lower limbs when 
they woke up in the morning during the period when pollution level was high. In 
contrast question 8 had yielded only a small negative net change of -1.4%, meaning 
the participants experienced shortness of breath slightly more frequently during 
episodes of normal air pollution and as a result had to sleep sitting up. No change was 
seen in question 12 which concerned the frequency of dizziness or light-headed 
feelings.
Changes in medication use
Question 7 is the only item in the questionnaire for the detection of changes in 
medication use. Nitroglycerin is a vasodilator that relieves angina pectoris, and only 
32 patients in the study were prescribed the drug. A negative net change of -2.7% was 
recorded, meaning there was a slight increase in the use of nitroglycerin tablets for 
cardiac symptoms during normal episodes of air pollution.
Changes in emotional well-being
Out of the eleven questions related to emotional well-being, only four yielded positive 
net changes (questions 2, 4, 6, and 10) with a range of 1.4% to 15.1%. The largest net 
change was seen in question 4, meaning the participants were more frequently limited 
by their cardiac symptoms when performing various activities during high levels of 
pollution. In contrast, 6 questions yielded negative net changes (questions 1, 11, 13, 
14, 16, and 17) with question 17 being the largest at -17.8%. This question reflected 
that the participants were more often felt excluded from doing things with other 
people due to their cardiac symptoms during normal levels of PMio. Question 15 was 
the only item that showed no difference between different pollution episodes.
177
Chapter 4 Results
Overall changes in cardiac symptoms score
In appendix 9.1 as shown at the top of the graphs (figure “a”, figure 1-17), which were 
the breakdown of answers of each question, the symptoms score for each question 
were similar between the two different PMio levels in overall. In general, there were 
little changes in symptoms score between different pollution episodes, and the 
distributions of the symptoms score had a tendency to skew towards the right, i.e. 
majority of the participants did not suffer from severe cardiac symptoms. Although 
occasionally there was larger number of participants scoring higher in normal days 
than high pollution days, such pattern was also seen in reverse in some cases. For 
example in figure 11a, in which there were more participants scoring high, i.e. 4-6, 
during high levels of air pollution, the pattern was reversed in figure 16a where there 
were more participants scoring low (i.e. 1-3) during normal pollution levels than high.
For the graphs displayed at the bottom of appendix 9.1 showing difference in 
symptoms score between high and normal pollution episodes (figure “b”, figure 1-17), 
a normal distribution pattern was seen in all of the graphs, with the most number of 
subjects having no change in their symptoms score. This indicated that there were 
little changes in symptoms at the individual level between the pollution episodes, and 
that the participants’ cardiac health was not hugely affected by the short-term increase 
in PMio levels.
4.4.2 Changes in cardiac symptoms score amongst the more severe cases 
between high and normal levels of PMio
A sub-sample of 33 participants defined as individuals suffering from more severe 
cardiac symptoms was chosen for this analysis, based on whether or not they reported 
low symptom scores of 1 to 3 for either or both questions 3 and 7. The mean age of 
these 33 patients was slightly lowered to 65years old. Table 4.42 summarises all the 
results obtained.
Changes in cardiac symptoms
All questions yielded positive net changes including those that had no change 
(question 12) or negative net change (question 8) when results from all 73 participants 
were analysed. The range of all positive net changes was 3% to 54.6%. Question 3 
had the highest positive net change meaning cardiac symptoms appeared more
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frequently during high levels of air pollution. Question 8, which yielded a negative net 
change previously, was reversed to +3% when only the more severe cases were 
analysed.
Changes in medication use
The net change of question 7 remained consistent and a larger negative net change of 
-7.1% was observed when only the more severe cases were analysed (n=14). This 
represented a slight increase in the use of nitroglycerin tablets for cardiac symptoms 
during episodes of normal pollution.
Changes in emotional well-being
All but two of the questions concerning emotional well-being yielded positive net 
changes, ranging from 6.1% to 45.5%. Question 6, which yielded the highest positive 
net change reflected that the participants’ cardiac symptoms had more limitations on 
their enjoyment of life when pollution level was high. Question 10 was the only item 
that yielded a negative net change, although the change was small at only -3%. No 
change was seen in question 16.
Changes in cardiac symptoms score between analyses using data from all cases and 
from only the severe cases is summarised in table 4.43.
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S y m p t o m s  s c o r e
Question
number W o r s e n I m p r o v e d N e t  c h a n g e (% )
Symptoms
3 5 23 5 4 .6
5 5 17 3 6 .4
8 6 7 3 .0
9 4 10 1 8 .2
12 6 13 21.2
Medication use
7 3 2 -7.1*
Emotional well-being
1 6 15 2 7 .3
2 7 14 21.2
4 1 12 3 3 .3
6 4 19 4 5 .5
10 9 8 -3 .0
11 7 13 18 .2
13 6 13 21.2
14 9 11 6.1
15 6 14 2 4 .2
16 10 10 0
17 7 10 9.1
*Only those who were prescribed nitoglycerin were included (n=14)
Table 4.42: Changes in cardiac symptoms amongst the more severe cases between 
epsidodes of high and normal air pollution levels (n=33).
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N e t  c h a n g e  (%)
Q u e s t io n
n u m b e r
A ll c a s e s
O n ly  s e v e r e  
c a s e s
Symptoms
3 5 .5 5 4 .6
5 8.2 3 6 .4
8 -1 .4 3 .0
9 11.0 18 .2
12 0 21.2
Medication use
7 -2.7* -7.1*
Em otional well-being
1 -2 .7 2 7 .3
2 2 .7 21.2
4 15.1 3 3 .3
6 1 .4 4 5 .5
10 4.1 -3 .0
11 -1 .4 18 .2
13 -6 .9 21.2
14 -2 .7 6.1
15 0 2 4 .2
16 -5 .5 0
17 -1 7 .8 9.1
* Only those who were prescribed nitoglycerin were included (n=32)
* Only those who were prescribed nitoglycerin were included (n=14)
Table 4.43: Changes in cardiac symptoms score between analyses 
using data from all cases (n=51) and only severe cases (n=33).
Overall changes in cardiac symptoms score
When only the more severe cases were included, as shown in appendix 9.2 figures 1 - 
17, the distributions of the graphs appeared to be different from those when all 73 
participants were included. For the graphs that showed the breakdown of answers of 
each question (figure “a”, figure 1-17), larger number of individuals scoring higher 
during normal pollution levels was seen in a number of questions. This was especially 
apparent in questions 2-5, 11, and 15, in which the green-coloured bars representing 
normal pollution levels were skewed to the right and in contrast the red-coloured bars 
representing high pollution levels were skewed to the left. This means more
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participants obtained better symptoms score during episodes of normal air pollution 
level and vice versa.
As for the graphs showing changes in symptoms score between high and normal 
pollution episodes (figure “b”, figure 1-17), although they were again showing normal 
distribution patterns with the highest number of participants reporting no change in 
symptoms score, a number of graphs had tendencies to skew to the right toward the 
positive change in symptoms score. This means more participants were reporting 
improvement in their cardiac symptoms when PMio levels were normal, compare to 
those who reported worsened symptoms.
4.5 Respiratory symptoms questionnaire analysis 
Outcome rates
This section focuses on the changes of symptoms in patients with chronic respiratory 
conditions between high and normal levels of PMio pollution, applying the same 
research method of both the asthma and cardiac symptoms comparison studies. The 
hypothesis was that symptoms of individuals with chronic respiratory disease would 
be worsened by the short-term increase in ambient PMio levels. As shown in table 
4.44, a total of 271 invitation letters were given out in various respiratory clinics in 
south Wales to their visiting patients. Through the clinics 167 replies were returned, 
of which 109 were eligible for the study. These individuals were then foliowed-up via 
the phone and eventually 69 agreed to take part. Throughout the study period, 8 
patients died and 10 withdrew due to illness. At the end a total of 51 complete sets of 
questionnaires were received. Any missing data were swiftly followed-up and 
subsequently filled in by contacting the patients via the phone. The mean age of the 
51 participants who had successfully completed the survey was 66yrs old, of which 
49% were male. Most of the participants resided in Cardiff (57%), and the others were 
from Swansea (29%), Cwmbran (8%), and Port Talbot (6%). Response rate of the 
study was 63%.
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N u m b e r  o f  p a r t i c ip a n ts  (n)
L etters handed ou t 271
R esp o n se  rece ived 167
Eligible re sp o n se s 109
R espon den ts who  
agreed  to take part 69
Withdrawn due to death 8
Withdrawn due to illness 10
C om pleted questionnaires 61
Table 4.44: Breakdown of responses to recruitment letters given out to 
respiratory patients.
4.5.1 Changes in respiratory symptoms score between high and normal levels 
of PMio
Items within the respiratory symptoms questionnaire can be divided into those that 
concerned changes in symptoms, medication use (question 22), and emotional well­
being (questions 8, 9, 12, 14, and 17-21). In addition, the symptoms questions were 
further divided into two subgroups and became items of general respiratory symptoms 
(questions 1, 2, 3, 5, 7, 13, and 16) and items of specific respiratory symptoms 
(questions 4, 6, 10, 11, and 15). Questions of general respiratory symptoms consisted 
of items that concerned the more general respiratory health such as coughs and 
production of phlegm. On the other hand, questions of specific respiratory symptoms 
were regarded as stronger indicators of respiratory health such as shortness of breath 
and chest tightness. The net changes of each item in the questionnaire were calculated 
and shown in table 4.45.
The breakdown of the answers of each question in the respiratory symptoms 
questionnaire are listed in appendix 10.1, figure “a” of figures 1-22. Same as those 
presented in the cardiac symptoms questionnaire analysis, each bar represents the total
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number of patients who had given a score for the corresponding question during both 
high and low pollution episodes, and the higher the symptoms score the better the 
patients were feeling in terms of their respiratory symptoms. Overall, changes in 
symptoms score between high and normal levels of air pollution were little, and at 
individual levels the distributions of the symptoms score frequently skewed towards 
the left, indicating that majority of the participants were suffering from severe 
respiratory symptoms (appendix 10.1, figure “b” of figures 1-22).
Changes in general respiratory symptoms
Out of the seven items in this section, questions 1, 2, and 7 had yielded positive net 
changes ranging from 2% to 9.6%. Question 2 had the largest positive net change 
meaning the participants were more likely to bring up phlegm during high levels of air 
pollution. The remaining items (questions 3, 5, 13, and 16) all yielded negative net 
changes with question 5 being the largest at -13.7%, meaning severe wheezing attacks 
were more frequently reported in the participants during episodes of normal air 
pollution levels.
Changes in specific respiratory symptoms
Three of out five items used for the detection of changes in specific respiratory 
symptoms yielded positive net changes. They were questions 6, 11, and 15, with 11 
having the highest net change of 17.7%. This reflected that the participants were more 
likely to suffer from shortness of breathe during high levels of air pollution. On the 
other hand, both question 4 and 10 yielded identical value of negative net change of 
-5.9%. These questions indicated that during normal levels of air pollution the 
participants had unpleasant attacks of chest troubles (question 4) and chest tightness 
(question 10) more frequently than during levels of high pollution.
Changes in medication use
Question 22 was the only item for the detection of changes in medication use, which 
in this case was the frequency of oxygen mask usage between different levels of air 
pollution. Results from only 31 individuals were included in the analysis because not 
every participant in the study required oxygen mask for breathing. A positive net 
change of 22.6% was observed, meaning the use of oxygen mask to help breathing 
was increased during high levels of PMio.
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Changes in emotional well-being
Amongst all the items within this section, questions 8, 17, 18, and 21 yielded positive 
net changes ranging from 2% to 25.5%. Oppositely questions 12, 14, 19, and 20 
yielded negative net changes, and there was no change in question 9. The largest 
positive net change was seen in question 21, meaning the participants were more often 
felt excluded from doing things with other people because of their respiratory 
symptoms. Question 20 was the item that yielded the largest negative net change of 
-13.7%, meaning the participants were more likely to feel discouraged due to their 
respiratory symptoms during episodes of normal pollution level.
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S y m p t o m s  s c o r e
Question
number W o r s e n Im p r o v e d N e t  c h a n g e  (%)
General respiratory symptor17S
1 11 14 5 .8
2 11 16 9 .6
3 16 11 -9 .6
5 19 12 -13 .7
7 20 21 2.0
13 17 14 -5 .9
16 20 16 -7 .8
Specific respiratory symptorns
4 15 12 -5 .9
6 16 17 2 . 0
10 16 13 -5.9
11 11 20 17.7
15 10 17 13.7
Medication use
22 2 9 2 2 .6 *
Emotional well-being
8 17 22 9.8
9 17 17 0
12 15 14 -2 .0
14 18 12 -11 .8
17 13 22 17 .7
18 14 15 2.0
19 19 16 -5 .9
20 21 14 -13 .7
21 10 23 2 5 .5
*Only those who used oxygen were included (n=31)
Table 4.45: Changes in respiratory symptoms between episodes of high and normal 
air pollution levels (n=51).
Overall changes in respiratory symptoms score
Changes in symptoms score were also examined graphically as shown in appendix 
10.1, figure “b” of figure 1-22. In almost all cases the proportion of participants who 
reported no changes in symptoms was always the largest and normal distribution
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patterns were seen in all of the graphs. The only exception was question 7, in which 
the number of participants who reported no changes in their symptoms score was 
slightly lower than those who reported a -1 change, and the number was also identical 
to those who reported a +1 change. Occasionally there may be increase or decrease in 
symptoms score between different levels of PMio pollution, however the magnitude 
was always small (+1 or -1) such as those seen in questions 17, 19, 20 and 21.
4.5.2 Changes in respiratory symptoms score amongst the more severe cases 
between high and normal levels of PMio
Table 4.46 below presents the net changes in symptoms scores obtained from a sub­
sample of 13 individuals with more severe respiratory cases. This was based on 
whether or not they reported low symptoms score of 1 to 2 for both questions 4 and 
10. The mean age of this subgroup of patients was slightly increased to 67yrs old.
Changes in general respiratory symptoms
Three out of the seven questions that concerned changes in general respiratory 
symptoms yielded positive net changes (questions 1, 2, and 13). The range was 7.7% 
to 23.1% with question 2 being the largest again as previous when all 51 sets of 
results were analysed. Questions 5, 7, and 16 yielded negative net changes with 
question 7 being the largest (-38.5%). Question 3 detected no change in symptoms 
score between different levels of PMio.
Changes in specific respiratory symptoms
Out of the five questions that focused on specific respiratory symptoms, 3 yielded 
positive net changes ranging from 7.7% to 30.8% (questions 4, 6, and 11). The largest 
effect size was seen in question 11, meaning shortness of breath was more frequently 
reported during high levels of PMio. Question 15 was the only item that yielded 
negative net change (-15.4%) and reflected that the participants had to sleep sitting up 
more often due to shortness of breathe during episodes of normal pollution. No 
change was seen in question 10.
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Changes in medication use
Eight subjects who regularly required the use of oxygen mask to help breathing were 
included in the analysis. A positive net change of 12.5% was observed, which was 
lower than that reported previously.
Changes in emotional well-being
Questions 9, 17, 19, and 20 yielded positive net changes ranging from 7.7% to 15.4%. 
Both questions 17 and 20 had the highest positive net change, but question 20 yielded 
a negative net change of -13.7% previously. Four questions yielded relatively large 
negative net changes, two of which were -23.1% (questions 12 and 18) and the other 
two were -30.8% (questions 14 and 21). Interestingly, question 21 was the question 
that had the largest positive net change previously. No change was observed in 
question 8.
Changes in respiratory symptoms score between analyses using data from all cases 
and from only the severe cases is summarised in table 4.47.
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S y m p t o m s  s c o r e
Q uestion
num ber W o r s e n I m p r o v e d N e t  c h a n g e  (%)
General respiratory symptorns
1 1 2 7.7
2 1 4 23.1
3 1 1 0
5 3 2 -7.7
7 7 2 -3 8 .5
13 4 6 15 .4
16 5 4 -7.7
Specific respiratory symptorns
4 0 2 15.4
6 3 4 7.7
10 2 2 0
11 2 6 30.8
15 3 1 -1 5 .4
Medication use
22 0 1 12.5*
Emotional well-being
8 4 4 0
9 4 5 7.7
12 4 1 -23.1
14 5 1 -30.8
17 2 4 15 .4
18 4 1 -23.1
19 4 5 7.7
20 4 6 1 5 .4
21 6 2 -30.8
*Only those who used oxygen were included (n=8).
Table 4.46: Changes in respiratory symptoms amongst the more severe cases 
between episodes of high and normal air pollution levels (n=13).
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N e t  c h a n g e  (%)
Q u e s t io n
n u m b e r
A ll c a s e s
O n ly  s e v e r e  
c a s e s
General respiratory symptoms
1 5 .8 7 .7
2 9.6 23.1
3 -9 .6 0
5 -1 3 .7 -7 .7
7 2.0 -38 .5
13 -5 .9 15 .4
16
00Ki -7 .7
Specific respiratory symptoms
4 -5 .9 15.4
6 2.0 7.7
10 -5 .9 0
11 17.7 30.8
15 13.7 -1 5 .4
M edication use
22 22.6* 12.5*
Em otional well-being
8 9 .8 0
9 0 7 .7
12 -2 .0 -23.1
14 -1 1 .8 -30 .8
17 17 .7 15 .4
18 2.0 -23.1
19 -5 .9 7 .7
20 -13 .7 15 .4
21 25 .5 -30 .8
* Only those who used oxygen were included (n=31).
# Only those who used oxygen were included (n=8).
Table 4.47: Changes in respiratory symptoms score between analyses 
using data from all cases (n=51) and only severe cases (n=13).
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Overall changes in respiratory symptoms score
The breakdown of the answers of each question in the respiratory symptoms 
questionnaire amongst the more severe cases are listed in appendix 10 .2 , figure “a” of 
figures 1 -22. Same as previously when all 51 cases were analysed, the overall changes 
in symptoms score between episodes of high and normal PMio levels were little, and 
majority of the participants reported low symptoms score regardless of the pollution 
episodes. In appendix 10.2, figure “b” of figures 1-22 shows the change in symptoms 
score at individual levels between high and low pollution levels. Again, the graphs 
resembled a normal distribution pattern with the highest number of participants 
reporting no change in nearly all of the case. Occasionally there were increase or 
decrease in symptoms score between different levels of PMio pollution, however the 
magnitude was always small (+1 or -1) such as those seen in questions 8 , 9, 13, 14, 
and 19-21.
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C h a pt e r  5 -  D isc u ssio n  a n d  C o n c l u sio n
Sec tio n  1 
E x p o su r e  C o m pa r iso n  St u d y
This study was carried out in the city of Cardiff which has 305,200 inhabitants 
according to the 2001 Census figures. It was estimated by the Cardiff Council that 
44,000 commuters travel to work in Cardiff each day of whom approximately 80% 
commute by car or by bus. Cardiff is also a popular tourist area with large number of 
visitors entering and leaving the city everyday. Development in recent years had 
demolished most of the heavy industries in the city. As a result of the city’s size and 
degree of economic activity, air quality has been an issue in certain parts of Cardiff 
caused by pollutants emitted from road transport. These are highlighted by high 
volumes of traffic queuing and buildings situated close to the roads. Main, arterial 
routes used to move people and goods are also areas of concern. Having said that, 
data from stationary air quality monitoring stations showed that the PMio air pollution 
level in Cardiff is not as significant as larger cities such as London. The mean annual 
level of PMio as measured by stationary monitoring station was 19.8pg/m3 in 2004 
and 19.7pg/m3 in 2005, which were approximately 10pg/m3 lower than the level 
measured in London Westminster. The PMio level of Cardiff centre is projected to 
reduce to 18.0pg/m3 in 2 0 1 0 .
5.1.1 Classification of street types and definition of exposure status of subjects
In order to investigate whether microenvironments, in terms of particulate pollution 
caused by local traffic, exist within an urban area, a number of streets from Cardiff 
were chosen in the study which were subsequently classified into exposed and control 
groups. Ideally the classification of streets into the appropriate group should be based 
on real data such as traffic flow volume or levels of air particulates in those areas, to 
ensure that the particulate levels in the exposed streets are truly different from the 
controls. However, traffic flow data was only available for a small number of high 
trafficked streets in Cardiff and the levels of air particulates were only monitored at 
fixed sites. As a result extra streets had to be introduced into the study using long­
term local knowledge of traffic queues and flow in order to bring up the total number 
of streets in the study. To prove that groups of chosen streets were actually different
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from each other in terms of pollution level, environmental survey work was carried 
out using portable equipment to provide information on particulate concentrations of 
various areas in relative terms. It is well know that levels of air particulates vary 
greatly during the course of the day and can be affected by a number of factors such 
as weather. Theoretically the best approach to quantify the levels of air particulates of 
a street is by long-term continuous monitoring. However, due to limited resources and 
time, only a limited number of measurements were made in the target areas. This led 
to the variations seen in air particulate levels within the same area during different 
period of time, as expressed by the different SE% obtained that ranged from 4% to 
12%. Nevertheless, these measurements were all made at random times between 9am 
and 6pm Monday to Friday when traffic within the city was busiest. One of the most 
effective ways of reducing variability is by increasing the number of measurements 
made in the same street. Throughout the study a total of 373 measurements were 
made in all target streets, with an average of 16 times per street. Each time 20mins of 
sampling was carried out and thus this converts into 320mins, or 5.3hrs of sampling 
time per street on average. Based on the findings obtained through the environmental 
survey work, the mean PM5 concentration of the exposed areas was 17.5pg/m and 
the control areas was 11.8pg/m3. Since the proportion of P M 5 in PMio in terms of 
total particle mass was estimated to be approximately 75% [DTI 1999], assuming that 
the proportion is constant, the level of ambient PM io found in the study would 
therefore be around 23.3pg/m3 and 15.7pg/m3 for the exposed and control areas 
respectively. The annual mean urban background PMio concentration in Cardiff as 
measured by fixed monitoring site was 19.7pg/m3 in 2005, which was about 15% 
lower than the PM io level estimated in the exposed areas, and about 25% higher than 
the PMio level estimated in the control areas.
5.1.2 Indoor levels of air particulates and its relationship with outdoor levels
The variation of indoor PM5 was not as large as that observed in outdoors, as shown 
by the smaller standard deviations of the indoor measurements. In exposed areas, the 
SD of all outdoor PM5 measurements was 40% higher than indoors, and similarly in 
control areas, the SD of outdoor PM5 levels was 13% higher than indoors. The median 
indoor PM5 concentration of the houses located in the exposed areas was 13.2pg/m 
and in the control areas was 9.4pg/m3, in which both values were around 80% of their
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corresponding outdoor median P M 5 concentrations. Therefore it may be possible that 
a proportion of up to 80% of the outdoor PM5 penetrated into the houses, and that the 
higher level of indoor PM 5 observed in the exposed group may be attributable to the 
higher level of P M 5 outdoor. In fact, a moderate correlation (r = 0.57) was found 
between indoor and outdoor PM5 levels in overall. Although correlations between two 
variables do not provide information on causality, in this case it was apparent that 
particulates entered the houses which led to the increased indoor levels and not the 
other way. This was because levels of P M 5 was always higher in outdoors and thus the 
concentration gradient would have driven the particles inside the houses. Furthermore, 
larger concentration gradients would be able to drive more particles indoor, thus 
explaining the finding that the correlation between indoor and outdoor P M 5 in the 
exposed group (r = 0.53) was higher than the controls (r = 0.36), because the 
difference between indoor and outdoor median PM5 was higher in the exposed areas 
(3.5pg/m3) than controls (2.1pg/m3). Based on the assumption that the frequency of 
gas or electricity appliances usage for cooking and heating were at similar levels in all 
sampled houses (i.e. the background levels of PM5 generated indoors), and since all 
the participating houses were non-smoking households, then the differences in PM5 
seen across different houses were very likely to be due to particles in the ambient air 
entering the house from the outside, especially when the architectural design of the 
house was found to have no influence on the levels of indoor PM5.
5.1.3 Trace element concentrations in environmental PMi0 samples
Environmental PM 10 samples were collected and four elements that are known 
specific markers of motor vehicles were analysed by ICP-MS -  vanadium is produced 
by fuel combustion; copper is produced from wearing of brake linings; bromine used 
to be a component of fuel additive but has been phased out; and antimony is released 
through engine wear and from lubricants in brake pads. Since ICP-MS is capable of 
analysing a suite of elements simultaneously other elements were also studied. The 
hypothesis was that the levels of these elements in air particulates would be higher in 
exposed than control areas. However, both vanadium and bromine were found to be 
higher in control areas, with only vanadium reached statistical significance. Antimony 
was only found in a small number of samples and comparison was not carried out. 
Higher levels of copper found in exposed areas reflected the possibility of increased
194
Chapter 5 Discussion & Conclusion
emissions from motor vehicles in those microenvironments, and the lack of statistical 
significance may be explained by the small sample size. However, if truly this was the 
case, the levels vanadium, bromine, and antimony should have followed the same 
trend since they were all emitted from motor vehicles, thus it was difficult to explain 
why one marker was higher in the exposed areas and the others were not. It was 
possible that copper was the best marker for vehicular emissions among the four, after 
all its median concentration found in the environmental PMio samples was relatively 
higher than the rest of the elements. Another possibility was that the higher level of 
copper observed in the exposed areas was due to unknown sources other than motor 
traffic. Interestingly the levels of sodium and chlorine were found to be significantly 
higher in the exposed areas. Any contamination of samples from salt on the surface of 
the skin would be expected to result in an overall increase in sodium and chlorine in 
all samples universally and not just those from the exposed areas. The other possible 
explanation is that Cardiff is a coastal city and therefore the sodium and chlorine 
found were very likely to be sea salt. But why were they significantly higher in 
exposed areas? At first it was thought that this may be related to the distance to the 
coast, which is on the eastern and south-eastern side of the city. However, all exposed 
and control areas (except Marshfield) were at similar distance to the coast, and levels 
of sodium and chlorine were not particularly higher in the Marshfield samples 
compared with the other control samples. Thus the distance from the coast of where 
the samples were taken could not explain the findings. Finally, the most probable 
explanation would be that salt were used during cold weather to melt ice on road 
surfaces, and being a major road with high traffic volume, i.e. streets from exposed 
group, are more likely to be treated than small streets or cul-de-sacs in the control 
areas.
5.1.4 Trace element concentrations in indoor dust samples
Dust were collected from inside the houses for the analysis of trace elements by ICP- 
MS. Eight known specific markers of motor vehicles including vanadium, manganese, 
iron, copper, zinc, barium, cerium, and lead were selected, and in addition a suite of 
other elements were also analysed. Vanadium, manganese, and cerium are used as 
fuel additives, lead is found in resuspended road dust due to long-term environmental 
pollution caused by the use of leaded fuel in the past; copper and barium are from 
brake wear; and iron and zinc are from engine wear. Results showed that the levels of
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almost all these elements were found to be higher in the exposed group than the 
control, ranged from 33% as seen in vanadium and cerium, to as high as 200% as seen 
in lead. Copper was the only exception in which the median concentration found in 
the control group was nearly 30% higher than the exposed group. In addition the 
levels of aluminium, cobalt, and tin were also found to be higher in samples from the 
exposed group. Although none of the differences found achieved statistical 
significance possibly due to small sample size, these data suggested two possibilities, 
a) that air particulates were entering the house from outdoor and b) harmful elements 
that were attached on the surfaces of the particles settled and accumulated in the 
house. However, it is worth mentioning that iron, copper, and zinc are common 
metals which may have been generated from indoor, and traces of lead can often be 
found in the old paint work of older houses. Finally, because the dust samples were 
collected over a much longer period of time than the environmental PMio samples 
(6mths v 24hrs), therefore the higher levels of trace elements found in the dust 
samples of the exposed group would indicate long-term increased exposure to air 
particulates generated from outdoors.
5.1.5 Trace element concentrations in blood and hair
Study subjects were allocated into the appropriate group according to the exposure 
status of the streets they resided in. Trace elements were analysed in both blood and 
hair samples collected from subjects residing in exposed and control areas. Whole 
blood samples were separated into sera for the analysis of copper, iron, zinc, and lead 
by ICP-MS. Hair samples were washed and analysed by NAA for the presence of 
vanadium, manganese, copper, bromine, antimony, and a suite of other elements. 
Except for copper, manganese, and bromine in hair, none of the elements in any of 
these samples demonstrated differences between their median concentrations in the 
exposed and control groups. Although manganese and bromine have median levels 
being 35% and 48% higher respectively in exposed than controls, none of the 
observed differences reached statistical significance. Lead was not detected in a large 
number of samples because sera were used instead of whole blood. As demonstrated 
in a Swedish study involving 372 adolescents, the median levels of lead found were 
16pg/l in whole blood but only 0.33jug/l in serum [Barany et al 2002]. Although the 
minimum detection for lead in serum (0.1 jug/1) is 10-fold higher than blood, the low
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levels of lead found in serum means that it is not an ideal choice for quantifying this 
metal in blood. The trace element concentrations found in both blood and hair showed 
that these biomarkers of exposure were not being taken up, despite the fact that 
subjects from the exposed group were exposed to higher levels of respirable particles 
in both indoor and outdoor environments. The possibility was that particles with trace 
elements adhered to the surface failed to penetrate into the deepest regions of the 
lungs and/or dissolve into the bloodstream, either due to particle size or the solubility 
of the elements. The American Conference of Governmental Industrial Hygienists 
(ACGIH) has assigned percentages of different particle fractions that can be carried to 
the various regions of the lungs, and in the case of PM5 it was estimated that only 30% 
of the particles are within the respirable fraction that can penetrate deep into the 
alveolar of the lungs [ACGIH 1999]. In relative terms, hair is a better long-term 
dosimeter of exposure than blood, not only because hair is an inert and chemically 
homogeneous substance and are able to fix trace elements once they are incorporated 
into it, but their extraction and storage are also easier than blood. Blood in contrast 
reflects exposure to trace elements in a shorter-term, and thus the levels found in 
blood are largely determined by the subject’s exposure to air pollutants shortly before 
(hours or days) the sample is extracted. A laboratory study showed that the 
concentrations of blood lead peaked after 4-5hrs of inhaling lead particles, and after 
reaching its maximum the level declined exponentially [Chamberlain et al 1978]. 
Hence blood is more suitable for the immediate measurement of exposure to trace 
elements, as it gives no indications of the cumulative levels of these elements in the 
body. Therefore unless subjects residing in the exposed areas inhaled large doses of 
copper-containing particles within the respirable fraction, significant differences in 
copper concentrations found in blood and hair seemed unlikely. The lack of 
correlation in copper concentrations between blood and hair suggested that the copper 
found in hair were due to long-term deposition of the metal from blood, rather than 
days before the blood samples were being taken.
5.1.6 Concentrations of platinum in urine
Platinum is released into the atmosphere from the catalytic converters of motor 
vehicles, and hence is an ideal indicator for exposure to road traffic. Twenty-eight 
samples from individuals residing in the exposed areas were analysed by ICP-MS for 
their presence of platinum. The median concentration of platinum found was 12ng/g
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creatinine with a range of 3.8-1412ng/g creatinine. The mean concentration was 
151ng/g creatinine, reflecting the presence of several extreme values toward the upper 
end. Urinary levels of platinum found in this study were similar to those found in a 
group of non-occupationally exposed individuals in London, UK (mean 113ng/g 
creatinine, range 48-224ng/g) [Farrago et al 1998], but were significantly higher than 
those found in Munich, Germany (mean 6.5ng/g creatinine; median 4.3ng/g 
creatinine) [Schierl 2000], Budapest, Hungry (mean lO.lng/g creatinine; median 7.8 
ng/g creatinine) and Vienna, Austria (mean 3.7ng/g creatinine; median 3.2ng/g 
creatinine) [Zaray et al 2004]. The fact that only samples from the exposed areas were 
included in the analysis may have resulted in the relatively higher median level of 
platinum found compared to other European studies. Platinum concentrations were 
also quantified in several other European studies [Bocca et al 2004, Spezia et al 
2005], but the authors did not control for the levels of creatinine in the urine and the 
levels were therefore incomparable. Two urine samples, one from Manor Way and the 
other Western Avenue, contained unexpectedly high levels of platinum that were 
almost 10-fold higher than the median platinum concentration found in the study. 
Traces of platinum can always be found in contaminated food and water, and 
according to Vaughan and Florence diet was the main route for platinum intake in 
Australia [Vaughan and Florence 1992]. However, the levels platinum in foodstuff are 
often low and therefore cannot explain the huge differences observed in the study by 
dietary intake alone. Another possible source of platinum is from dental alloy 
restorations that contain platinum, which has been found to increase the body load of 
platinum by more than 10-fold [Herr et al 2003].
5.1.7 Levels of PAH in the environment and 1-HP concentrations in urine
Nine environmental samples were collected for the detection of PAH by HPLC. 
However, all of them contained insufficient quantities that were above the minimum 
detection limit (5ng/m3). In contrast, levels of 1-HP were detected in the urine 
samples, which are metabolites of one of the most abundant PAH in the environment 
pyrene. Higher median concentration of 1-HP was found in the control group by 62%. 
This finding was not consistent with the fact that no PAH were detected in the 
environmental samples. One of the possibilities was that the 1-HP found in the body 
was through intake of food and water that were contaminated by PAH. As discussed 
in chapter 1, food is one of the major sources of PAH found in the body and they can
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be found in substantial quantities in some foods depending on the mode of cooking, 
preservation, and storage. As for the significant difference in 1-HP found in samples 
from exposed and control subjects, it could be explained by the different dietary 
habits of the subjects, which in certain extent is linked to social status.
Recommendation for future work
This section summarises the shortcomings and difficulties encountered in the 
Exposure Comparison Study in retrospect, and discusses the possibilities of how it 
can be improved should studies of the similar kind be carried out.
Recruitment
As with most epidemiological studies the most challenging issue in the Exposure 
Comparison Study was the recruitment of subjects. In the study over 8,000 invitation 
letters were sent out within a window of 24mths of which only 5% were returned. The 
bottleneck of the recruitment process was due to the lack of respondents when the 
invitation letters were sent out. These letters were mass-mailed to all households in 
the target streets with no information on the names of the residents. With the number 
of commercial advertising junk mails each household receives nowadays, it was likely 
that most of the invitation letters were discarded even before being read. At first the 
use of GP records for information on the people who reside in the target streets had 
been proposed. However, due to the Data Protection Act the clinics were not allowed 
to release contact information of their patients unless permissions were granted. 
Another way was to ask the clinics to send out invitations on the researcher’s behalf, 
but with the extra administrative works required and no clear benefits to the clinics it 
was doubtful if cooperation could be obtained. In the future if recruitment of such 
kind is required, it may be possible to employ research assistants to cover all target 
areas and speak to the residents in person. Although the process will be time 
consuming and labour intensive, this method can largely increase the number of 
people who will be given the information and thus potentially increase the number of 
participating subjects. Moreover, the eligibility status of those who refused to 
participate can also be obtained for the calculation of response rate.
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Collecting environmental PM10 samples
Much difficulty was encountered when collecting environmental PMio samples for 
trace elements and PAH analyses. The task required the setting up of heavy duty air 
pumps inside the participating households that had to operate for 24hrs continuously. 
Not only were the pumps noisy and cumbersome to set up, the need of placing the 
inlet head outdoors meant that windows had to be opened throughout the night. As a 
result security was the main reason of why the request of setting up the pumps inside 
the houses was declined by majority of the participants. While this problem was 
minimised in the control areas because most houses had garages which was an ideal 
place to setup the pumps with minimal distraction and inconvenience, such option 
was not available in most of the houses in the exposed areas. The recent requisition of 
a mobile air monitoring vehicle in the department would have solved the problem 
should it have been available prior to the beginning of the study. This vehicle is 
capable of automatically carrying out environmental surveys without the need of 
external power supply. By simply parking the vehicle in the target streets PMio 
samples can therefore be easily collected at anytime and for long durations.
Measuring indoor and outdoor air particulate levels
In the study both indoor and outdoor levels of PM5 were measured by the portable 
QCM for a short period inside and outside the participating households respectively. 
While this method provided information on the particulate levels inside the sampled 
house and its corresponding outdoor environment, the short sampling time may not 
have been able to capture the short-term variance in particulate level such as during 
rush hours, and therefore may not have reflected accurately the true indoor level of 
the house. Ideally the sampling time should be at least 24hrs so that any short-term 
changes in particulate levels can be monitored. This would require a piece of 
monitoring equipment that is capable of registering real-time particulate levels like 
the QCM, but with a higher maximum operating time and lower noise level to 
minimise distraction. Most importantly, sampling should take place simultaneously in 
indoor and outdoor in order to provide the most accurate data for studying 
correlations of air particulates inside and outside the house.
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Collecting biological samples
Out of the three types of biological samples that had to be collected in the study, i.e. 
blood, hair, and urine, collecting blood sample was the one that presented most 
concerns. Throughout the duration of the study, only 84 out of the possible 123 sets of 
blood samples were collected. The main reason was that due to health and safety 
issues blood samples could only be extracted by a qualified medical staff, which 
means the participants had to attend the phlebotomy clinic at the University Hospital 
of Wales in order to donate a blood sample. This was found to be extremely 
inconvenient for the participants not only because some of them resided or work far 
away from the hospital, but also because the clinic only opens between 9am and 5pm 
Monday to Friday, while most people were at work. Effort have been made to 
increase the number of blood samples donated by sending out reminder letters and 
making follow-up phone calls, as well as providing travel expense reimbursements, 
but the decision of whether to attend the clinic or not was entirely the subjects’ own 
wishes. In future studies when blood samples are required a nurse or phlebotomist can 
be employed to carry out the task at the participant’s home or work place. In addition 
the use of other biological samples such as urine for the analysis of trace elements can 
be considered as an alternative to blood.
Even if blood samples were donated they present another concern. As discussed 
previously blood is a short-term dosimeter of exposure to air particulates arise from 
motor traffic, therefore the concentrations found in blood would only reflect the 
subjects’ exposure to air particulates several days prior to giving blood. This potential 
problem can be overcome by asking the subjects to keep an activity diary several days 
before donating a blood sample. This would allow detailed records of each 
individual’s daily activities be examined and any unusual patterns such as prolonged 
travelling in motor vehicles or exposure to environmental tobacco smoke can be 
accounted for. In addition this can also be accompanied by the use of personal 
particulate samplers that can monitor the levels of air particulates to which each 
individual was exposed to, since the trace elements of interest are most likely 
associated with particles. However, these would have to be specially designed and 
built as equipment of such kind is not commercially available at present. The same 
research method can be applied to the analysis of 1-HP in urine samples since they are 
both short-term biomarkers of exposure to motor vehicles.
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5.1.9 Conclusion
Results of the Exposure Comparison Study have shown that levels of PM5 vary 
between microenvironments within a city by approximately 50%, and higher levels of 
particulate air pollution were associated with high volumes of local traffic. 
Moderately high correlation between indoor and outdoor particulate levels, together 
with the higher levels of several trace elements specific to motor vehicles found in 
indoor dusts suggested that harmful substances emitted from traffic were able to 
penetrate into houses and settled in the indoor environments. Having said that, there 
was no evidence showing human uptake of any of these harmful substances despite 
increased exposure. This was reflected by the null findings in the study that none of 
the biomarkers of exposure have shown any significant differences in concentrations 
from biological samples of subjects residing in different exposure areas. Having said 
that, because each individual is exposed to a number of different microenvironments, 
it was difficult to conclude if the exposure biomarkers found in the biological samples 
could truly reflect the levels of exposure from their local area. Due to the relatively 
small sample size compared to other large-scale ecological studies, this study was 
unable to demonstrate any major findings with high levels of statistical significance. 
Nevertheless this study has shown that microenvironments with different levels of 
respirable air particulates attributable to local traffic volume can be found within a 
city, which was independent to whether a difference in biological uptake existed. 
Therefore the research work carried out can be regarded as a pilot study which has 
managed to find some evidence of the existence of microenvironments, and further 
studies will be required to establish the possibility of increased uptake of biological 
markers of exposure to motor vehicles as a result of residing within proximity to 
motor traffic.
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Se c t io n  2 
Sy m p t o m s  C o m p a r iso n  S t u d y
5.2.1 Asthma symptoms questionnaire 
Changes in symptoms
Different changes in asthma symptoms were observed in the study which lacked 
consistency across symptoms. The most significant change was seen in wheezing 
which is one of the strongest indicators of one’s asthma condition. Improvement was 
also seen in shortness of breath despite discrepancies between “short of breath” and 
“very short of breath”, that is, improvement was only seen in “very short of breath” 
and not the other. This suggested that short-term increase in PMio levels appeared to 
have larger affects on the more severe asthma symptoms such as very short of breath 
and less on milder asthma symptoms such as difficulties in breathing. Indeed, when 
only cases of severe asthma were studied positive effect sizes were seen in all items, 
which coincides with the explanation that respirable particulate air pollution has more 
significant effects on patients suffering from severe asthma.
Changes in medication use
The frequency of asthma medication use reflects how asthma symptoms are affecting 
an individual. Positive effect size for medication use was seen when all cases of 
asthma subjects were studied, and the effect was further increased when only the 
extreme cases were included. This again suggested that increase in PMio levels has 
more significant negative effects on patients with more severe asthma, and resulted in 
the increased medication use for their exacerbated symptoms.
Changes in emotional well-being
A number of items in the questionnaire concerned about changes in emotional well­
being. Different degrees of changes in each item were observed but an overall 
improvement was seen in those focused on activities and symptoms-related emotions. 
In terms of activities, little changes were seen between high and normal pollution 
episodes in patients when they were carrying out moderate and social activities. 
However, when it comes to performing strenuous activities, less limitation was 
reported during normal levels of PMio as reflected by a large positive effect size. The 
effect seen was further increased when only the severe cases were included, which is
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consistent with previous findings that air particulate levels have larger effects on 
severe asthma. In terms of symptoms-related emotions, high pollution levels have 
caused distress or discomfort due chest tightness and coughs in patients and with a 
much higher magnitude in the more severe cases. Because these were emotional well­
being questions that were related to symptoms, therefore they further support the 
finding that high levels of particulate air pollution exacerbate asthma symptoms, and 
especially in the severe cases. Although it has been shown that both asthma symptoms 
and the need of asthma medications were improved during normal episodes of air 
pollution, the subjects appeared to be concerned about their asthma symptoms and 
had always felt bothered by heavy breathing regardless of the level of PMio. This 
suggested that they worried about having asthma all the time and that the concerns 
were independent to whether or not their symptoms were affected by air pollution.
5.2.2 Cardiac symptoms questionnaire 
Changes in symptoms
Some improvement in cardiac symptoms was seen in patients during normal episodes 
of air pollution as represented by the positive net changes seen in several questions 
that concerned symptoms. The effect was further amplified when only the severe 
cases were included, suggesting that individuals with more severe cardiac symptoms 
were more likely to be affected by high levels of PMio pollution. Furthermore, the 
effects of air pollution was particularly apparent in the more specific cardiac 
symptoms including chest pain, chest tightness, angina, and shortness of breath.
Changes in medication use
While cardiac symptoms have appeared to improve during normal episodes of air 
pollution, little changes were observed in the use of nitroglycerin for the relief of 
angina symptoms. Since nitoglycerins are prescribed by doctors and can either be 
taken regularly or only when required, it was therefore possible that majority of the 
patients were taking the drug regularly and as a result only little changes were seen 
between different pollution episodes. Another explanation was that those who were 
prescribed the drug were possibly suffering from more severe cardiac symptoms and 
required constant medical usage at all time.
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Changes in emotional well-being
Results from questions that focused on changes in emotional well-being were 
consistent with the symptoms questions. Nearly all items in the questionnaire have 
shown little changes between episodes of air pollution, however when only the severe 
cases were included the magnitude of change was markedly increased in nearly all 
items, which coincides with the previous suggestion that high levels of particulate air 
pollution have stronger effects on individuals suffering from more severe cardiac 
symptoms.
5.2.3 Respiratory symptoms questionnaire 
Changes in symptoms
Items of the general and specific respiratory symptoms have shown different levels of 
net changes in both directions. It was difficult to determine the overall effects of air 
pollution on respiratory symptoms with absolute certainty. However, the moderately 
large positive net changes observed in two of the specific respiratory symptoms items 
suggested that high levels of PMio had greater effects on more specific respiratory 
symptoms such as shortness of breath than general respiratory symptoms such as 
cough and production of phlegm. It was when only the severe cases were studied that 
improvement was seen in some of the general respiratory symptoms when pollution 
level was normal.
Changes in medication use
Positive net change in medication use as represented by the decreased use of oxygen 
mask to help breathing in normal air pollution episode was seen in the study. 
However the magnitude of the net change was decreased when only the severe cases 
were studied. This was due to the fact that only a very small number of patients were 
identified as severe cases and that all but one of them reported no changes in oxygen 
use between high and normal levels of PMio.
Changes in emotional well-being
Changes in emotional well-being were similar to those observed in symptoms because 
changes were seen in different directions and at different levels. In overall however, 
the patients’ abilities to perform activities seemed to have benefited from lower levels 
of PMio, and in contrast their enjoyment of life appeared to have been affected by
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normal levels of air pollution. Large negative net changes were observed in a number 
of items when only the severe cases were included in the analysis, thus showing the 
patients’ emotional well-being was worse during normal pollution episodes. However 
they must be treated with caution since the number of individuals included was very 
small and therefore any small changes in symptoms score will be magnified and 
appeared to be large.
5.2.4 Recommendation for future work 
Recruitment
The decision of using specialist hospital outpatient clinics for the recruitment of 
subjects in the study seemed to have served the purpose well. However, in retrospect 
the use of invitation letters was rather passive and inefficient. It appeared that some 
patients failed to reply to the invitation letters as reflected by the difference in the 
number of letters given out and the number of actual replies received. It was possible 
that the patients were either not interested in the study or that they did not read the 
invitation letters while waiting for their consultations. In the future, this problem can 
be solved by having research assistants stationed at the clinics and speak to the 
patients in person. The advantage is that the patients can definitely be informed of the 
study and it also compensates the inefficiency of the invitation letters. Moreover, the 
research assistants can also collect their contact information immediately and answer 
any questions they may have, thereby reducing the workload on follow-ups and the 
risk of the patients forgetting to include their contact details when returning the reply 
cards.
Episodes o f particulate air pollution
One of the issues most frequently raised by the participants of the Symptoms 
Comparison Study was that of whether it was possible to let them know in advance as 
to when the questionnaires will be sent out. Some participants reported difficulties in 
answering questions that concerned about their symptoms during the week of interest, 
despite the fact that the questionnaires were received before the end of the target 
week. Because it was impossible to predict changes in PMio levels, therefore a 
different approach will be required should this study be repeated in the future. One of 
the solutions is by the use of symptoms diaries to record their changes in symptoms 
between episodes of air pollution. Key questions from the symptoms questionnaires
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can be extracted and modified to form a disease specific symptoms diary. Each 
subjects can be asked to complete a daily diary which can then be matched to the 
changes in PMio levels retrospectively.
Questionnaire design
All the items were extracted from validated instruments which strengthened the 
validity and usefulness of the symptoms questionnaires used in the study. However, 
the items were extracted from different instruments and hence the standard analytical 
methods of these questionnaires as devised by their authors could not be used. While 
this represent little problems with the asthma symptoms questionnaire, difficulties 
were encountered when analysing results of the cardiac and respiratory 
questionnaires. Because the answers of these questionnaires were in ordinal format 
and were unsuitable for the calculation of means and medians, no statistical tests were 
able to inspect the differences observed. Therefore if these questionnaires are to be 
used again in the future, the format of the answers should be revised to allow the 
calculations of mean symptoms score as well as the use of statistical tests to examine 
the differences observed.
5.2.5 Conclusion
Results of the Symptoms Comparison Study showed that the levels of respirable 
particulate air pollution have displayed effects on symptoms, medication use, and 
emotional welling-being on individuals who were suffering from asthma, chronic 
cardiac disease, and chronic respiratory disease. While most results of the asthma 
symptoms questionnaire appeared to be statistically insignificant, this could be 
explained by the fact that all studies involved only a small number of patients and 
unless the sample size can be increased it would be difficult to achieve statistical 
significance. Majority of the patients reported no changes in symptoms score between 
high and normal episodes of air pollution, although the results suggested that 
individuals with more severe asthma and cardiac disease appeared to benefit more 
from normal levels of air pollution. The fact that respiratory patients were less 
benefited was because their quality of life, as reflected by disease symptoms, was 
generally poorer than those suffering from asthma and heart disease, and therefore 
slight changes in air pollution levels was unlikely to have any significant 
improvements on their symptoms. In summary this study can be considered as a pilot
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study that has successfully demonstrated some of acute health effects caused by short­
term changes in PMio levels.
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Appendix 1
Coleg Meddygaeth Prifsgol Cymru 
University of Wales College of Medicine
The Resident 
«House_number» «street» 
«area»
«town»
«postcode»
«ID»
Dear Resident
A Research Study o f the Levels o f Exposure to Air Pollution from Motor Vehicles
The University of Wales College of Medicine is investigating the ways that air 
pollution might affect breathing and heart problems. We are asking healthy men 
between the ages of 50 and 70, who do not smoke, if they would be willing to take 
part in this study. If you are male between these ages with no history of chest disease, 
heart disease, diabetes or arthritis we would be grateful if you would consider taking 
part. A researcher will then describe the study to you in more detail and answer any 
questions you may have.
Please answer the questions below and return this sheet in the FREEPOST envelope 
enclosed, you do NOT need to use a stamp.
I am happy to have a member of the research team 
contact me to discuss my taking part in the study
I am male and between the ages of 50 and 70
Are you a smoker
Do you suffer from chest or heart disease, diabetes or 
arthritis
My name is
My date of birth is
My telephone number is
YES NO □ □□ □□ □□ □
THANK YOU FOR YOUR HELP
Professor Ian Matthews
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INFORMATION SHEET
A Research Study o f the Levels o f Exposure to Air Pollution from
Motor Vehicles
We invite you to take part in a research study which is investigating the links between 
air pollution caused by motor vehicles and health. Before you decide we would like to 
explain why the research is being done and what it will involve. Please take time to 
read the following information carefully and ask us if you would like more 
information.
There is growing evidence to suggest that very small and invisible particles from motor 
vehicle exhausts may cause minor but long term inflammation of the lung. In turn this 
may, over a period of years, lead to breathing problems and possibly heart symptoms.
The purpose o f this research is to investigate whether the levels of certain pollutants 
from vehicle exhausts in their blood, urine, and hair are different in healthy people 
living in different areas of the city.
We would like healthy men between the ages of 50 and 70 who do not smoke, to take 
part in this study. We are writing to households close to roads and households distant 
from roads and aim to recruit a total of one hundred and fifty men.
If you decide to take part then a researcher from the University of Wales College of 
Medicine will answer any questions which you may have and you will be asked to sign 
a consent form and you will be given a copy of this to keep. If you decide to take part 
you are still free to withdraw at any time and without giving a reason.
If you do take part this will involve:
• answering a short questionnaire
• donating a venous blood sample on two occasions which are six months apart
• donating a urine sample on two occasions which are six months apart
• donating a few fibres of head hair on two occasions which are six months apart
We will arrange for a clinician to take the blood sample in the University Hospital of 
Wales, Heath Park, at a date and time convenient to you and reimburse you for your 
travel expenses. Any information which you provide is kept strictly confidential.
This research is needed to decide if the current legal standard for air quality is adequate 
to protect health and the results of the research may show that air pollution should be 
reduced below current levels.
The research is organised by the Housing and Neighbourhood and Health (HANAH) 
research team at the University of Wales College o f Medicine. HANAH is funded by 
the Medical Research Council, the National Asthma Campaign and the Welsh Office of 
Research and Development. We intend to publish the result of this study in 
approximately eighteen months time in a medical research journal and at that time we 
will also inform all participants of the results. If you would like any further 
information then please telephone Professor Ian Matthews on 029 20 742324.
September 2002
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A)Previous day’s activities (in the past 24hrs):
1. Details of your whereabouts.
2. Have you been travelling in motor vehicles, if so how long?
3. Have you been exposed to other peoples’ tobacco smoke, if so how long?
B) Travel history:
1. Have you been away from your residence overnight in the past month? If so 
when was it and for how long?
C) About your house:
1. How many sheltered sides does the house have?
2. How many windows are there in the house?
3. How many of these windows are regularly opened during the day?
4. How many of these windows are double-glazed?
5. How many external doors are there in the house?
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CONSENT FORM
A Research Study of the Levels of Exposure to Air Pollution 
from Motor Vehicles
Participant identification number of this research project.........................
I confirm that I have read and understood the information sheet dated 
September 2002 for the above study and have had the opportunity to ask 
questions.
I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason.
I agree to take part in the above study.
Name Date:................................................
Signature........................................
Researcher Date:................................................
Signature........................................
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Site name Cardiff Briardene
Site type R o a d sid e
L ocated  ad jacen t to the  
heavily  trafficked North 
R oad  with a daily traffic 
flow  of 4 9 ,0 0 0
Site type Urban background
B a se d  in playing fields  
a d ja cen t to sch o o l buildings 
w hich  is an  urban / sem i-  
rural environm ent
Site name C w m bran
Site name Port Talbot
Site type Urban background
L ocated  within the grounds  
o f a sm all hospital 75m  from  
th e  M4 m otorw ay and 700m  
from a large stee lw ork s
Site name S w a n s e a
Site type Urban centre
L ocated  in a pedestrian  
Note  a rea  3 0 -4 0 m  from a busy  
dual carriagew ay
(Source: www. welsh air quality, co. uk)
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«Title» «FirstName» «LastName» 
«JobTitle»
«Company»
«Addressl»
«Address2»
«Address3»
«City»
«PostalCode»
Dear «Title» «LastName»
Re: Research study into the effects of episodes of high ambient air pollution upon the 
quality of life of susceptible patients.
We have a number of research programmes underway in the department funded by the MRC 
which are investigating various aspects of the health effects of ambient air pollution.
There is good epidemiological evidence that when ambient air pollution increases markedly in 
a short time period the incidence of hospital admissions and mortality increases in the sub­
population with underlying respiratory disease. We wish to investigate how large an effect 
such pollution peaks have upon the quality of life of patients. We are, therefore, seeking to 
recruit individuals into a research study to investigate this. I have discussed the research with 
Professor Dennis Shale (UWCM) and I write to seek your co-operation.
I attach, for your information, the application which we have submitted for ethical approval 
and which describes the methodology to be used. We first request that clinic attendees read 
an information sheet describing what the study involves (i.e. completion of quality of 
life/symptoms questionnaires). Then if they think that they may wish to participate we ask 
them to supply contact details on a card which they leave in the clinic for subsequent 
collection by our researcher. Further contact with the patient and obtaining of informed 
consent etc. is all undertaken by the research group and clinic staff will have no demand 
placed upon them.
Please would you inform me if you are prepared for patients to be recruited from your clinic. 
If so, one of our researchers would arrange a visit to speak to your clinic manager and leave 
the information sheets and contact cards.
I will of course be happy to answer any queries you may have.
Yours sincerely
Professor Ian Matthews 
Enc.
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Dear Sir or Madam,
A research study of the effects of a ir pollution on heart, asthm a, and other lung 
symptoms
We are carrying out a study of the effects of air pollution on heart, asthma, and other 
lung symptoms. We are looking to recruit people who would be willing to complete a 
short questionnaire about their symptoms on six separate occasions throughout the 
year.
An information sheet giving full details of the study is attached with the letter.
Please complete the purple card with this letter and leave it at the clinic to let us know 
whether or not you are willing to take part in this study. If you think that you may be 
willing to take part a researcher will contact you in the future on the phone number 
you provide to answer any questions you may have.
Thank you very much.
Professor Ian Matthews
July 03, V1.01
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INFORMATION SHEET
A RESEARCH STUDY OF THE EFFECTS OF AIR POLLUTION ON HEART, 
ASTHMA, AND OTHER LUNG SYMPTOMS 
Who are we?
W e are a group of scientists b ased  at the  University of W ales College of Medicine in 
Cardiff and w e carry out research  into how the  environm ent affects our health.
Why are we studying air pollution and heart and lung symptoms?
Many studies carried out in Europe and  the  USA have show n tha t w hen background 
levels of air pollution increase  there  is an increase in adm issions to hospital for 
people with heart and breathing problem s. It is also likely tha t sym ptom s may be 
w orse at th e se  tim es for people who are  not adm itted to the  hospital.
We wish to find out if heart and iung symptoms are worse when air pollution is 
high. 
Why are we studying air pollution and asthma symptoms?
The UK G overnm ent’s  Com m ittee on the  Medical Effects of Air Pollutants (COMEAP) 
have reviewed th e  scientific research  evidence concerning the  effects upon 
asthm atics at a rise in environm ental air pollution. COMEAP concludes that there is a 
relationship betw een increased  air pollution and sym ptom s of asthm a.
How will we carry out the study?
W e will find out the  levels of air pollution everyday in the  next 12 m onths. W e will also 
need help of individuals with heart or lung symptom , who live in South W ales.
How can you help?
W e would like you to com plete a  short questionnaire (it takes  about fifteen minutes) 
about your sym ptom s. W e will sen d  the  questionnaire to you in the  post four tim es in 
the next 12 m onths and  it will a sk  you abou t your sym ptom s a t that tim e.
What about privacy and confidentiality?
Your privacy and  confidentiality will be respected  at all times. Your questionnaires will 
be identified by a  num ber and your personal details will not be disclosed. Your 
questionnaire re sp o n se s  will be held securely  and  confidentially a t the  Departm ent of 
Epidemiology, Statistics, and Public Health in full com pliance with the Data 
Protection Act.
What happens next?
P lease  fill out the  g reen  card  and  leave it with the  clinic clerk/receptionist. If you have 
indicated a possib le w illingness to take part in this research  then a researcher will 
contact you in th e  future on the  phone num ber you provide to answ er any questions 
you may have.
Further information
If you would like any further information p lease  contact Christopher Au-Yeung on 
02920-743637 or 07787-545414.
July 03, V1.01
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Reply Card
Please read the letter and the information sheet 
provided before filling in the form.
I am interested in knowing more about the study.
Yes* □  No □
*lf you have answ ered  yes p lease  also fill in the  
following:
Print name: Mr/Ms/Mrs/Others
Date of birth:_______________________
Phone number (Including area code):
Consultant’s name:___________________
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CONSENT FORM
A RESEARCH STUDY OF THE EFFECTS OF AIR POLLUTION 
ON HEART, ASTHMA, AND OTHER LUNG SYMPTOMS
Participant identification number of this research project.........................
I confirm that I have read and understood the information sheet dated 
July 2003 for the above study and have had the opportunity to ask 
questions.
I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason.
I agree to take part in the above study.
Name Date:................................................
Signature.........................................
Researcher Date:................................................
Signature.........................................
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Asthma Symptoms Questionnaire
July 2003 (V I.01)
Department o f Epidemiology, Statistics and Public Health 
University o f Wales College o f Medicine 
Heath Park 
CF14 4XN
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Asthma Symptoms Questionnaire
We are interested in the symptoms you have experienced in the week following the date mentioned in the enclosed letter. 
We refer to this in the questionnaire as the “week of interest”. This questionnaire is designed to help us learn much more 
about how your asthma is troubling you and how it affects your life.
Please complete all questions by circling the number that best describes how you have been during the week of interest as a 
result of your asthma, like this:
EXAMPLE:
How limited have you been over the week of interest in these activities as a result of your asthma?
Totally Extremely Very Moderate Some A Little Not at all 
Limited Limited Limited Limitation Limitation Limitation Limited
1. Strenuous activities (such as hurrying, exercising etc) 1 2
The numbers inside the boxes are just to make it easier to type in the information when all the booklets have been collected, 
they have no special meaning.
Appendix 
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Before you begin...
Please print name:____________________________
1. Over the week of interest, have you had a respiratory infection that affected your chest?
□ ,  Yes 
I I , No
2. Over the week of interest, did you stay overnight somewhere further than lOmiles from your home for more than 3 davs? 
□  , Yes
I I, No
If you have answered “Yes” for any of the questions above please DO NOT continue to complete the questionnaire and 
return it to us using the prepaid envelope provided.
If you have answered “No” for both questions above then please proceed to the next page and fill in the questionnaire 
accordingly.
Appendix 
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Section 1: Your symptoms
How limited have you been over the week of interest in these activities as a result of your asthma?
Totally Extremely Very Moderate Some A Little 
Limited Limited Limited Limitation Limitation Limitation
1. Strenuous activities (such as hurrying, exercising etc)
2. Moderate activities (such as walking, housework, 
gardening, shopping, climbing stairs, bathing and 
dressing)
3. Social activities (such as talking, playing with 
pets/children, visiting friends/relatives)
In general, how much of the time over the week of interest did you:
All of the Most of the A Good Bit Some of A Little of
Time Time of the Time the Time the Time
Hardly 
Any of the 
Time
4. Feel short of breath as a result of your asthma?
5. Feel VERY short of breath as a result of your asthma?
Not at all 
Limited
7
7
7
None of the 
Time
7
7
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6. Experience asthma symptoms as a result of being 
exposed to cigarette smoke?
7. Experience a wheeze in your chest?
8. Feel frustrated as a result of your asthma?
9. Experience a feeling of chest heaviness?
10. Need to use medication for your asthma?
11. Feel the need to clear your throat?
12. Experience asthma symptoms as a result of being 
exposed to dust?
13. Experience difficulty breathing out as a result of your 
asthma?
N>Os
Most of the A Good Bit Some of
Time of the Time the Time
A Little of  . Hardi^  None of theAny of the the Time i,. TimeTime
2 22 L 2 22 22 k
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14. Wake up in the morning with asthma symptoms? 1
15. Experience asthma symptoms as a result of the 
weather or air pollution outside?
16. Avoid or limit going outside because of the weather 
or air pollution?
17. Experience asthma symptoms as a result of being 
exposed to strong smells or perfume?
18. Did you get interfered with getting a good night’s 
sleep by your asthma?
Most of the A Good Bit Some of A Little of . ^ ar<j)y None of the
Time of the Time the Time the Time n^ .° * e TimeTime
How limited have you been over the week of interest:
Most 
Activities 
Not Done
19. Think of all the overall range of activities that you 
would have liked to have done over the week of interest. ^
How much has your range of activities been limited by 
your asthma?
Totally
Limited
20. Overall, among all the activities that you have done
over the week of interest, how limited have you been by 1
your asthma?
Several 
Activities 
Not Done
2 3 4
Extremely Very Moderate
Limited Limited Limitation
2 3 4
Very Few No
Activities Activity
Not Done Limitation
5 6 7
Some A Little Not at All 
Limitation Limitation Limited
5 6 7
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In general, how much discomfort or distress have you felt over the week of interest:
AVerv A Great A Good Moderate „ T. ,
Great Deal Deal Deal Amount Some VayLrtfle
21. As a result of chest tightness?
22. As a result of coughing?
Over the week of interest how many times did you:
Everyday
3 or more 
times, 
but not 
eveiyday
1-2 times Never over the week
23. Use inhalers to help breathing?
None
7
264
In general, how much of the time over the week of interest did you:
All of the 
Time
Most of the 
Time
A Good Bit 
of the Time
Some of
the Time
A Little of 
the Time
Hardly 
Any of the 
Time
None of the 
Time
24. Feel concerned about having asthma?
25. Feel bothered by heavy breathing?
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That’s it! Thank you.
Would you please check that you have answered all the questions.
We would be most grateful if you could return the questionnaire to us at your earliest convenience.
Please remember to use the self-addressed prepaid envelope when returning your questionnaire.
If you have any questions about the study or need any help, please ring:
Christopher Au-Yeung on S02920 743637 or 07787 545414.
Or write to:
Christopher Au-Yeung
Department of Epidemiology, Statistics & Public Health
University of Wales College of Medicine
Heath Park
Cardiff
CF14 4XN
Or email to:
AU-YEUNGHC@CF.AC.UK
Appendix 
8.1
Appendix 8.2
A p p e n d ix  8.2
266
Appendix 8.2
Cardiac Symptoms Questionnaire
6 S  9 a e t h  f y f .
MEM
^ l e  s Co
D epartm ent o f  Epidem iology, Statistics and Public Health 
U niversity o f  W ales College o f  M edicine 
H eath Park 
CF14 4XN
^ 3
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Cardiac Symptoms Questionnaire
We are interested in the symptoms you have experienced in the week 
following the date mentioned in the enclosed letter. We refer to this in the 
questionnaire as the “week of interest”. This questionnaire is designed to 
help us learn much more about how your heart symptoms are troubling 
you and how they affect your life.
Please complete all the questions by putting a tick in the box next to the 
answer that best describes how you have been doing over the week of 
interest as a result of your heart symptoms, like this:
EXAMPLE:
1. How limited have you been over the week of interest when doing strenuous 
activities (such as hurrying, exercising etc) as a result of your heart symptoms?
□  , Totally limited
2 Extremely limited
3 Very limited
□  4 Moderate limitation
□  5 Some limitation
□  6 Not at all limited
The numbers next to the boxes are just to make it easier to type in the 
information when all the booklets have been collected, they have no 
special meaning.
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Before you begin...
Please print name:_____
1. Over the week of interest, have you had a bug (an infection) that affected your 
chest?
0  , Yes
1 I , No
2. Over the week of interest, did you stay overnight somewhere further than 1 Omiles 
from your home for more than 3 days?
□1 Yes
2 No
If you have answered “Yes” for any of the questions above please DO 
NOT continue to complete the questionnaire and return it to us using the 
prepaid envelope provided.
If you have answered “No” for both questions above then please proceed 
to the next page and fill in the questionnaire accordingly.
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1. How limited have you been over the week of interest when doing strenuous 
activities (such as hurrying, exercising etc) as a result of your heart symptoms?
□  , Totally limited
□  2 Extremely limited
□  3 Very limited
□  4 Moderate limitation
□  5 Some limitation
□  6 Not at all limited
2. How limited have you been over the week of interest when doing Moderate 
activities (such as walking, housework, gardening, shopping, climbing stairs, bathing, 
dressing) as a result of your heart symptoms?□□□□□□
1 Totally limited
2 Extremely limited
3 Very limited
4 Moderate limitation
5 Some limitation
6 Not at all limited
3. Over the week of interest, on average, how many times have you had chest pain, 
chest tightness, angina, or shortness of breath?
I had chest pain, chest tightness, angina, or shortness of breath...
□  , All of the time□□□□□
Several times per day 
At least once a day 
3 or more times over the week 
1 -2 times over the week 
Never over the week
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4. Over the week of interest, on average, how many times has chest pain, chest 
tightness, angina, or shortness of breath limited your ability to do what you want?
□  , Everyday
3 or more times, but not everyday
□  3 1 -2 times
□  4 Never over the week
5. Over the week of interest, how often did you have chest pain, chest tightness, 
angina, or shortness of breath when doing your most strenuous level of activity?
I have had chest pain, chest tightness, angina, or shortness of breath...□□□□□□
All of the time 
Most of the time 
A good bit of the time
Some of the time Q
Hardly any of the time [/ 7/,  -...v
None of the time
6 . Over the week of interest, how much has your chest pain, chest tightness, angina, or 
shortness of breath limited your enjoyment of life?
□  ! It has limited my enjoyment of life extremely
□  2 It has limited my enjoyment of life quite a bit
□  3 It has limited my enjoyment of life moderately
□  4 It has limited my enjoyment of life slightly
□  5 It has not limited my enjoyment of life at all
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7. Over the week of interest, on average, how many times have you had to take nitros 
(nitroglycerin tablets) for your chest pain, chest tightness, or angina?□□□□□□
1 4 or more times per day
2 1-3 times per day
3 3 or more times over the week, but not everyday
4 1-2 times over the week
5 None over the week
6 I am not prescribed nitros
8 . Over the week of interest, how many times have you been forced to sleep sitting up 
in a chair or with pillows to prop you up because of shortness of breath?
□□□□
Every night
3 or more times, but not everyday 
1 -2 times
Never over the week
9. Over the week of interest, how many times did you have swelling in your feet, 
ankles or legs when you woke up in the morning?
□  , Every morning
□  » 3 or more times, but not everyday 
| | 3 1-2 times
□  4 Never over the week
10. Over the week of interest, how much has swelling in your feet, ankles or legs 
bothered you?
It has been...
1 1 j Extremely bothersome
□  2 Quite a bit bothersome
□  3 Moderately bothersome
□  4 Slightly bothersome
□  5 Not bothersome at all
□  6 I’ve had no swelling
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11. Over the week of interest, how often have you been bothered by aching or tired 
legs?
□□□
□□
All of the time 
Most of the time 
A good bit of the time 
Some of the time 
Hardly any of the time 
None of the time
12. Over the week of interest, how often have you felt dizzy or light-headed? 
□  , All of the time
□□□□□
Most of the time 
A good bit of the time 
Some of the time 
Hardly any of the time 
None of the time
13. Over the week of interest, on average, how many times has fatigue limited your 
ability to do what you want?
□□□□□□
All of the time 
Several times per day 
At least once a day 
3 or more times, but not everyday 
1 -2 times
Never over the week
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14. Over the week of interest, how much has fatigue bothered you?
□  i Extremely bothersome
□  2 Quite a bit bothersome
□  3 Moderately bothersome 
  4 Slightly bothersome
□  5 Not bothersome at all□6 I’ve had no fatigue
15. Over the week of interest, in general, how much of the time have you felt 
frustrated or impatient as a result of your heart symptoms?
□  ] All of the time
□  2 Most of the time
□  3 A good bit of the time
□  4 Some of the time
□  5 Hardly any of the time
□  6 None of the time ^
16. Over the week of interest, in general, did you feel discouraged or down in the 
dumps because of your heart symptoms?
□□
□
All of the time 
Most of the time 
A good bit of the time 
Some of the time 
Hardly any of the time 
None of the time
-----------------------------------------------------------------------------------------------------------------------------------------------------    Appendix 8.2
17. Over the week of interest, how often have you felt excluded from doing things 
with other people because of your heart symptoms?
□  i All of the time
□  2 Most of the time
A good bit of the time
□  4 Some of the time
□  5 Hardly any of the time
□  6 None of the time
That’s it! Thank you.
Would you please check that you have answered all the questions.
We would be most grateful if you could return the questionnaire to us at 
your earliest convenience.
Please remember to use the self-addressed prepaid envelope when 
returning your questionnaire.
If you have any questions about the study or need any help, please ring: 
Christopher Au-Yeung on S02920 743637 or 07787 545414.
Or write to:
Christopher Au-Yeung
Department of Epidemiology, Statistics & Public Health
University of Wales College of Medicine
Heath Park
Cardiff
CF14 4XN
Or email to:
AU-YEUNGHC@CF.AC.UK
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Appendix 8.3
Respiratory Symptoms Questionnaire
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Respiratory Symptoms Questionnaire
We are interested in the symptoms you have experienced in the week 
following the date mentioned in the enclosed letter. We refer to this in the 
questionnaire as the “week of interest”. This questionnaire is designed to 
help us learn much more about how your breathing is troubling you and 
how it affects your life.
Please complete all the questions by putting a tick in the box next to the 
answer that best describes how you have been doing over the week of 
interest as a result of your chest, like this:
EXAMPLE:
1. Over the week of interest, I have coughed...
□ . Everyday
□> 3 or more days but not everyday
0 . 1 -2  days
Only with chest infections
Not at all
The numbers next to the boxes are just to make it easier to type in the 
information when all the booklets have been collected, they have no 
special meaning.
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Before you begin...
Please p rin t n a m e :______
1. Over the week of interest, have you had a respiratory infection that affected your 
chest?
I— 11 Yes 
I I , No
2. Over the week of interest, did you stay overnight somewhere further than 1 Omiles 
from your home for more than 3 days?
□  , Yes 
I L No
If you have answered “Yes” for any of the questions above please DO 
NOT continue to complete the questionnaire and return it to us using the 
prepaid envelope provided.
If you have answered “No” for both questions above then please proceed 
to the next page and fill in the questionnaire accordingly.
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1. Over the week of interest, I have coughed...
□  i Everyday
□  > 3 or more days but not everyday 
I I 3 1-2 days
□  4 Only with chest infections
□  5 Not at all
2. Over the week of interest, I have brought up phlegm (sputum)...
| 1 ] Everyday
□  2 3 or more days but not everyday 
I I 3 1-2 days
□  4 Only with chest infections x
□  5 Not at all
3. Over the week of interest, I have had attacks of wheezing...
□  i Everyday
3 or more days but not everyday 
1 1 3 1 -2 days
□  4 Only with chest infections
□  5 Not at all
4. Over the week of interest, how many severe or very unpleasant attacks of chest 
trouble have you had?
□  , More than 3 attacks
3 attacks 
2 attacks 
I— I 4 1 attack
□  s No attacks
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5. Over the week of interest, how many severe or very unpleasant wheezing attacks 
have you had?
□  I More than 3 attacks
□  2 3 attacks
□  3 2 attacks
□  4 1 attack□5 No wheezing
6 . Over the week of interest, how long did the worst attack of chest trouble last?
I— I i 3 or more days 
I— I 2 1 -2 days 
I— I 3 Less than a day 
D  4 I’ve had no severe attacks
7. Over the week of interest, how many good days (with little chest trouble) have you 
had?
□  , Less than a day
n (I— I 2 1 -2 days
□  3 3 or more days but not everyday□4 Everyday
8 . How limited have you been over the week of interest when doing strenuous 
activities (such as hurrying, exercising etc) as a result of your chest?
| | , Totally limited
| | 2 Extremely limited
□  3 Very limited 
| | 4 Moderate limitation
| | 5 Some limitation
□  6 Not at all limited
\
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9. How limited have you been over the week of interest when doing moderate 
activities (such as walking, housework, gardening, shopping, climbing stairs, bathing, 
dressing etc) as a result of your chest?
□  i Totally limited
| | 2 Extremely limited
| | 3 Very limited
| | 4 Moderate limitation
| | 5 Some limitation
□  6 Not at all limited
10. Over the week of interest, on average, how many times have you had shortness of 
breath?
I had shortness of breath ...
□  x All of the time
□  2 Several times per day
□  3 At least once a day
□  4 3 or more times over the week
1 -2 times over the week
□  6 Never over the week
11. Over the week of interest, on average, how many times have you had chest 
tightness?
I had chest tightness...
□  , All of the time
□  2 Several times per day
□  3 At least once a day
3 or more times over the week 
  5 1 -2 times over the week
□  6 Never over the week
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12. Over the week of interest, on average, how many times has chest tightness or 
shortness of breath limited your ability to do what you want?
□  , Everyday
3 or more times, but not everyday 
1-2 times
□  4 Never over the week
13. Over the week of interest, how often did you have chest tightness or shortness of 
breath when doing your most strenuous level of activity?
I have had chest tightness or shortness of breath...□□□□□□
All of the time 
Most of the time 
A good bit of the time 
Some of the time 
Hardly any of the time 
None of the time
14. Over the week of interest, how much has your chest tightness or shortness of 
breath limited your enjoyment of life?
□  , It has limited my enjoyment of life extremely
□  2 It has limited my enjoyment of life quite a bit
□  3 It has limited my enjoyment of life moderately
□  4 It has limited my enjoyment of life slightly
□  5 It has not limited my enjoyment of life at all
15. Over the week of interest, how many times have you been forced to sleep sitting 
up in a chair or with pillows to prop you up because of shortness of breath?
□  i Every night
3 or more times, but not every night 
1-2 times
□  4 Never over the week
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16. Over the week of interest, how often have you felt dizzy or light-headed?
| | i All of the time
Most of the time 
A good bit of the time
| | 4 Some of the time 
| | 5 Hardly any of the time
□  6 None of the time
17. Over the week of interest, on average, how many times has fatigue limited your 
ability to do what you want?
□  , All of the time
2 Several times per day
3 At least once a day
3 or more times, but not everyday 
1 -2 times
□  6 Never over the week
18. Over the week of interest, how much has fatigue bothered you?
| | , Extremely bothersome
| | 2 Quite a bit bothersome
| | 3 Moderately bothersome
| | 4 Slightly bothersome
□  5 Not bothersome at all
□  6 I’ve had no fatigue
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19. Over the week of interest, in general, how much of the time have you felt 
frustrated or impatient as a result of your chest?
All of the time
□  2 Most of the time
□  3 A good bit of the time
□  4 Some of the time 
| | 5 Hardly any of the time
□  6 None of the time
20. Over the week of interest, in general, did you feel discouraged or down in the 
dumps as a consequence of your chest?
| | , All of the time
| | 2 Most of the time
| | 3 A good bit of the time
□  4 Some of the time 
| | 5 Hardly any of the time
I— I o| I 6 None of the time
21. Over the week of interest, how often have you felt excluded from doing things 
with other people because of your chest?
| | , All of the time
| | 2 Most of the time (a
□  3 A good bit of the time 
| | 4 Some of the time
| | 5 Hardly any of the time
□  6 None of the time
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22. Over the week of interest, how many times did you use oxygen mask to help 
breathing?
□  i Everyday
3 or more times, but not everyday
□  3 1-2 times
□  4 Never over the week
I do not use oxygen
That’s it! Thank you.
Would you please check that you have answered all the questions.
We would be most grateful if you could return, the questionnaire to us at 
your earliest convenience.
Please remember to use the self-addressed prepaid envelope when 
returning your questionnaire.
If you have any questions about the study or need any help, please ring: 
Christopher Au-Yeung on S02920 743637 or 07787 545414.
Or write to:
Christopher Au-Yeung
Department of Epidemiology, Statistics & Public Health
University of Wales College of Medicine
Heath Park
Cardiff
CF14 4XN
Or email to:
AU-YEUNGHC@CF.AC.UK
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Figure la: Breakdown of cardiac symptoms score of question 1 and count of participant 
number, high v normal levels of PMi0.
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Figure lb: Changes in cardiac symptoms score between occasions o f high and normal
PMio pollution, question 1.
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Figure 2a: Breakdown of cardiac symptoms score of question 2 and count of participant 
number, high v normal levels of PMi0.
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Figure 2b: Changes in cardiac symptoms score between occasions of high and normal
PMio pollution, question 2.
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Figure 3a: Breakdown of cardiac symptoms score of question 3 and count of participant 
number, high v normal levels of PMi0.
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Figure 3b: Changes in cardiac symptoms score between occasions o f high and normal
PMjo pollution, question 3.
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Figure 4a: Breakdown of cardiac symptoms score of question 4 and count of participant 
number, high v normal levels of PMi0.
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Figure 4b: Changes in cardiac symptoms score between occasions o f high and normal
PMio pollution, question 4.
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Figure 5a: Breakdown of cardiac symptoms score of question 5 and count of participant 
number, high v normal levels of PM10.
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Figure 5b: Changes in cardiac symptoms score between occasions of high and normal
PMio pollution, question 5.
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Figure 6a: Breakdown of cardiac symptoms score of question 6 and count of participant 
number, high v normal levels of PMi0.
Bc(0a
o
'€cva
Q)A
E
3
4 0 -
3 5 -
3 0 -
2 5 -
2 0 -
1 5 -
1 0 -
C h a n g e s  in s y m p to m s  s c o r e
Figure 6b: Changes in cardiac symptoms score between occasions of high and normal
PM jo pollution, question 6.
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Figure 7a: Breakdown of cardiac symptoms score of question 7 and count of participant 
number, high v normal levels of PM jo.
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Figure 7b: Changes in cardiac symptoms score between occasions of high and normal
PMio pollution, question 7.
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Figure 8a: Breakdown of cardiac symptoms score of question 8 and count of participant 
number, high v normal levels of PMi0.
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Figure 8b: Changes in cardiac symptoms score between occasions of high and normal
PM jo pollution, question 8.
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Figure 9a: Breakdown of cardiac symptoms score of question 9 and count of participant 
number, high v normal levels of PMio.
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Figure 9b: Changes in cardiac symptoms score between occasions of high and normal
PMio pollution, question 9.
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Figure 10a: Breakdown of cardiac symptoms score of question 10 and count of 
participant number, high v normal levels of PM)0.
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Figure 10b: Changes in cardiac symptoms score between occasions o f high and normal
PMio pollution, question 10.
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Figure 11a: Breakdown of cardiac symptoms score of question 11 and count of 
participant number, high v normal levels of PMi0.
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Figure l ib :  Changes in cardiac symptoms score between occasions of high and normal
PM 10 pollution, question 11.
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Figure 12a: Breakdown of cardiac symptoms score of question 12 and count of 
participant number, high v normal levels of PMio.
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Figure 12b: Changes in cardiac symptoms score between occasions o f high and normal
PMio pollution, question 12.
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Figure 13a: Breakdown of cardiac symptoms score of question 13 and count of 
participant number, high v normal levels of PM)0.
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Figure 13b: Changes in cardiac symptoms score between occasions of high and normal
PMio pollution, question 13.
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Figure 14a: Breakdown of cardiac symptoms score of question 14 and count of 
participant number, high v normal levels of PMi0.
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Figure 14b: Changes in cardiac symptoms score between occasions of high and normal
PM 10 pollution, question 14.
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Figure 15a: Breakdown of cardiac symptoms score of question 15 and count of 
participant number, high v normal levels of PMj0.
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Figure 15b: Changes in cardiac symptoms score between occasions of high and normal
PMio pollution, question 15.
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Figure 16a: Breakdown of cardiac symptoms score of question 16 and count of 
participant number, high v normal levels of PM10.
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Figure 16b: Changes in cardiac symptoms score between occasions of high and normal
PM10 pollution, question 16.
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Figure 17a: Breakdown of cardiac symptoms score of question 17 and count of 
participant number, high v normal levels of PMi0.
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Figure 17b: Changes in cardiac symptoms score between occasions o f high and normal
PMio pollution, question 17.
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Figure la: Breakdown of cardiac symptoms score of question 1 and count of participant 
number amongst the more severe cases, high v normal levels of PMi0.
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Figure lb: Changes in cardiac symptoms score between occasions o f high and normal
PM 10 pollution amongst the more severe cases, question 1.
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Figure 2a: Breakdown of cardiac symptoms score of question 2 and count of participant 
number amongst the more severe cases, high v normal levels of PM10.
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Figure 2b: Changes in cardiac symptoms score between occasions o f high and normal
PMio pollution amongst the more severe cases, question 2.
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Figure 3a: Breakdown of cardiac symptoms score of question 3 and count of participant 
number amongst the more severe cases, high v normal levels of PMi0.
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Figure 3b: Changes in cardiac symptoms score between occasions o f high and normal
PMio pollution am ongst the more severe cases, question 3.
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Figure 4a: Breakdown of cardiac symptoms score of question 4 and count of participant 
number amongst the more severe cases, high v normal levels of PM)0.
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Figure 4b: Changes in cardiac symptoms score between occasions of high and normal
PMio pollution amongst the more severe cases, question 4.
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Figure 5a: Breakdown of cardiac symptoms score of question 5 and count of participant 
number amongst the more severe cases, high v normal levels of PM,0.
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Figure 5b: Changes in cardiac symptoms score between occasions o f high and normal
PM 10 pollution amongst the more severe cases, question 5.
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Figure 6a: Breakdown of cardiac symptoms score of question 6 and count of participant 
number amongst the more severe cases, high v normal levels of PM|0.
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Figure 6b: Changes in cardiac symptoms score between occasions o f high and normal
PM 10 pollution amongst the more severe cases, question 6.
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Figure 7a: Breakdown of cardiac symptoms score of question 7 and count of participant 
number amongst the more severe cases, high v normal levels of PM10 (n=14).
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Figure 7b: Changes in cardiac symptoms score between occasions o f high and normal
PMio pollution amongst the more severe cases, question 7 (n=14).
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Figure 8a: Breakdown of cardiac symptoms score of question 8 and count of participant 
number amongst the more severe cases, high v normal levels of PMi0.
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Figure 8b: Changes in cardiac symptoms score between occasions o f high and normal
PMio pollution amongst the more severe cases, question 8.
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Figure 9a: Breakdown of cardiac symptoms score of question 9 and count of participant 
number amongst the more severe cases, high v normal levels of PMi0.
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Figure 9b: Changes in cardiac symptoms score between occasions o f high and normal
PMio pollution amongst the more severe cases, question 9.
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Figure 10a: Breakdown of cardiac symptoms score of question 10 and count of 
participant number amongst the more severe cases, high v normal levels of PMjq.
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Figure 10b: Changes in cardiac symptoms score between occasions of high and normal
PMio pollution amongst the more severe cases, question 10.
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Figure 11a: Breakdown of cardiac symptoms score of question 11 and count of 
participant number amongst the more severe cases, high v normal levels of PMio.
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Figure l ib :  Changes in cardiac symptoms score between occasions of high and normal
PMio pollution amongst the more severe cases, question 11.
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Figure 12a: Breakdown of cardiac symptoms score of question 12 and count of 
participant number amongst the more severe cases, high v normal levels of PMio.
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Figure 12b: Changes in cardiac symptoms score between occasions of high and normal
PM]0 pollution amongst the more severe cases, question 12.
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Figure 13a: Breakdown of cardiac symptoms score of question 13 and count of 
participant number amongst the more severe cases, high v normal levels of PMj0.
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Figure 13b: Changes in cardiac symptoms score between occasions of high and normal
PM]0 pollution amongst the more severe cases, question 13.
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Figure 14a: Breakdown of cardiac symptoms score of question 14 and count of 
participant number amongst the more severe cases, high v normal levels of PM10.
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Figure 14b: Changes in cardiac symptoms score between occasions of high and normal
PMio pollution amongst the more severe cases, question 14.
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Figure 15a: Breakdown of cardiac symptoms score of question 15 and count of 
participant number amongst the more severe cases, high v normal levels of PMi0.
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Figure 15b: Changes in cardiac symptoms score between occasions of high and normal
PMio pollution amongst the more severe cases, question 15.
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Figure 16a: Breakdown of cardiac symptoms score of question 16 and count of 
participant number amongst the more severe cases, high v normal levels of PMi0.
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Figure 16b: Changes in cardiac symptoms score between occasions of high and normal
PMio pollution amongst the more severe cases, question 16.
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Figure 17a: Breakdown of cardiac symptoms score of question 17 and count of 
participant number amongst the more severe cases, high v normal levels of PMi0.
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Figure 17b: Changes in cardiac symptoms score between occasions of high and normal
PMio pollution amongst the more severe cases, question 17.
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Figure la: Breakdown of respiratory symptoms score of question 1 and count of 
participant number, high v normal levels of PM10.
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Figure lb: Changes in respiratory symptoms score between occasions of high and
normal PM J0 pollution, question 1.
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Figure 2a: Breakdown of respiratory symptoms score of question 2 and count of 
participant number, high v normal levels of PMi0.
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Figure 2b: Changes in respiratory symptoms score between occasions of high and
normal PMj0 pollution, question 2.
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Figure 3a: Breakdown of respiratory symptoms score of question 3 and count of 
participant number, high v normal levels of PMi0.
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Figure 3b: Changes in respiratory symptoms score between occasions of high and
normal PM i0 pollution, question 3.
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Figure 4a: Breakdown of respiratory symptoms score of question 4 and count of 
participant number, high v normal levels of PM f0.
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Figure 4b: Changes in respiratory symptoms score between occasions of high and
normal PM 10 pollution, question 4.
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Figure 5a: Breakdown of respiratory symptoms score of question 5 and count of 
participant number, high v normal levels of PM |0.
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Figure 5b: Changes in respiratory symptoms score between occasions of high and
normal PMi0 pollution, question 5.
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Figure 6a: Breakdown of respiratory symptoms score of question 6 and count of 
participant number, high v normal levels of PMi0.
2 0 -
15 H
i2c<0
.S 10^o
OJ
I -  5 -o
I 0
- 3 - 2 -1
C h a n g e s  in s y m p to m s  s c o r e
Figure 6b: Changes in respiratory symptoms score between occasions o f high and
normal PMio pollution, question 6.
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Figure 7a: Breakdown of respiratory symptoms score of question 7 and count of 
participant number, high v normal levels of PM )0.
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Figure 7b: Changes in respiratory symptoms score between occasions of high and
normal PM ,0 pollution, question 7.
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Figure 8a: Breakdown of respiratory symptoms score of question 8 and count of 
participant number, high v normal levels of PMi0.
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Figure 8b: Changes in respiratory symptoms score between occasions o f high and
normal PM )0 pollution, question 8.
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Figure 9a: Breakdown of respiratory symptoms score of question 9 and count of 
participant number, high v normal levels of PMJ0.
2 0 -
BcCZQ
O
'€
COa
o>-Q
E3
1 5 “
1 0 -
D
- 3 - 2 -1 0 1 2  3 4  5
C h a n g e s  in s y m p t o m s  s c o r e
Figure 9b: Changes in respiratory symptoms score between occasions of high and
normal PM ,0 pollution, question 9.
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Figure 10a: Breakdown of respiratory symptoms score of question 10 and count of 
participant number, high v normal levels of PM)0.
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Figure 10b: Changes in respiratory symptoms score between occasions of high and
normal PM i0 pollution, question 10.
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Figure 11a: Breakdown of respiratory symptoms score of question 11 and count of 
participant number, high v normal levels of PMio.
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Figure l ib :  Changes in respiratory symptoms score between occasions o f high and
normal PM i0 pollution, question 11.
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Figure 12a: Breakdown of respiratory symptoms score of question 12 and count of 
participant number, high v normal levels of PM)0.
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Figure 12b: Changes in respiratory symptoms score between occasions of high and
normal PMj0 pollution, question 12.
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Figure 13a: Breakdown of respiratory symptoms score of question 13 and count of 
participant number, high v normal levels of PMi0.
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Figure 13b: Changes in respiratory symptoms score between occasions of high and
normal PM jo pollution, question 13.
336
Appendix 10.1
30
PM10 level
■  High 
|  Normal
1 2 3 4 5
Symptoms score
Figure 14a: Breakdown of respiratory symptoms score of question 14 and count of 
participant number, high v normal levels of PMj0.
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Figure 14b: Changes in respiratory symptoms score between occasions of high and
normal PM )0 pollution, question 14.
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Figure 15a: Breakdown of respiratory symptoms score of question 15 and count of 
participant number, high v normal levels of PM]0.
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Figure 15b: Changes in respiratory symptoms score between occasions of high and
normal PM ,0 pollution, question 15.
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Figure 16a: Breakdown of respiratory symptoms score of question 16 and count of 
participant number, high v normal levels of PMi0.
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Figure 16b: Changes in respiratory symptoms score between occasions o f high and
normal PM 10 pollution, question 16.
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Figure 17a: Breakdown of respiratory symptoms score of question 17 and count of 
participant number, high v normal levels of PM )0.
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Figure 17b: Changes in respiratory symptoms score between occasions of high and
normal PMio pollution, question 17.
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Figure 18a: Breakdown of respiratory symptoms score of question 18 and count of 
participant number, high v normal levels of PMi0.
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Figure 18b: Changes in respiratory symptoms score between occasions of high and
normal PM i0 pollution, question 18.
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Figure 19a: Breakdown of respiratory symptoms score of question 19 and count of 
participant number, high v normal levels of PMi0.
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Figure 19b: Changes in respiratory symptoms score between occasions of high and
normal PMj0 pollution, question 19.
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Figure 20a: Breakdown of respiratory symptoms score of question 20 and count of 
participant number, high v normal levels of PM10.
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Figure 20b: Changes in respiratory symptoms score between occasions o f high and
normal PM !0 pollution, question 20.
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Figure 21a: Breakdown of respiratory symptoms score of question 21 and count of 
participant number, high v normal levels of PMj0.
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Figure 21b: Changes in respiratory symptoms score between occasions o f high and
normal PM )0 pollution, question 21.
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Figure 22a: Breakdown of respiratory symptoms score of question 22 and count of 
participant number, high v normal levels of PMi0 (n=31)
- 3 - 2 - 1 0 1 2 3
C h a n g e s  in s y m p to m s  s c o r e
Figure 22b: Changes in respiratory symptoms score between occasions of high and
normal PM ,0 pollution, question 22 (n=31).
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Figure la: Breakdown of respiratory symptoms score of question 1 and count of 
participant number amongst the more severe cases, high v normal levels of PM jo.
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Figure lb: Changes in respiratory symptoms score between occasions of high
and normal PM)0 pollution amongst the more severe cases, question 1.
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Figure 2a: Breakdown of respiratory symptoms score of question 2 and count of 
participant number amongst the more severe cases, high v normal levels of PM jq.
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Figure 2b: Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 2.
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Figure 3a: Breakdown of respiratory symptoms score of question 3 and count of 
participant num ber amongst the more severe cases, high v normal levels of PM iq.
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Figure 3b: Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 3.
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Figure 4a: Breakdown of respiratory symptoms score of question 4 and count of 
participant num ber amongst the more severe cases, high v normal levels of PMio.
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Figure 4b: Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 4.
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Figure 5a: Breakdown of respiratory symptoms score of question 5 and count of 
participant num ber amongst the more severe cases, high v normal levels of PMio.
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Figure 5b: Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 5.
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Figure 6a: Breakdown of respiratory symptoms score of question 6 and count of 
participant num ber amongst the more severe cases, high v normal levels of PMio.
□
C h a n g e s  in s y m p to m s  s c o r e
Figure 6b: Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 6.
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Figure 7a: Breakdown of respiratory symptoms score of question 7 and count of 
participant num ber amongst the more severe cases, high v normal levels of PMio.
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Figure 7b: Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 7.
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Figure 8a: Breakdown of respiratory symptoms score of question 8 and count of 
participant num ber amongst the more severe cases, high v normal levels of PMi0.
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Figure 8b: Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 8.
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Figure 9a: Breakdown of respiratory symptoms score of question 9 and count of 
participant num ber amongst the more severe cases, high v normal levels of PMio.
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Figure 9b: Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 9.
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Figure 10a: Breakdown of respiratory symptoms score of question 10 and count 
of participant num ber amongst the more severe cases, high v normal levels of 
PMio.
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Figure 10b: Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 10.
356
Appendix 10.2
Pollution level
N o r m a l
1 2 3 4 6
Symptoms score
Figure 11a: Breakdown of respiratory symptoms score of question 11 and count 
of participant num ber amongst the more severe cases, high v normal levels of 
PMI0.
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Figure lib :  Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 11.
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Figure 12a: Breakdown of respiratory symptoms score of question 12 and count 
of participant number amongst the more severe cases, high v normal levels of 
PMi0.
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Figure 12b: Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 12.
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Figure 13a: Breakdown of respiratory symptoms score of question 13 and count 
of participant number amongst the more severe cases, high v normal levels of 
PMi0.
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Figure 13b: Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 13.
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Figure 14a: Breakdown of respiratory symptoms score of question 14 and count 
of participant number amongst the more severe cases, high v normal levels of 
PM10.
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Figure 14b: Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 14.
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Figure 15a: Breakdown of respiratory symptoms score of question 15 and count 
of participant number amongst the more severe cases, high v normal levels of 
PMi0.
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Figure 15b: Changes in respiratory symptoms score between occasions of high
and normal PMio pollution amongst the more severe cases, question 15.
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Figure 16a: Breakdown of respiratory symptoms score of question 16 and count of 
participant number amongst the more severe cases, high v normal levels of PM10.
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Figure 16b: Changes in respiratory symptoms score between occasions of high and
normal PM ,0 pollution amongst the more severe cases, question 16.
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Figure 17a: Breakdown of respiratory symptoms score of question 17 and count of 
participant number amongst the more severe cases, high v normal levels of PMi0.
PP
- 5 - 4 - 3 - 2 -1
C h a n g e s  in s y m p to m s  s c o r e
Figure 17b: Changes in respiratory symptoms score between occasions of high and
normal PM 10 pollution amongst the more severe cases, question 17.
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Figure 18a: Breakdown of respiratory symptoms score of question 18 and count of 
participant number amongst the more severe cases, high v normal levels of PMi0.
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Figure 18b: Changes in respiratory symptoms score between occasions of high and
normal PMio pollution amongst the more severe cases, question 18.
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Figure 19a: Breakdown of respiratory symptoms score of question 19 and count of 
participant number amongst the more severe cases, high v normal levels of PMi0.
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Figure 19b: Changes in respiratory symptoms score between occasions of high and
normal PM 10 pollution amongst the more severe cases, question 19.
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Figure 20a: Breakdown of respiratory symptoms score of question 20 and count of 
participant number amongst the more severe cases, high v normal levels of PM]0.
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Figure 20b: Changes in respiratory symptoms score between occasions of high and
normal PM 10 pollution amongst the more severe cases, question 20.
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Figure 21a: Breakdown of respiratory symptoms score of question 21 and count of 
participant number amongst the more severe cases, high v normal levels of PMi0.
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Figure 21b: Changes in respiratory symptoms score between occasions of high and
normal PM ,0 pollution amongst the more severe cases, question 21.
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Figure 22a: Breakdown of respiratory symptoms score of question 22 and count of 
participant number amongst the more severe cases, high v normal levels of PM|0(n=8).
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Figure 22b: Changes in respiratory symptoms score between occasions of high and
normal PMio pollution amongst the more severe cases, question 22 (n=8).
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